# ::id 1_nonfiction_GENIA-1999;99101510,1;NE
# ::snt Regulation of IL-6 synthesis in human peripheral blood mononuclear cells by C3a and C3a_desArg .
∃ ATTRIB[4] EVENT[6] GROUP[3] GROUP[5] ENTITY[2] ENTITY[1] (
 human(ATTRIB[4]) ∧
  is_peripheral_blood_mononuclear_cells_ATTRIBUTE(GROUP[3], ATTRIB[4]) ∧
   is_IL-6_synthesis_in(ENTITY[2], GROUP[3]) ∧
    is_element_of(ENTITY[C3a], GROUP[5]) ∧ is_element_of(ENTITY[C3a_desArg], GROUP[5]) ∧
     is_Regulation_by(ENTITY[1], GROUP[5]) ∧ is_Regulation_of(ENTITY[1], ENTITY[2]) ∧
      xxx(EVENT[6]) ∧ LINK(EVENT[6]) = ENTITY[1])

# ::id 2_nonfiction_GENIA-1999;99101510,2;NE
# ::snt The anaphylatoxin C3a has been reported to have immunomodulatory effects on a number of different cell types .
∃ ATTRIB[7] ATTRIB[4] EVENT[8] EVENT[2] ENTITY[1] GROUP[6] ENTITY[5] GROUP[3] (
 anaphylatoxin(ENTITY[1]) ∧
  is_-ENTITY-_namely(ENTITY[C3a], ENTITY[1]) ∧
   immunomodulatory(ATTRIB[4]) ∧
    different(ATTRIB[7]) ∧
     is_cell_types_ATTRIBUTE(GROUP[6], ATTRIB[7]) ∧
      is_number_of(ENTITY[5], GROUP[6]) ∧
       is_effects_on(GROUP[3], ENTITY[5]) ∧ is_effects_ATTRIBUTE(GROUP[3], ATTRIB[4]) ∧
        has_reported(EVENT[2], _, ENTITY[C3a], have(EVENT[8], ENTITY[C3a], GROUP[3])))

# ::id 3_nonfiction_GENIA-1999;99101510,3;NE
# ::snt In this study we investigated the effects of C3a and C3a_desArg on gene expression and protein secretion of IL-6 in human PBMCs , either alone or in combination with LPS or IL-1beta .
∃ ATTRIB[12] ATTRIB[11] REF1[2] ATTRIB[10] EVENT[16] EVENT[15] EVENT[15] GROUP[14] ENTITY[13] ENTITY[7] ENTITY[8] GROUP[6] GROUP[9] ENTITY[5] GROUP[4] GROUP[3] ENTITY[1] (
 study(ENTITY[1]) ∧
  is_element_of(ENTITY[C3a], GROUP[4]) ∧ is_element_of(ENTITY[C3a_desArg], GROUP[4]) ∧
   gene_expression(ENTITY[7]) ∧
    protein_secretion(ENTITY[8]) ∧
     is_element_of(ENTITY[7], GROUP[6]) ∧ is_element_of(ENTITY[8], GROUP[6]) ∧
      is_of(ENTITY[5], ENTITY[IL-6]) ∧ is_equals(ENTITY[5], GROUP[6]) ∧
       human(ATTRIB[10]) ∧
        is_PBMCs_ATTRIBUTE(GROUP[9], ATTRIB[10]) ∧
         is_effects_in(GROUP[3], GROUP[9]) ∧ is_effects_on(GROUP[3], ENTITY[5]) ∧ is_effects_of(GROUP[3], GROUP[4]) ∧
          REF1[2] = we ∧
           alone(ATTRIB[11]) ∧
            CONJ_or(is_element_of(ENTITY[LPS], GROUP[14]), is_element_of(ENTITY[IL-1beta], GROUP[14])) ∧
             is_combination_with(ENTITY[13], GROUP[14]) ∧
              is_in(ATTRIB[12], ENTITY[13]) ∧
               past(EVENT[16]) ∧
                CONJ_and(investigated(EVENT[16], REF1[2], GROUP[3]) ∧ In(EVENT[16]) = ENTITY[1],
                 CONJ_either_or(xxx(EVENT[15], GROUP[3], ATTRIB[11]), xxx(EVENT[15], GROUP[3], ATTRIB[12]))))

# ::id 4_nonfiction_GENIA-1999;99101510,4;NE
# ::snt C3a or C3a_desArg alone exhibited no effect on the expression or secretion of IL-6 .
∃ SITUATION[8] GROUP[1] ENTITY[5] ENTITY[6] GROUP[4] ENTITY[3] (
 expression(ENTITY[5]) ∧
  secretion(ENTITY[6]) ∧
   CONJ_or(is_element_of(ENTITY[5], GROUP[4]), is_element_of(ENTITY[6], GROUP[4])) ∧
    is_of(ENTITY[3], ENTITY[IL-6]) ∧ is_equals(ENTITY[3], GROUP[4]) ∧
     CONJ_or(is_element_of(ENTITY[C3a], GROUP[1]), is_element_of(ENTITY[C3a_desArg], GROUP[1])) ∧
      alone(SITUATION[8]) ∧
       is_FACT_THAT(SITUATION[8],
        ¬ ∃ EVENT[7] ENTITY[2] (
              is_effect_on(ENTITY[2], ENTITY[3]) ∧ past(EVENT[7]) ∧ exhibited(EVENT[7], GROUP[1], ENTITY[2]))))

# ::id 5_nonfiction_GENIA-1999;99101510,5;NE
# ::snt However , when PBMC were stimulated with LPS or IL-1beta , both C3a and C3a_desArg were found to enhance IL-6 release by PBMC in a dose-dependent manner .
∃ SITUATION[10] (
 ADV_however(SITUATION[10]) ∧
  is_FACT_THAT(SITUATION[10],
   ∀ EVENT[2] GROUP[1] CND_when(
       CONJ_or(is_element_of(ENTITY[LPS], GROUP[1]), is_element_of(ENTITY[IL-1beta], GROUP[1])) ∧ past(EVENT[2]) ∧
        stimulated(EVENT[2], _, ENTITY[PBMC]) ∧ with(EVENT[2]) = GROUP[1],
       BOTH GROUP[4] group[3] ((is_element_of(ENTITY[C3a], GROUP[4]) ∧ is_element_of(ENTITY[C3a_desArg], GROUP[4]) ∧ is_equals(group[3], GROUP[4])),
        ∃ ATTRIB[8] EVENT[9] EVENT[5] ENTITY[7] ENTITY[6] (
         is_IL-6_release_by(ENTITY[6], ENTITY[PBMC]) ∧
          dose-dependent(ATTRIB[8]) ∧
           is_manner_ATTRIBUTE(ENTITY[7], ATTRIB[8]) ∧
            past(EVENT[5]) ∧
             found(EVENT[5], _, group[3],
              enhance(EVENT[9], group[3], ENTITY[6]) ∧ in(EVENT[9]) = ENTITY[7]))))))

# ::id 6_nonfiction_GENIA-1999;99101510,6;NE
# ::snt Since C3a has been shown to induce PGE2 production by monocytes , and PGE2 has been shown to influence cytokine production , we investigated the potential role of PGE2 in C3a-mediated enhancement of LPS- and IL-1beta- induced IL-6 production .
∃ SITUATION[2] REF1[1] SITUATION[14] ATTRIB[13] ATTRIB[11] EVENT[6] EVENT[4] EVENT[9] EVENT[7] EVENT[18] ENTITY[5] GROUP[3] ENTITY[8] EVENT[17] ENTITY[16] GROUP[15] ENTITY[12] ENTITY[10] (
 potential(ATTRIB[11]) ∧
  c3a-mediated(ATTRIB[13]) ∧
   is_element_of(ENTITY[LPS-], GROUP[15]) ∧ is_element_of(ENTITY[IL-1beta-], GROUP[15]) ∧
    IL-6_production(ENTITY[16]) ∧
     is_ABS-FACT_THAT(SITUATION[14], induced(EVENT[17], GROUP[15], ENTITY[16])) ∧
      is_enhancement_of(ENTITY[12], SITUATION[14]) ∧ is_enhancement_ATTRIBUTE(ENTITY[12], ATTRIB[13]) ∧
       is_role_in(ENTITY[10], ENTITY[12]) ∧ is_role_of(ENTITY[10], ENTITY[PGE2]) ∧ is_role_ATTRIBUTE(ENTITY[10], ATTRIB[11]) ∧
        REF1[1] = we ∧
         monocytes(GROUP[3]) ∧
          PGE2_production(ENTITY[5]) ∧
           cytokine_production(ENTITY[8]) ∧
            is_FACT_THAT(SITUATION[2],
             CONJ_and(has_shown(EVENT[4], _, ENTITY[C3a], induce(EVENT[6], ENTITY[C3a], ENTITY[5])) ∧
                   by(EVENT[4]) = GROUP[3],
              has_shown(EVENT[7], _, ENTITY[PGE2], influence(EVENT[9], ENTITY[PGE2], ENTITY[8])))) ∧
             past(EVENT[18]) ∧ investigated(EVENT[18], REF1[1], ENTITY[10]) ∧ Since(EVENT[18]) = SITUATION[2])

# ::id 7_nonfiction_GENIA-1999;99101510,7;NE
# ::snt Indomethacin blocked PGE2 release , but had no influence on the observed effects of C3a , suggesting that the effects of C3a on IL-6 production are independent of PGE2 formation by monocytes .
∃ ATTRIB[4] ATTRIB[12] EVENT[9] EVENT[7] EVENT[1] ENTITY[8] GROUP[6] ENTITY[5] GROUP[11] ENTITY[3] GROUP[2] (
 observed(ATTRIB[12]) ∧
  is_effects_of(GROUP[11], ENTITY[C3a]) ∧ is_effects_ATTRIBUTE(GROUP[11], ATTRIB[12]) ∧
   IL-6_production(ENTITY[3]) ∧
    is_effects_of(GROUP[2], ENTITY[C3a]) ∧ is_effects_on(GROUP[2], ENTITY[3]) ∧
     PGE2_release(ENTITY[8]) ∧
      monocytes(GROUP[6]) ∧
       is_PGE2_formation_by(ENTITY[5], GROUP[6]) ∧
        is_independent_of(ATTRIB[4], ENTITY[5]) ∧
         past(EVENT[9]) ∧
          CONJ_and(CONJ_but(blocked(EVENT[9], ENTITY[Indomethacin], ENTITY[8]),
                ¬ ∃ EVENT[13] ENTITY[10] (
                      is_influence_on(ENTITY[10], GROUP[11]) ∧
                       past(EVENT[13]) ∧ had(EVENT[13], ENTITY[Indomethacin], ENTITY[10]))),
           suggesting(EVENT[1], ENTITY[Indomethacin], copula(EVENT[7], GROUP[2], ATTRIB[4]))))

# ::id 8_nonfiction_GENIA-1999;99101510,8;NE
# ::snt Northern blot analysis showed that C3a as well as C3a_desArg enhanced LPS-induced mRNA levels for IL-6 .
∃ ATTRIB[5] EVENT[6] EVENT[2] GROUP[4] GROUP[3] ENTITY[1] (
 Northern_blot_analysis(ENTITY[1]) ∧
  CONJ_as_well(is_element_of(ENTITY[C3a], GROUP[3]), is_element_of(ENTITY[C3a_desArg], GROUP[3])) ∧
   lps-induced(ATTRIB[5]) ∧
    is_mRNA_levels_ATTRIBUTE(GROUP[4], ATTRIB[5]) ∧
     is_before(EVENT[6], EVENT[2]) ∧
      past(EVENT[2]) ∧
       showed(EVENT[2], ENTITY[1], enhanced(EVENT[6], GROUP[3], GROUP[4]) ∧ for(EVENT[6]) = ENTITY[IL-6]))

# ::id 9_nonfiction_GENIA-1999;99101510,9;NE
# ::snt Pretreatment of PBMCs with pertussis toxin blocked the functions of C3a and C3a_desArg , indicating that the actions of these two molecules are mediated by a G protein-coupled pathway .
∃ ATTRIB[10] EVENT[12] EVENT[11] EVENT[6] ENTITY[3] GROUP[2] ENTITY[9] ENTITY[1] GROUP[5] GROUP[8] GROUP[7] GROUP[4] (
 is_element_of(ENTITY[C3a], GROUP[5]) ∧ is_element_of(ENTITY[C3a_desArg], GROUP[5]) ∧
  is_functions_of(GROUP[4], GROUP[5]) ∧
   (CD_two(GROUP[8]), molecules(GROUP[8])) ∧
    is_actions_of(GROUP[7], GROUP[8]) ∧
     pertussis_toxin(ENTITY[3]) ∧
      is_PBMCs_with(GROUP[2], ENTITY[3]) ∧
       is_Pretreatment_of(ENTITY[1], GROUP[2]) ∧
        is_protein-coupled_comp(ATTRIB[10], ENTITY[G]) ∧
         is_pathway_ATTRIBUTE(ENTITY[9], ATTRIB[10]) ∧
          past(EVENT[12]) ∧
           CONJ_and(blocked(EVENT[12], ENTITY[1], GROUP[4]),
            indicating(EVENT[6], GROUP[4], mediated(EVENT[11], ENTITY[9], GROUP[7]))))

# ::id 10_nonfiction_GENIA-1999;99101510,10;NE
# ::snt Furthermore , we investigated the effects of C3a and C3a_desArg on induction of NF-kappaB and activating protein-1 binding .
∃ REF1[1] EVENT[10] EVENT[9] ENTITY[5] ENTITY[8] ENTITY[6] GROUP[4] GROUP[3] GROUP[2] (
 is_element_of(ENTITY[C3a], GROUP[3]) ∧ is_element_of(ENTITY[C3a_desArg], GROUP[3]) ∧
  is_induction_of(ENTITY[5], ENTITY[NF-kappaB]) ∧
   protein-1_binding(ENTITY[8]) ∧
    activating(EVENT[9], ENTITY[6], ENTITY[8]) ∧
     is_element_of(ENTITY[5], GROUP[4]) ∧ is_element_of(ENTITY[6], GROUP[4]) ∧
      is_effects_on(GROUP[2], GROUP[4]) ∧ is_effects_of(GROUP[2], GROUP[3]) ∧
       REF1[1] = we ∧ ADV_furthermore(EVENT[10]) ∧ past(EVENT[10]) ∧ investigated(EVENT[10], REF1[1], GROUP[2]))

# ::id 11_nonfiction_GENIA-1999;99101510,11;NE
# ::snt Both molecules enhanced LPS-induced NF-kappaB and activating protein-1 binding activity .
BOTH GROUP[1] (molecules(GROUP[1]),
 ∃ EVENT[8] GROUP[2] (
  ∃ ATTRIB[3] (lps-induced(ATTRIB[3]) ∧ is_ATTRIBUTE(ENTITY[NF-kappaB], ATTRIB[3]) ∧ is_element_of(ENTITY[NF-kappaB], GROUP[2])) ∧
   ∃ EVENT[7] ENTITY[6] ENTITY[4] (protein-1_binding_activity(ENTITY[6]) ∧ activating(EVENT[7], ENTITY[4], ENTITY[6]) ∧ is_element_of(ENTITY[4], GROUP[2])) ∧
   past(EVENT[8]) ∧ enhanced(EVENT[8], GROUP[1], GROUP[2])))

# ::id 12_nonfiction_GENIA-1999;99101510,12;NE
# ::snt These results demonstrate the capacity of intact C3a and its circulating des-Arg form to exert immunmodulatory effects in vitro .
∃ ATTRIB[8] ATTRIB[6] REF1[5] EVENT[11] EVENT[9] ENTITY[4] GROUP[7] GROUP[3] ENTITY[2] GROUP[1] (
 results(GROUP[1]) ∧
  REF1[5] = its ∧
   circulating(ATTRIB[6]) ∧
    is_des-Arg_form_ATTRIBUTE(ENTITY[4], ATTRIB[6]) ∧ is_des-Arg_form_POS(ENTITY[4], REF1[5]) ∧
     is_element_of(ENTITY[intact_C3a], GROUP[3]) ∧ is_element_of(ENTITY[4], GROUP[3]) ∧
      immunmodulatory(ATTRIB[8]) ∧
       is_effects_ATTRIBUTE(GROUP[7], ATTRIB[8]) ∧
        is_capacity_of(ENTITY[2], GROUP[3]) ∧ is_capacity_to(ENTITY[2], exert(EVENT[9], _, GROUP[7])) ∧
         ADV_in_vitro(EVENT[9]) ∧ demonstrate(EVENT[11], GROUP[1], ENTITY[2]))

# ::id 13_nonfiction_GENIA-1999;99101524,1;NE
# ::snt Comparison of primary sensitization of naive human T cells to varicella-zoster virus peptides by dendritic cells in vitro with responses elicited in vivo by varicella vaccination .
∃ ATTRIB[9] ATTRIB[8] ATTRIB[5] ATTRIB[3] EVENT[13] EVENT[15] GROUP[7] GROUP[6] GROUP[4] ENTITY[12] GROUP[10] ENTITY[2] ENTITY[1] (
 primary(ATTRIB[3]) ∧
  naive(ATTRIB[5]) ∧
   is_human_T_cells_ATTRIBUTE(GROUP[4], ATTRIB[5]) ∧
    varicella-zoster_virus_peptides(GROUP[6]) ∧
     dendritic(ATTRIB[8]) ∧
      is_cells_ATTRIBUTE(GROUP[7], ATTRIB[8]) ∧
       in_vitro(ATTRIB[9]) ∧
        is_sensitization_ATTRIBUTE(ENTITY[2], ATTRIB[9]) ∧ is_sensitization_by(ENTITY[2], GROUP[7]) ∧ is_sensitization_to(ENTITY[2], GROUP[6]) ∧
         is_sensitization_of(ENTITY[2], GROUP[4]) ∧ is_sensitization_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
         varicella_vaccination(ENTITY[12]) ∧
          elicited(EVENT[13], GROUP[10]) ∧ by(EVENT[13]) = ENTITY[12] ∧ responses(GROUP[10]) ∧
           is_Comparison_with(ENTITY[1], GROUP[10]) ∧ is_Comparison_of(ENTITY[1], ENTITY[2]) ∧
            ADV_in_vivo(EVENT[13]) ∧ xxx(EVENT[15]) ∧ LINK(EVENT[15]) = ENTITY[1])

# ::id 14_nonfiction_GENIA-1999;99101524,2;NE
# ::snt Dendritic cells -LRB- DC -RRB- are potent APC during primary and secondary immune responses .
∃ ATTRIB[4] ATTRIB[2] EVENT[12] GROUP[5] ENTITY[3] GROUP[1] (
 dendritic(ATTRIB[2]) ∧
  is_cells_ATTRIBUTE(GROUP[1], ATTRIB[2]) ∧
   is_-GROUP-_namely(GROUP[1], ENTITY[DC]) ∧
    potent(ATTRIB[4]) ∧
     is_APC_ATTRIBUTE(ENTITY[3], ATTRIB[4]) ∧
      ∃ ATTRIB[8] ATTRIB[7] GROUP[6] (
       primary(ATTRIB[7]) ∧
        immune(ATTRIB[8]) ∧
         is_responses_ATTRIBUTE(GROUP[6], ATTRIB[8]) ∧ is_responses_ATTRIBUTE(GROUP[6], ATTRIB[7]) ∧ is_subset_of_or_equal_to(GROUP[6], GROUP[5])) ∧
       ∃ ATTRIB[11] ATTRIB[10] GROUP[9] (
        secondary(ATTRIB[10]) ∧
         immune(ATTRIB[11]) ∧
          is_responses_ATTRIBUTE(GROUP[9], ATTRIB[11]) ∧ is_responses_ATTRIBUTE(GROUP[9], ATTRIB[10]) ∧ is_subset_of_or_equal_to(GROUP[9], GROUP[5])) ∧
       copula(EVENT[12], GROUP[1], ENTITY[3]) ∧ during(EVENT[12]) = GROUP[5])

# ::id 15_nonfiction_GENIA-1999;99101524,3;NE
# ::snt The first objective of this study was to determine whether human DC mediate in vitro sensitization of naive CD4+ T cells to epitopes of the immediate early 62 -LRB- IE62 -RRB- protein of varicella zoster virus -LRB- VZV -RRB- .
∃ ATTRIB[13] ATTRIB[2] EVENT[5] EVENT[4] ENTITY[3] ENTITY[14] ENTITY[12] ENTITY[1] (
 first(ATTRIB[2]) ∧
  study(ENTITY[3]) ∧
   is_objective_of(ENTITY[1], ENTITY[3]) ∧ is_objective_ATTRIBUTE(ENTITY[1], ATTRIB[2]) ∧
    immediate_early(ATTRIB[13]) ∧
     varicella_zoster_virus(ENTITY[14]) ∧
      is_-ENTITY-_namely(ENTITY[14], ENTITY[VZV]) ∧
       is_62_protein_of(ENTITY[12], ENTITY[14]) ∧ is_62_protein_ATTRIBUTE(ENTITY[12], ATTRIB[13]) ∧
        is_-ENTITY-_namely(ENTITY[12], ENTITY[IE62]) ∧
         past(EVENT[4]) ∧
          copula(EVENT[4], ENTITY[1],
           determine(EVENT[5], ENTITY[1],
            QUEST(∃ ATTRIB[9] ATTRIB[7] EVENT[15] GROUP[11] GROUP[10] ENTITY[8] GROUP[6] (
                  human(ATTRIB[7]) ∧
                   is_DC_ATTRIBUTE(GROUP[6], ATTRIB[7]) ∧
                    in_vitro(ATTRIB[9]) ∧
                     naive_CD4+_T_cells(GROUP[10]) ∧
                      is_epitopes_of(GROUP[11], ENTITY[12]) ∧
                       is_sensitization_to(ENTITY[8], GROUP[11]) ∧ is_sensitization_of(ENTITY[8], GROUP[10]) ∧
                        is_sensitization_ATTRIBUTE(ENTITY[8], ATTRIB[9]) ∧ mediate(EVENT[15], GROUP[6], ENTITY[8]))))))

# ::id 16_nonfiction_GENIA-1999;99101524,4;NE
# ::snt The induction of CD4+ T cell proliferative responses to eight synthetic peptides representing amino acid sequences of the VZV IE62 protein was assessed using T cells and DC from VZV-susceptible donors .
∃ ATTRIB[14] ATTRIB[4] EVENT[16] EVENT[15] GROUP[13] GROUP[10] ENTITY[9] EVENT[8] ENTITY[7] GROUP[6] GROUP[3] GROUP[2] ENTITY[1] (
 synthetic(ATTRIB[4]) ∧
  VZV_IE62_protein(ENTITY[7]) ∧
   is_amino_acid_sequences_of(GROUP[6], ENTITY[7]) ∧
    (CD_eight(GROUP[3]), representing(EVENT[8], GROUP[3], GROUP[6]) ∧ is_peptides_ATTRIBUTE(GROUP[3], ATTRIB[4])) ∧
     is_CD4+_T_cell_proliferative_responses_to(GROUP[2], GROUP[3]) ∧
      is_induction_of(ENTITY[1], GROUP[2]) ∧
       ∃ GROUP[11] (T_cells(GROUP[11]) ∧ is_subset_of_or_equal_to(GROUP[11], GROUP[10])) ∧
        ∃ GROUP[12] (DC(GROUP[12]) ∧ is_subset_of_or_equal_to(GROUP[12], GROUP[10])) ∧
        vzv-susceptible(ATTRIB[14]) ∧
         is_donors_ATTRIBUTE(GROUP[13], ATTRIB[14]) ∧
          is_from(ENTITY[9], GROUP[13]) ∧ is_equals(ENTITY[9], GROUP[10]) ∧
           past(EVENT[16]) ∧
            CONJ_and(assessed(EVENT[16], _, ENTITY[1]), using(EVENT[15], ENTITY[1], ENTITY[9])))

# ::id 17_nonfiction_GENIA-1999;99101524,5;NE
# ::snt The second objective was to compare in vitro responses of naive T cells with responses to VZV peptides induced in vivo after immunization with varicella vaccine .
∃ ATTRIB[5] ATTRIB[2] EVENT[12] EVENT[14] EVENT[3] GROUP[6] ENTITY[11] ENTITY[10] GROUP[8] GROUP[7] GROUP[4] ENTITY[1] (
 second(ATTRIB[2]) ∧
  is_objective_ATTRIBUTE(ENTITY[1], ATTRIB[2]) ∧
   in_vitro(ATTRIB[5]) ∧
    naive_T_cells(GROUP[6]) ∧
     is_responses_of(GROUP[4], GROUP[6]) ∧ is_responses_ATTRIBUTE(GROUP[4], ATTRIB[5]) ∧
      VZV_peptides(GROUP[8]) ∧
       varicella_vaccine(ENTITY[11]) ∧
        is_immunization_with(ENTITY[10], ENTITY[11]) ∧
         induced(EVENT[12], GROUP[7]) ∧ after(EVENT[12]) = ENTITY[10] ∧ is_responses_to(GROUP[7], GROUP[8]) ∧
          ADV_in_vivo(EVENT[12]) ∧
           past(EVENT[3]) ∧
            copula(EVENT[3], ENTITY[1], compare(EVENT[14], ENTITY[1], GROUP[4]) ∧ with(EVENT[14]) = GROUP[7]))

# ::id 18_nonfiction_GENIA-1999;99101524,6;NE
# ::snt T cell proliferation was induced by three peptides , P1 , P4 , and P7 , in 71-100 % of the donors tested before and after vaccination using DC as APC .
∃ EVENT[18] GROUP[2] ENTITY[4] GROUP[3] ENTITY[1] EVENT[11] EVENT[17] EVENT[16] EVENT[17] ENTITY[10] ENTITY[9] ENTITY[7] ENTITY[15] ENTITY[14] ENTITY[12] GROUP[5] (
 DC(ENTITY[9]) ∧
  APC(ENTITY[10]) ∧
   using(EVENT[11], ENTITY[7], ENTITY[9]) ∧ as(EVENT[11]) = ENTITY[10] ∧ vaccination(ENTITY[7]) ∧
    DC(ENTITY[14]) ∧
     APC(ENTITY[15]) ∧
      using(EVENT[16], ENTITY[12], ENTITY[14]) ∧ as(EVENT[16]) = ENTITY[15] ∧ vaccination(ENTITY[12]) ∧
       CONJ_and(tested(EVENT[17], _, GROUP[5]) ∧ before(EVENT[17]) = ENTITY[7],
        tested(EVENT[17], _, GROUP[5]) ∧ after(EVENT[17]) = ENTITY[12]) ∧ donors(GROUP[5]) ∧
        T_cell_proliferation(ENTITY[1]) ∧
         (CD_three(GROUP[3]), peptides(GROUP[3])) ∧
          is_element_of(ENTITY[P1], GROUP[2]) ∧ is_element_of(ENTITY[P4], GROUP[2]) ∧ is_element_of(ENTITY[P7], GROUP[2]) ∧
           is_-GROUP-_namely(GROUP[3], GROUP[2]) ∧
            (CD_71-100(ENTITY[4]), is%of(ENTITY[4], GROUP[5])) ∧
             past(EVENT[18]) ∧
              induced(EVENT[18], _, ENTITY[1]) ∧ in(EVENT[18]) = ENTITY[4] ∧
               by(EVENT[18]) = GROUP[3])

# ::id 19_nonfiction_GENIA-1999;99101524,7;NE
# ::snt Monocytes were effective APC for VZV peptides only after immunization .
∃ ATTRIB[3] ENTITY[6] GROUP[4] ENTITY[2] GROUP[1] (
 Monocytes(GROUP[1]) ∧
  effective(ATTRIB[3]) ∧
   is_APC_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
    VZV_peptides(GROUP[4]) ∧
     immunization(ENTITY[6]) ∧
      ONLY ENTITY[5] (is_of(ENTITY[5], ENTITY[6]),
       ∃ EVENT[7] (
        past(EVENT[7]) ∧
         copula(EVENT[7], GROUP[1], ENTITY[2]) ∧ after(EVENT[7]) = ENTITY[5] ∧
          for(EVENT[7]) = GROUP[4])))

# ::id 20_nonfiction_GENIA-1999;99101524,8;NE
# ::snt Two peptides , P2 and P8 , induced naive T cell proliferation less effectively and were also less immunogenic for T cells from vaccinated or naturally immune donors .
∃ ATTRIB[6] EVENT[4] EVENT[13] GROUP[1] ENTITY[3] GROUP[8] GROUP[7] GROUP[2] (
 (CD_two(GROUP[2]), peptides(GROUP[2])) ∧
  is_element_of(ENTITY[P2], GROUP[1]) ∧ is_element_of(ENTITY[P8], GROUP[1]) ∧
   is_-GROUP-_namely(GROUP[2], GROUP[1]) ∧
    naive_T_cell_proliferation(ENTITY[3]) ∧
     CONJ_or(∃ ATTRIB[10] GROUP[9] (vaccinated(ATTRIB[10]) ∧ is_donors_ATTRIBUTE(GROUP[9], ATTRIB[10]) ∧ is_subset_of_or_equal_to(GROUP[9], GROUP[8])),
      ∃ ATTRIB[12] GROUP[11] (naturally_immune(ATTRIB[12]) ∧ is_donors_ATTRIBUTE(GROUP[11], ATTRIB[12]) ∧ is_subset_of_or_equal_to(GROUP[11], GROUP[8]))) ∧
      is_T_cells_from(GROUP[7], GROUP[8]) ∧
       is_less_immunogenic_for(ATTRIB[6], GROUP[7]) ∧
        ADV_less_effectively(EVENT[4]) ∧
         past(EVENT[4]) ∧
          ADV_also(EVENT[13]) ∧
           past(EVENT[13]) ∧
            CONJ_and(induced(EVENT[4], GROUP[2], ENTITY[3]),
             copula(EVENT[13], GROUP[2]) ∧ ATTRIBUTE(EVENT[13]) = ATTRIB[6]))

# ::id 21_nonfiction_GENIA-1999;99101524,9;NE
# ::snt T cell recognition of specific peptides was concordant between naive , DC-mediated responses , and postvaccine responses using monocytes as APC in 69 % of comparisons -LRB- p = 0.05 ; chi2 -RRB- ;
∃ ATTRIB[4] ATTRIB[3] EVENT[16] EVENT[15] GROUP[2] GROUP[5] GROUP[14] ENTITY[13] ENTITY[12] GROUP[11] ENTITY[1] (
 specific(ATTRIB[3]) ∧
  is_peptides_ATTRIBUTE(GROUP[2], ATTRIB[3]) ∧
   is_T_cell_recognition_of(ENTITY[1], GROUP[2]) ∧
    ∃ ATTRIB[8] ATTRIB[7] GROUP[6] (
     naive(ATTRIB[7]) ∧
      dc-mediated(ATTRIB[8]) ∧
       is_responses_ATTRIBUTE(GROUP[6], ATTRIB[8]) ∧ is_responses_ATTRIBUTE(GROUP[6], ATTRIB[7]) ∧ is_subset_of_or_equal_to(GROUP[6], GROUP[5])) ∧
     ∃ ATTRIB[10] GROUP[9] (postvaccine(ATTRIB[10]) ∧ is_responses_ATTRIBUTE(GROUP[9], ATTRIB[10]) ∧ is_subset_of_or_equal_to(GROUP[9], GROUP[5])) ∧
     is_concordant_between(ATTRIB[4], GROUP[5]) ∧
      monocytes(GROUP[11]) ∧
       APC(ENTITY[12]) ∧
        comparisons(GROUP[14]) ∧
         (CD_69(ENTITY[13]), is%of(ENTITY[13], GROUP[14])) ∧
          past(EVENT[16]) ∧
           CONJ_and(copula(EVENT[16], ENTITY[1]) ∧ ATTRIBUTE(EVENT[16]) = ATTRIB[4],
            using(EVENT[15], ENTITY[1], GROUP[11]) ∧ in(EVENT[15]) = ENTITY[13] ∧
             as(EVENT[15]) = ENTITY[12]))

# ::id 22_nonfiction_GENIA-1999;99101524,9;NE
# ::snt the predictive value of a positive response to an IE62 peptide before immunization for T cell sensitization in vivo was 82 % .
∃ ATTRIB[8] ATTRIB[4] ATTRIB[2] EVENT[10] ENTITY[9] ENTITY[7] ENTITY[6] ENTITY[5] ENTITY[3] ENTITY[1] (
 predictive(ATTRIB[2]) ∧
  positive(ATTRIB[4]) ∧
   IE62_peptide(ENTITY[5]) ∧
    immunization(ENTITY[6]) ∧
     in_vivo(ATTRIB[8]) ∧
      is_T_cell_sensitization_ATTRIBUTE(ENTITY[7], ATTRIB[8]) ∧
       is_response_for(ENTITY[3], ENTITY[7]) ∧ is_response_before(ENTITY[3], ENTITY[6]) ∧ is_response_to(ENTITY[3], ENTITY[5]) ∧
        is_response_ATTRIBUTE(ENTITY[3], ATTRIB[4]) ∧
        is_value_of(ENTITY[1], ENTITY[3]) ∧ is_value_ATTRIBUTE(ENTITY[1], ATTRIB[2]) ∧
         (CD_82(ENTITY[9]), %(ENTITY[9])) ∧
          past(EVENT[10]) ∧ copula(EVENT[10], ENTITY[1], ENTITY[9]))

# ::id 23_nonfiction_GENIA-1999;99101524,10;NE
# ::snt These observations indicate that primary T cell responses detected in vitro using DC as APC may be useful to characterize the potential immunogenicity of viral protein epitopes in vivo .
∃ ATTRIB[14] ATTRIB[13] ATTRIB[11] EVENT[7] EVENT[2] ENTITY[6] GROUP[5] GROUP[3] GROUP[12] ENTITY[10] GROUP[1] (
 observations(GROUP[1]) ∧
  potential(ATTRIB[11]) ∧
   viral(ATTRIB[13]) ∧
    is_protein_epitopes_ATTRIBUTE(GROUP[12], ATTRIB[13]) ∧
     in_vivo(ATTRIB[14]) ∧
      is_immunogenicity_ATTRIBUTE(ENTITY[10], ATTRIB[14]) ∧ is_immunogenicity_of(ENTITY[10], GROUP[12]) ∧ is_immunogenicity_ATTRIBUTE(ENTITY[10], ATTRIB[11]) ∧
       DC(GROUP[5]) ∧
        APC(ENTITY[6]) ∧
         detected_using(EVENT[7], GROUP[3], GROUP[5]) ∧ as(EVENT[7]) = ENTITY[6] ∧ primary_T_cell_responses(GROUP[3]) ∧
          ADV_in_vitro(EVENT[7]) ∧
           indicate(EVENT[2], GROUP[1],
            MD_may(∃ ATTRIB[9] EVENT[15] EVENT[16] (
                  is_useful_to(ATTRIB[9], characterize(EVENT[15], _, ENTITY[10])) ∧
                   copula(EVENT[16], GROUP[3], ATTRIB[9])))))

# ::id 24_nonfiction_GENIA-1999;99102085,1;NE
# ::snt Mildly oxidized low-density lipoproteins decrease early production of interleukin 2 and nuclear factor kappaB binding to DNA in activated T-lymphocytes .
∃ ATTRIB[3] ATTRIB[2] EVENT[12] GROUP[4] GROUP[1] (
 mildly_oxidized(ATTRIB[2]) ∧
  low-density(ATTRIB[3]) ∧
   is_lipoproteins_ATTRIBUTE(GROUP[1], ATTRIB[3]) ∧ is_lipoproteins_ATTRIBUTE(GROUP[1], ATTRIB[2]) ∧
    ∃ ATTRIB[6] ENTITY[5] (
     early(ATTRIB[6]) ∧
      is_production_of(ENTITY[5], ENTITY[interleukin_2]) ∧ is_production_ATTRIBUTE(ENTITY[5], ATTRIB[6]) ∧ is_element_of(ENTITY[5], GROUP[4])) ∧
     ∃ ATTRIB[11] ATTRIB[8] GROUP[10] ENTITY[9] ENTITY[7] (
      nuclear(ATTRIB[8]) ∧
       DNA(ENTITY[9]) ∧
        activated(ATTRIB[11]) ∧
         is_T-lymphocytes_ATTRIBUTE(GROUP[10], ATTRIB[11]) ∧
          is_factor_kappaB_binding_in(ENTITY[7], GROUP[10]) ∧ is_factor_kappaB_binding_to(ENTITY[7], ENTITY[9]) ∧ is_factor_kappaB_binding_ATTRIBUTE(ENTITY[7], ATTRIB[8]) ∧
           is_element_of(ENTITY[7], GROUP[4])) ∧ decrease(EVENT[12], GROUP[1], GROUP[4]))

# ::id 25_nonfiction_GENIA-1999;99102085,2;NE
# ::snt Activated T-lymphocytes are found early in atherosclerosis lesions ,
∃ ATTRIB[2] EVENT[4] GROUP[3] GROUP[1] (
 activated(ATTRIB[2]) ∧
  is_T-lymphocytes_ATTRIBUTE(GROUP[1], ATTRIB[2]) ∧
   atherosclerosis_lesions(GROUP[3]) ∧
    TMP_early(EVENT[4]) ∧ found(EVENT[4], _, GROUP[1]) ∧ in(EVENT[4]) = GROUP[3])

# ::id 26_nonfiction_GENIA-1999;99102085,2;NE
# ::snt but little is known about their role .
LITTLE ENTITY[1] ∃ REF1[3] EVENT[4] ENTITY[2] (
 REF1[3] = their ∧
  is_role_POS(ENTITY[2], REF1[3]) ∧ known(EVENT[4], _, ENTITY[1]) ∧ about(EVENT[4]) = ENTITY[2])

# ::id 27_nonfiction_GENIA-1999;99102085,3;NE
# ::snt Oxidized low-density lipoproteins -LRB- oxLDLs -RRB- are considered to be involved in the pathogenesis of the lesions ,
∃ ATTRIB[4] ATTRIB[3] EVENT[8] EVENT[5] ENTITY[1] GROUP[2] GROUP[7] ENTITY[6] (
 lesions(GROUP[7]) ∧
  is_pathogenesis_of(ENTITY[6], GROUP[7]) ∧
   oxidized(ATTRIB[3]) ∧
    low-density(ATTRIB[4]) ∧
     is_lipoproteins_ATTRIBUTE(GROUP[2], ATTRIB[4]) ∧ is_lipoproteins_ATTRIBUTE(GROUP[2], ATTRIB[3]) ∧
      oxLDLs(ENTITY[1]) ∧
       is_-GROUP-_namely(GROUP[2], ENTITY[1]) ∧
        considered(EVENT[5], _, GROUP[2],
         involved(EVENT[8], _, GROUP[2]) ∧ in(EVENT[8]) = ENTITY[6]))

# ::id 28_nonfiction_GENIA-1999;99102085,3;NE
# ::snt and we have previously demonstrated that oxLDLs inhibit not only interleukin -LRB- IL -RRB- -2 -receptor expression on the surface of in vitro-activated T-lymphocytes but also their proliferation .
∃ SITUATION[14] REF1[1] ATTRIB[10] EVENT[13] EVENT[2] GROUP[4] GROUP[3] GROUP[9] ENTITY[8] (
 in(ATTRIB[10]) ∧ vitro-activated(ATTRIB[10]) ∧
  is_T-lymphocytes_ATTRIBUTE(GROUP[9], ATTRIB[10]) ∧
   is_surface_of(ENTITY[8], GROUP[9]) ∧
    REF1[1] = we ∧
     oxLDLs(GROUP[3]) ∧
      CONJ_but_also(NOT ENTITY[7] (is_interleukin-2-receptor_expression_on(ENTITY[7], ENTITY[8]),
            ONLY ENTITY[6] (is_of(ENTITY[6], ENTITY[7]),
             ∃ ENTITY[5] (IL(ENTITY[5]) ∧ is_-ENTITY-_namely(ENTITY[6], ENTITY[5]) ∧ is_element_of(ENTITY[6], GROUP[4])))),
       ∃ REF2[12] ENTITY[11] (REF2[12] = their ∧ is_proliferation_POS(ENTITY[11], REF2[12]) ∧ is_element_of(ENTITY[11], GROUP[4]))) ∧
       TMP_previously(SITUATION[14]) ∧ is_FACT_THAT(SITUATION[14], have_demonstrated(EVENT[2], REF1[1], inhibit(EVENT[13], GROUP[3], GROUP[4]))))

# ::id 29_nonfiction_GENIA-1999;99102085,4;NE
# ::snt We have now investigated the effect of oxLDLs on blast differentiation , on IL-2 synthesis and on the activation of the nuclear factor kappaB -LRB- NF-kappaB -RRB- system in activated lymphocytes .
∃ REF1[1] ATTRIB[10] ATTRIB[8] EVENT[11] ENTITY[4] ENTITY[5] GROUP[9] ENTITY[7] ENTITY[6] GROUP[3] ENTITY[2] (
 oxLDLs(GROUP[3]) ∧
  blast_differentiation(ENTITY[4]) ∧
   IL-2_synthesis(ENTITY[5]) ∧
    nuclear(ATTRIB[8]) ∧
     is_factor_kappaB_system_ATTRIBUTE(ENTITY[7], ATTRIB[8]) ∧
      is_-ENTITY-_namely(ENTITY[7], ENTITY[NF-kappaB]) ∧
       activated(ATTRIB[10]) ∧
        is_lymphocytes_ATTRIBUTE(GROUP[9], ATTRIB[10]) ∧
         is_activation_in(ENTITY[6], GROUP[9]) ∧ is_activation_of(ENTITY[6], ENTITY[7]) ∧
          CONJ_and(is_effect_on(ENTITY[2], ENTITY[4]) ∧ is_effect_of(ENTITY[2], GROUP[3]),
           is_effect_on(ENTITY[2], ENTITY[5]) ∧ is_effect_of(ENTITY[2], GROUP[3]),
           is_effect_on(ENTITY[2], ENTITY[6]) ∧ is_effect_of(ENTITY[2], GROUP[3])) ∧
           REF1[1] = we ∧ TMP_now(EVENT[11]) ∧ have_investigated(EVENT[11], REF1[1], ENTITY[2]))

# ::id 30_nonfiction_GENIA-1999;99102085,5;NE
# ::snt Mildly oxLDLs -LRB- 50 and 100 microgram/ml -RRB- decreased the number of lymphoblasts and the level of IL-2 concentration in the culture supernatants after activation of lymphocytes by phytohaemagglutinin and PMA+ionomycin .
∃ EVENT[12] ENTITY[1] GROUP[11] GROUP[10] ENTITY[9] GROUP[3] GROUP[2] GROUP[5] ENTITY[4] ENTITY[7] ENTITY[6] GROUP[8] (
 lymphoblasts(GROUP[5]) ∧
  is_number_of(ENTITY[4], GROUP[5]) ∧
   IL-2_concentration(ENTITY[7]) ∧
    is_level_of(ENTITY[6], ENTITY[7]) ∧
     culture_supernatants(GROUP[8]) ∧
      ADV_mildly(GROUP[2]) ∧ oxLDLs(GROUP[2]) ∧
       (CD_50_and_100(ENTITY[1]), microgram__slash__ml(ENTITY[1])) ∧
        is_-GROUP-_namely(GROUP[2], ENTITY[1]) ∧
         is_element_of(ENTITY[4], GROUP[3]) ∧ is_element_of(ENTITY[6], GROUP[3]) ∧
          lymphocytes(GROUP[10]) ∧
           is_element_of(ENTITY[phytohaemagglutinin], GROUP[11]) ∧ is_element_of(ENTITY[PMA+ionomycin], GROUP[11]) ∧
            is_activation_by(ENTITY[9], GROUP[11]) ∧ is_activation_of(ENTITY[9], GROUP[10]) ∧
             past(EVENT[12]) ∧
              decreased(EVENT[12], GROUP[2], GROUP[3]) ∧ after(EVENT[12]) = ENTITY[9] ∧
               in(EVENT[12]) = GROUP[8])

# ::id 31_nonfiction_GENIA-1999;99102085,6;NE
# ::snt The inhibition of IL-2 production was observed in the CD3 T-lymphocyte cytoplasm as early as 4 h after activation by PMA+ionomycin .
∃ EVENT[6] ENTITY[5] ENTITY[4] ENTITY[2] ENTITY[3] ENTITY[1] (
 IL-2_production(ENTITY[2]) ∧
  is_inhibition_of(ENTITY[1], ENTITY[2]) ∧
   CD3_T-lymphocyte_cytoplasm(ENTITY[3]) ∧
    is_activation_by(ENTITY[5], ENTITY[PMA+ionomycin]) ∧
     (CD_4(ENTITY[4]), is_h_after(ENTITY[4], ENTITY[5])) ∧
      is_TMP_as_early_as(EVENT[6], ENTITY[4]) ∧
       past(EVENT[6]) ∧ observed(EVENT[6], _, ENTITY[1]) ∧ in(EVENT[6]) = ENTITY[3])

# ::id 32_nonfiction_GENIA-1999;99102085,7;NE
# ::snt The study of NF-kappaB showed that oxLDLs led to a decrease of activation-induced p65/p50 NF-kappaB heterodimer binding to DNA , whereas the presence of the constitutive nuclear form of p50 dimer was unchanged .
∃ ATTRIB[13] SITUATION[7] ATTRIB[11] ATTRIB[10] EVENT[14] EVENT[15] EVENT[2] ENTITY[6] ENTITY[5] ENTITY[4] GROUP[3] ENTITY[12] ENTITY[9] ENTITY[8] ENTITY[1] (
 is_study_of(ENTITY[1], ENTITY[NF-kappaB]) ∧
  constitutive(ATTRIB[10]) ∧
   nuclear(ATTRIB[11]) ∧
    p50_dimer(ENTITY[12]) ∧
     is_form_ATTRIBUTE(ENTITY[9], ATTRIB[11]) ∧ is_form_of(ENTITY[9], ENTITY[12]) ∧ is_form_ATTRIBUTE(ENTITY[9], ATTRIB[10]) ∧
      is_presence_of(ENTITY[8], ENTITY[9]) ∧
       oxLDLs(GROUP[3]) ∧
        DNA(ENTITY[6]) ∧
         is_activation-induced_p65__slash__p50_NF-kappaB_heterodimer_binding_to(ENTITY[5], ENTITY[6]) ∧
          is_decrease_of(ENTITY[4], ENTITY[5]) ∧
           unchanged(ATTRIB[13]) ∧
            is_FACT_THAT(SITUATION[7], copula(EVENT[14], ENTITY[8], ATTRIB[13])) ∧
             is_before(EVENT[14], EVENT[2]) ∧
              is_before(EVENT[15], EVENT[2]) ∧
               past(EVENT[2]) ∧
                showed(EVENT[2], ENTITY[1],
                 led(EVENT[15], GROUP[3]) ∧ whereas(EVENT[15]) = SITUATION[7] ∧
                  to(EVENT[15]) = ENTITY[4]))

# ::id 33_nonfiction_GENIA-1999;99102085,8;NE
# ::snt This was correlated with an unchanged level of the active form of the cytosolic inhibitor protein IkappaB-alpha .
∃ ATTRIB[3] ATTRIB[7] ATTRIB[5] EVENT[8] ENTITY[2] ENTITY[6] ENTITY[4] ENTITY[1] (
 active(ATTRIB[5]) ∧
  cytosolic(ATTRIB[7]) ∧
   is_inhibitor_protein_ATTRIBUTE(ENTITY[6], ATTRIB[7]) ∧
    is_-ENTITY-_namely(ENTITY[IkappaB-alpha], ENTITY[6]) ∧
     is_form_of(ENTITY[4], ENTITY[IkappaB-alpha]) ∧ is_form_ATTRIBUTE(ENTITY[4], ATTRIB[5]) ∧
      unchanged(ATTRIB[3]) ∧
       is_level_of(ENTITY[2], ENTITY[4]) ∧ is_level_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
        past(EVENT[8]) ∧ was_correlated(EVENT[8], ENTITY[1]) ∧ with(EVENT[8]) = ENTITY[2])

# ::id 34_nonfiction_GENIA-1999;99102085,9;NE
# ::snt Taken together , these observations suggest that the immunosuppressive effect of oxLDLs might operate via a dysregulation of the T-lymphocyte activation mechanisms .
∃ ATTRIB[6] EVENT[2] EVENT[4] GROUP[7] GROUP[9] ENTITY[5] GROUP[1] (
 observations(GROUP[1]) ∧
  immunosuppressive(ATTRIB[6]) ∧
   oxLDLs(GROUP[7]) ∧
    is_effect_of(ENTITY[5], GROUP[7]) ∧ is_effect_ATTRIBUTE(ENTITY[5], ATTRIB[6]) ∧
     T-lymphocyte_activation_mechanisms(GROUP[9]) ∧
      ADV_together(EVENT[2]) ∧
       CONJ_and(taken(EVENT[2], GROUP[1]),
        suggest(EVENT[4], GROUP[1],
         MD_might(∃ ENTITY[8] EVENT[10] (
               is_dysregulation_of(ENTITY[8], GROUP[9]) ∧
                operate(EVENT[10], ENTITY[5]) ∧ via(EVENT[10]) = ENTITY[8])))))

# ::id 35_nonfiction_GENIA-1999;99102381,1;NE
# ::snt The activity of the CCAAT -box binding factor NF-Y is modulated through the regulated expression of its A subunit during monocyte to macrophage differentiation :
∃ REF1[6] ATTRIB[4] EVENT[9] ENTITY[8] ENTITY[7] ENTITY[2] ENTITY[5] ENTITY[3] ENTITY[1] (
 CCAAT-box_binding_factor(ENTITY[2]) ∧
  is_-ENTITY-_namely(ENTITY[NF-Y], ENTITY[2]) ∧
   is_activity_of(ENTITY[1], ENTITY[NF-Y]) ∧
    regulated(ATTRIB[4]) ∧
     REF1[6] = its ∧
      is_A_subunit_POS(ENTITY[5], REF1[6]) ∧
       is_expression_of(ENTITY[3], ENTITY[5]) ∧ is_expression_ATTRIBUTE(ENTITY[3], ATTRIB[4]) ∧
        monocyte(ENTITY[7]) ∧
         macrophage_differentiation(ENTITY[8]) ∧
          modulated(EVENT[9], _, ENTITY[1]) ∧ to(EVENT[9]) = ENTITY[8] ∧
           during(EVENT[9]) = ENTITY[7] ∧ through(EVENT[9]) = ENTITY[3])

# ::id 36_nonfiction_GENIA-1999;99102381,1;NE
# ::snt regulation of tissue-specific genes through a ubiquitous transcription factor .
∃ ATTRIB[5] ATTRIB[3] EVENT[6] ENTITY[4] GROUP[2] ENTITY[1] (
 tissue-specific(ATTRIB[3]) ∧
  is_genes_ATTRIBUTE(GROUP[2], ATTRIB[3]) ∧
   ubiquitous(ATTRIB[5]) ∧
    is_transcription_factor_ATTRIBUTE(ENTITY[4], ATTRIB[5]) ∧
     is_regulation_through(ENTITY[1], ENTITY[4]) ∧ is_regulation_of(ENTITY[1], GROUP[2]) ∧
      xxx(EVENT[6]) ∧ LINK(EVENT[6]) = ENTITY[1])

# ::id 37_nonfiction_GENIA-1999;99102381,2;NE
# ::snt In this study , we analyzed the regulation of NF-Y expression during human monocyte to macrophage maturation .
∃ REF1[2] ATTRIB[6] EVENT[8] ENTITY[7] ENTITY[5] ENTITY[4] ENTITY[3] ENTITY[1] (
 study(ENTITY[1]) ∧
  NF-Y_expression(ENTITY[4]) ∧
   human(ATTRIB[6]) ∧
    macrophage_maturation(ENTITY[7]) ∧
     is_monocyte_to(ENTITY[5], ENTITY[7]) ∧ is_monocyte_ATTRIBUTE(ENTITY[5], ATTRIB[6]) ∧
      is_regulation_during(ENTITY[3], ENTITY[5]) ∧ is_regulation_of(ENTITY[3], ENTITY[4]) ∧
       REF1[2] = we ∧
        past(EVENT[8]) ∧ analyzed(EVENT[8], REF1[2], ENTITY[3]) ∧ In(EVENT[8]) = ENTITY[1])

# ::id 38_nonfiction_GENIA-1999;99102381,3;NE
# ::snt NF-Y is a ubiquitous and evolutionarily conserved transcription factor that binds specifically to the CCAAT motif present in the 5' promoter region of a wide variety of genes .
∃ ATTRIB[3] ATTRIB[2] ATTRIB[10] ATTRIB[8] ATTRIB[6] ATTRIB[10] ATTRIB[8] ATTRIB[6] EVENT[12] EVENT[12] EVENT[14] ENTITY[1] GROUP[11] ENTITY[9] ENTITY[7] ENTITY[5] GROUP[11] ENTITY[9] ENTITY[7] ENTITY[5] (
 5'(ATTRIB[8]) ∧
  wide(ATTRIB[10]) ∧
   genes(GROUP[11]) ∧
    is_variety_of(ENTITY[9], GROUP[11]) ∧ is_variety_ATTRIBUTE(ENTITY[9], ATTRIB[10]) ∧
     is_promoter_region_of(ENTITY[7], ENTITY[9]) ∧ is_promoter_region_ATTRIBUTE(ENTITY[7], ATTRIB[8]) ∧
      is_present_in(ATTRIB[6], ENTITY[7]) ∧
       is_CCAAT_motif_ATTRIBUTE(ENTITY[5], ATTRIB[6]) ∧
        5'(ATTRIB[8]) ∧
         wide(ATTRIB[10]) ∧
          genes(GROUP[11]) ∧
           is_variety_of(ENTITY[9], GROUP[11]) ∧ is_variety_ATTRIBUTE(ENTITY[9], ATTRIB[10]) ∧
            is_promoter_region_of(ENTITY[7], ENTITY[9]) ∧ is_promoter_region_ATTRIBUTE(ENTITY[7], ATTRIB[8]) ∧
             is_present_in(ATTRIB[6], ENTITY[7]) ∧
              is_CCAAT_motif_ATTRIBUTE(ENTITY[5], ATTRIB[6]) ∧
               ubiquitous(ATTRIB[2]) ∧
                evolutionarily_conserved(ATTRIB[3]) ∧
                 CONJ_and(binds(EVENT[12], ENTITY[1]) ∧ to(EVENT[12]) = ENTITY[5] ∧
                       is_transcription_factor_ATTRIBUTE(ENTITY[1], ATTRIB[2]),
                  binds(EVENT[12], ENTITY[1]) ∧ to(EVENT[12]) = ENTITY[5] ∧
                   is_transcription_factor_ATTRIBUTE(ENTITY[1], ATTRIB[3])) ∧
                  ADV_specifically(EVENT[12]) ∧ ADV_specifically(EVENT[12]) ∧ copula(EVENT[14], ENTITY[NF-Y], ENTITY[1]))

# ::id 39_nonfiction_GENIA-1999;99102381,4;NE
# ::snt We show here that in circulating monocytes , NF-Y binding activity is not detected on the CCAAT motif present in the promoters of genes such as major histocompatibility complex -LRB- MHC -RRB- class II , gp91-phox , mig , and fibronectin , whereas during macrophage differentiation , a progressive increase in NF-Y binding activity is observed on these promoters .
∃ SITUATION[23] ATTRIB[11] ATTRIB[6] SITUATION[3] REF1[1] ATTRIB[21] ATTRIB[17] ATTRIB[14] EVENT[9] EVENT[2] ENTITY[7] ENTITY[5] ENTITY[4] ENTITY[12] GROUP[10] GROUP[8] ENTITY[19] ENTITY[20] GROUP[18] GROUP[16] GROUP[15] ENTITY[13] (
 promoters(GROUP[8]) ∧
  genes(GROUP[16]) ∧
   major(ATTRIB[21]) ∧
    is_histocompatibility_complex_class_II_ATTRIBUTE(ENTITY[20], ATTRIB[21]) ∧
     MHC(ENTITY[19]) ∧
      is_-ENTITY-_namely(ENTITY[20], ENTITY[19]) ∧
       is_element_of(ENTITY[20], GROUP[18]) ∧ is_element_of(ENTITY[gp91-phox], GROUP[18]) ∧ is_element_of(ENTITY[mig], GROUP[18]) ∧
        is_element_of(ENTITY[fibronectin], GROUP[18]) ∧
        is_such_as(ATTRIB[17], GROUP[18]) ∧
         is_promoters_ATTRIBUTE(GROUP[15], ATTRIB[17]) ∧ is_promoters_of(GROUP[15], GROUP[16]) ∧
          is_present_in(ATTRIB[14], GROUP[15]) ∧
           is_CCAAT_motif_ATTRIBUTE(ENTITY[13], ATTRIB[14]) ∧
            REF1[1] = we ∧
             macrophage_differentiation(ENTITY[4]) ∧
              progressive(ATTRIB[6]) ∧
               NF-Y_binding_activity(ENTITY[7]) ∧
                is_increase_in(ENTITY[5], ENTITY[7]) ∧ is_increase_ATTRIBUTE(ENTITY[5], ATTRIB[6]) ∧
                 is_FACT_THAT(SITUATION[3],
                  observed(EVENT[9], _, ENTITY[5]) ∧ on(EVENT[9]) = GROUP[8] ∧
                   during(EVENT[9]) = ENTITY[4]) ∧
                  circulating(ATTRIB[11]) ∧
                   is_monocytes_ATTRIBUTE(GROUP[10], ATTRIB[11]) ∧
                    NF-Y_binding_activity(ENTITY[12]) ∧
                     LOC_here(SITUATION[23]) ∧
                      is_FACT_THAT(SITUATION[23],
                       show(EVENT[2], REF1[1],
                        ¬ ∃ EVENT[22] (
                              detected(EVENT[22], _, ENTITY[12]) ∧
                               on(EVENT[22]) = ENTITY[13] ∧
                                in(EVENT[22]) = GROUP[10]))))

# ::id 40_nonfiction_GENIA-1999;99102381,5;NE
# ::snt Analysis of NF-Y subunit expression indicates that the absence of NF-Y activity in circulating monocytes is caused by a lack of the A subunit .
∃ ATTRIB[7] EVENT[10] EVENT[3] ENTITY[2] ENTITY[8] ENTITY[1] GROUP[6] ENTITY[5] ENTITY[9] ENTITY[4] (
 circulating(ATTRIB[7]) ∧
  is_monocytes_ATTRIBUTE(GROUP[6], ATTRIB[7]) ∧
   is_NF-Y_activity_in(ENTITY[5], GROUP[6]) ∧
    is_absence_of(ENTITY[4], ENTITY[5]) ∧
     A_subunit(ENTITY[9]) ∧
      NF-Y_subunit_expression(ENTITY[2]) ∧
       is_Analysis_of(ENTITY[1], ENTITY[2]) ∧
        is_lack_of(ENTITY[8], ENTITY[9]) ∧ indicates(EVENT[3], ENTITY[1], caused(EVENT[10], ENTITY[8], ENTITY[4])))

# ::id 41_nonfiction_GENIA-1999;99102381,6;NE
# ::snt Furthermore , addition of the recombinant NF-YA subunit restores NF-Y binding .
∃ EVENT[4] ENTITY[3] ENTITY[1] ENTITY[2] (
 recombinant_NF-YA_subunit(ENTITY[2]) ∧
  is_addition_of(ENTITY[1], ENTITY[2]) ∧ NF-Y_binding(ENTITY[3]) ∧ ADV_furthermore(EVENT[4]) ∧ restores(EVENT[4], ENTITY[1], ENTITY[3]))

# ::id 42_nonfiction_GENIA-1999;99102381,7;NE
# ::snt We show that the lack of NF-YA protein is due to posttranscriptional regulation and not to a specific proteolytic activity .
∃ ATTRIB[11] ATTRIB[10] ATTRIB[7] ATTRIB[5] REF1[1] EVENT[12] EVENT[2] ENTITY[6] ENTITY[9] ENTITY[4] ENTITY[3] (
 NF-YA_protein(ENTITY[4]) ∧
  is_lack_of(ENTITY[3], ENTITY[4]) ∧
   REF1[1] = we ∧
    posttranscriptional(ATTRIB[7]) ∧
     is_regulation_ATTRIBUTE(ENTITY[6], ATTRIB[7]) ∧
      specific(ATTRIB[10]) ∧
       proteolytic(ATTRIB[11]) ∧
        is_activity_ATTRIBUTE(ENTITY[9], ATTRIB[11]) ∧ is_activity_ATTRIBUTE(ENTITY[9], ATTRIB[10]) ∧
         CONJ_and(is_due_to(ATTRIB[5], ENTITY[6]), NOT ENTITY[8] (is_of(ENTITY[8], ENTITY[9]), is_due_to(ATTRIB[5], ENTITY[8]))) ∧
          show(EVENT[2], REF1[1], copula(EVENT[12], ENTITY[3]) ∧ ATTRIBUTE(EVENT[12]) = ATTRIB[5]))

# ::id 43_nonfiction_GENIA-1999;99102381,8;NE
# ::snt In fact , NF-YA mRNA is present at the same level at all days of monocyte cultivation , whereas the protein is absent in freshly isolated monocytes but is progressively synthesized during the maturation process .
∃ ATTRIB[12] ATTRIB[10] SITUATION[8] ATTRIB[3] ATTRIB[5] EVENT[13] EVENT[15] EVENT[17] GROUP[11] ENTITY[2] ENTITY[1] ENTITY[4] ENTITY[14] ENTITY[9] (
 same(ATTRIB[5]) ∧
  is_level_ATTRIBUTE(ENTITY[4], ATTRIB[5]) ∧
   protein(ENTITY[9]) ∧
    maturation_process(ENTITY[14]) ∧
     fact(ENTITY[1]) ∧
      NF-YA_mRNA(ENTITY[2]) ∧
       ALL ENTITY[7] GROUP[6] ((monocyte_cultivation(ENTITY[7]) ∧ is_days_of(GROUP[6], ENTITY[7])),
        is_present_at(ATTRIB[3], GROUP[6]) ∧ is_present_at(ATTRIB[3], ENTITY[4])) ∧
        isolated(ATTRIB[12]) ∧
         ADV_freshly(GROUP[11]) ∧ is_monocytes_ATTRIBUTE(GROUP[11], ATTRIB[12]) ∧
          is_absent_in(ATTRIB[10], GROUP[11]) ∧
           is_FACT_THAT(SITUATION[8],
            CONJ_but(copula(EVENT[13], ENTITY[9]) ∧ ATTRIBUTE(EVENT[13]) = ATTRIB[10],
             is_synthesized(EVENT[15], ENTITY[9]) ∧ during(EVENT[15]) = ENTITY[14])) ∧
            ADV_progressively(EVENT[15]) ∧
             copula(EVENT[17], ENTITY[2]) ∧ whereas(EVENT[17]) = SITUATION[8] ∧
              ATTRIBUTE(EVENT[17]) = ATTRIB[3] ∧ In(EVENT[17]) = ENTITY[1])

# ::id 44_nonfiction_GENIA-1999;99102381,9;NE
# ::snt We thus conclude that the NF-YA subunit plays a relevant role in activating transcription of genes highly expressed in mature monocytes .
∃ SITUATION[14] ATTRIB[11] ATTRIB[9] SITUATION[6] ATTRIB[5] REF1[1] EVENT[12] EVENT[13] EVENT[2] GROUP[10] GROUP[8] ENTITY[7] ENTITY[4] ENTITY[3] (
 NF-YA_subunit(ENTITY[3]) ∧
  REF1[1] = we ∧
   relevant(ATTRIB[5]) ∧
    mature(ATTRIB[11]) ∧
     is_monocytes_ATTRIBUTE(GROUP[10], ATTRIB[11]) ∧
      is_highly_expressed_in(ATTRIB[9], GROUP[10]) ∧
       is_genes_ATTRIBUTE(GROUP[8], ATTRIB[9]) ∧
        is_transcription_of(ENTITY[7], GROUP[8]) ∧
         is_FACT_THAT(SITUATION[6], activating(EVENT[12], _, ENTITY[7])) ∧
          is_role_in(ENTITY[4], SITUATION[6]) ∧ is_role_ATTRIBUTE(ENTITY[4], ATTRIB[5]) ∧
           ADV_thus(SITUATION[14]) ∧
            is_FACT_THAT(SITUATION[14], conclude(EVENT[2], REF1[1], plays(EVENT[13], ENTITY[3], ENTITY[4]))))

# ::id 45_nonfiction_GENIA-1999;99102381,10;NE
# ::snt In line with this conclusion , we show that the cut/CDP protein , a transcriptional repressor that inhibits gpc91-phox gene expression by preventing NF-Y binding to the CAAT box , is absent in monocytes .
∃ ATTRIB[14] REF1[3] ATTRIB[6] EVENT[16] EVENT[4] GROUP[15] ENTITY[1] EVENT[11] EVENT[12] ENTITY[2] ENTITY[10] ENTITY[9] ENTITY[8] ENTITY[5] ENTITY[13] (
 conclusion(ENTITY[2]) ∧
  cut__slash__CDP_protein(ENTITY[13]) ∧
   transcriptional(ATTRIB[6]) ∧
    gpc91-phox_gene_expression(ENTITY[8]) ∧
     CAAT_box(ENTITY[10]) ∧
      is_NF-Y_binding_to(ENTITY[9], ENTITY[10]) ∧
       CRD_by(preventing(EVENT[11], ENTITY[8], ENTITY[9]), inhibits(EVENT[12], ENTITY[5], ENTITY[8])) ∧
        is_repressor_ATTRIBUTE(ENTITY[5], ATTRIB[6]) ∧
        is_-ENTITY-_namely(ENTITY[13], ENTITY[5]) ∧
         is_line_with(ENTITY[1], ENTITY[2]) ∧
          REF1[3] = we ∧
           monocytes(GROUP[15]) ∧
            is_absent_in(ATTRIB[14], GROUP[15]) ∧
             show(EVENT[4], REF1[3], copula(EVENT[16], ENTITY[13], ATTRIB[14])) ∧ In(EVENT[4]) = ENTITY[1])

# ::id 46_nonfiction_GENIA-1999;99102590,1;NE
# ::snt Accessing Epstein-Barr virus-specific T-cell memory with peptide-loaded dendritic cells .
∃ ATTRIB[4] ATTRIB[3] EVENT[5] GROUP[2] ENTITY[1] (
 Epstein-Barr_virus-specific_T-cell_memory(ENTITY[1]) ∧
  peptide-loaded(ATTRIB[3]) ∧
   dendritic(ATTRIB[4]) ∧
    is_cells_ATTRIBUTE(GROUP[2], ATTRIB[4]) ∧ is_cells_ATTRIBUTE(GROUP[2], ATTRIB[3]) ∧
     accessing(EVENT[5], _, ENTITY[1]) ∧ with(EVENT[5]) = GROUP[2])

# ::id 47_nonfiction_GENIA-1999;99102590,2;NE
# ::snt The conventional means of studying Epstein-Barr virus -LRB- EBV -RRB- -induced cytotoxic T-lymphocyte -LRB- CTL -RRB- memory , by in vitro stimulation with the latently infected autologous lymphoblastoid cell line -LRB- LCL -RRB- , has important limitations .
∃ ATTRIB[17] ATTRIB[14] ATTRIB[11] ATTRIB[9] ATTRIB[6] SITUATION[3] ATTRIB[2] EVENT[18] GROUP[16] EVENT[15] ENTITY[7] ENTITY[8] ENTITY[4] ENTITY[12] ENTITY[13] ENTITY[10] ENTITY[5] GROUP[1] (
 conventional(ATTRIB[2]) ∧
  Epstein-Barr_virus(ENTITY[8]) ∧
   EBV(ENTITY[7]) ∧
    is_-ENTITY-_namely(ENTITY[8], ENTITY[7]) ∧
     is-induced_comp(ATTRIB[6], ENTITY[8]) ∧
      cytotoxic(ATTRIB[9]) ∧
       is_T-lymphocyte_memory_ATTRIBUTE(ENTITY[5], ATTRIB[9]) ∧ is_T-lymphocyte_memory_ATTRIBUTE(ENTITY[5], ATTRIB[6]) ∧
        CTL(ENTITY[4]) ∧
         is_-ENTITY-_namely(ENTITY[5], ENTITY[4]) ∧
          in_vitro(ATTRIB[11]) ∧
           latently_infected(ATTRIB[14]) ∧
            is_autologous_lymphoblastoid_cell_line_ATTRIBUTE(ENTITY[13], ATTRIB[14]) ∧
             LCL(ENTITY[12]) ∧
              is_-ENTITY-_namely(ENTITY[13], ENTITY[12]) ∧
               is_stimulation_with(ENTITY[10], ENTITY[13]) ∧ is_stimulation_ATTRIBUTE(ENTITY[10], ATTRIB[11]) ∧
                is_FACT_THAT(SITUATION[3], studying(EVENT[15], _, ENTITY[5]) ∧ by(EVENT[15]) = ENTITY[10]) ∧
                 is_means_ATTRIBUTE(GROUP[1], ATTRIB[2]) ∧ is_means_of(GROUP[1], SITUATION[3]) ∧
                  important(ATTRIB[17]) ∧ is_limitations_ATTRIBUTE(GROUP[16], ATTRIB[17]) ∧ has(EVENT[18], GROUP[1], GROUP[16]))

# ::id 48_nonfiction_GENIA-1999;99102590,3;NE
# ::snt First , it gives no information on memory to lytic cycle antigens ;
∃ SITUATION[7] REF1[1] (
 REF1[1] = it ∧
  TMP_first(SITUATION[7]) ∧
   is_FACT_THAT(SITUATION[7],
    ¬ ∃ ATTRIB[5] EVENT[6] ENTITY[3] GROUP[4] ENTITY[2] (
          memory(ENTITY[3]) ∧
           is_information_on(ENTITY[2], ENTITY[3]) ∧
            lytic(ATTRIB[5]) ∧
             is_cycle_antigens_ATTRIBUTE(GROUP[4], ATTRIB[5]) ∧ gives(EVENT[6], REF1[1], ENTITY[2], GROUP[4]))))

# ::id 49_nonfiction_GENIA-1999;99102590,3;NE
# ::snt second , it preferentially amplifies the dominant components of latent antigen-specific memory at the expense of key subdominant reactivities .
∃ REF1[1] ATTRIB[10] ATTRIB[9] ATTRIB[6] ATTRIB[5] ATTRIB[3] EVENT[11] ENTITY[4] GROUP[8] ENTITY[7] GROUP[2] (
 dominant(ATTRIB[3]) ∧
  latent(ATTRIB[5]) ∧
   antigen-specific(ATTRIB[6]) ∧
    is_memory_ATTRIBUTE(ENTITY[4], ATTRIB[6]) ∧ is_memory_ATTRIBUTE(ENTITY[4], ATTRIB[5]) ∧
     is_components_of(GROUP[2], ENTITY[4]) ∧ is_components_ATTRIBUTE(GROUP[2], ATTRIB[3]) ∧
      key(ATTRIB[9]) ∧
       subdominant(ATTRIB[10]) ∧
        is_reactivities_ATTRIBUTE(GROUP[8], ATTRIB[10]) ∧ is_reactivities_ATTRIBUTE(GROUP[8], ATTRIB[9]) ∧
         is_expense_of(ENTITY[7], GROUP[8]) ∧
          REF1[1] = it ∧
           second(EVENT[11]) ∧
            ADV_preferentially(EVENT[11]) ∧ amplifies(EVENT[11], REF1[1], GROUP[2]) ∧ at(EVENT[11]) = ENTITY[7])

# ::id 50_nonfiction_GENIA-1999;99102590,4;NE
# ::snt Here we describe an alternative approach , based on in vitro stimulation with epitope peptide-loaded dendritic cells -LRB- DCs -RRB- , which allows one to probe the CTL repertoire for any individual reactivity of choice ;
∃ SITUATION[22] REF2[14] ATTRIB[11] ATTRIB[10] ATTRIB[9] ATTRIB[6] ATTRIB[3] REF1[1] EVENT[12] EVENT[15] EVENT[21] ENTITY[7] GROUP[8] ENTITY[5] ENTITY[2] ENTITY[16] (
 CTL_repertoire(ENTITY[16]) ∧
  REF1[1] = we ∧
   alternative(ATTRIB[3]) ∧
    in_vitro(ATTRIB[6]) ∧
     epitope(ATTRIB[9]) ∧
      peptide-loaded(ATTRIB[10]) ∧
       dendritic(ATTRIB[11]) ∧
        is_cells_ATTRIBUTE(GROUP[8], ATTRIB[11]) ∧ is_cells_ATTRIBUTE(GROUP[8], ATTRIB[10]) ∧ is_cells_ATTRIBUTE(GROUP[8], ATTRIB[9]) ∧
         DCs(ENTITY[7]) ∧
          is_-GROUP-_namely(GROUP[8], ENTITY[7]) ∧
           is_stimulation_with(ENTITY[5], GROUP[8]) ∧ is_stimulation_ATTRIBUTE(ENTITY[5], ATTRIB[6]) ∧
            REF2[14] = one ∧
             based(EVENT[12], _, ENTITY[2]) ∧ on(EVENT[12]) = ENTITY[5] ∧
              allows(EVENT[15], ENTITY[2], REF2[14],
               ANY ATTRIB[18] ENTITY[19] ENTITY[17] (
                (individual(ATTRIB[18]) ∧ choice(ENTITY[19]) ∧
                 is_reactivity_of(ENTITY[17], ENTITY[19]) ∧ is_reactivity_ATTRIBUTE(ENTITY[17], ATTRIB[18])),
                ∃ EVENT[20] (probe(EVENT[20], REF2[14], ENTITY[16]) ∧ for(EVENT[20]) = ENTITY[17]))) ∧
               is_approach_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
              LOC_here(SITUATION[22]) ∧ is_FACT_THAT(SITUATION[22], describe(EVENT[21], REF1[1], ENTITY[2])))

# ::id 51_nonfiction_GENIA-1999;99102590,4;NE
# ::snt this method proved significantly more efficient than stimulation with peptide alone .
∃ ATTRIB[2] EVENT[6] ENTITY[5] ENTITY[3] ENTITY[1] (
 method(ENTITY[1]) ∧
  peptide(ENTITY[5]) ∧
   ALONE ENTITY[4] (is_of(ENTITY[4], ENTITY[5]), is_stimulation_with(ENTITY[3], ENTITY[4])) ∧
    is_significantly_more_efficient_than(ATTRIB[2], ENTITY[3]) ∧ past(EVENT[6]) ∧ proved(EVENT[6], ENTITY[1], ATTRIB[2]))

# ::id 52_nonfiction_GENIA-1999;99102590,5;NE
# ::snt Using this approach we first show that reactivities to the immunodominant and subdominant lytic cycle epitopes identified by T cells during primary EBV infection are regularly detectable in the CTL memory of virus carriers ;
∃ SITUATION[21] ATTRIB[17] REF1[1] ATTRIB[15] ATTRIB[11] ATTRIB[9] EVENT[3] EVENT[20] EVENT[4] GROUP[5] EVENT[16] ENTITY[2] GROUP[8] GROUP[10] ENTITY[14] GROUP[13] GROUP[7] ENTITY[6] GROUP[19] ENTITY[18] (
 approach(ENTITY[2]) ∧
  immunodominant(ATTRIB[9]) ∧
   is_lytic_cycle_epitopes_ATTRIBUTE(GROUP[8], ATTRIB[9]) ∧
    subdominant(ATTRIB[11]) ∧
     is_lytic_cycle_epitopes_ATTRIBUTE(GROUP[10], ATTRIB[11]) ∧
      is_subset_of_or_equal_to(GROUP[8], GROUP[7]) ∧ is_subset_of_or_equal_to(GROUP[10], GROUP[7]) ∧
       T_cells(GROUP[13]) ∧
        primary(ATTRIB[15]) ∧
         is_EBV_infection_ATTRIBUTE(ENTITY[14], ATTRIB[15]) ∧
          identified(EVENT[16], GROUP[13], ENTITY[6]) ∧ during(EVENT[16]) = ENTITY[14] ∧
           is_equals(ENTITY[6], GROUP[7]) ∧
           virus_carriers(GROUP[19]) ∧
            is_CTL_memory_of(ENTITY[18], GROUP[19]) ∧
             REF1[1] = we ∧
              is_reactivities_to(GROUP[5], ENTITY[6]) ∧
               is_regularly_detectable_in(ATTRIB[17], ENTITY[18]) ∧
                ADV_first(SITUATION[21]) ∧
                 CONJ_and(using(EVENT[3], REF1[1], ENTITY[2]),
                  is_FACT_THAT(SITUATION[21], show(EVENT[4], REF1[1], copula(EVENT[20], GROUP[5], ATTRIB[17])))))

# ::id 53_nonfiction_GENIA-1999;99102590,5;NE
# ::snt this implies that in such carriers chronic virus replication remains under direct T-cell control .
∃ ATTRIB[8] ATTRIB[6] ATTRIB[4] EVENT[9] EVENT[2] ENTITY[7] ENTITY[5] GROUP[3] ENTITY[1] (
 such(ATTRIB[4]) ∧
  is_carriers_ATTRIBUTE(GROUP[3], ATTRIB[4]) ∧
   chronic(ATTRIB[6]) ∧
    is_virus_replication_ATTRIBUTE(ENTITY[5], ATTRIB[6]) ∧
     direct(ATTRIB[8]) ∧
      is_T-cell_control_ATTRIBUTE(ENTITY[7], ATTRIB[8]) ∧
       implies(EVENT[2], ENTITY[1],
        remains(EVENT[9], ENTITY[5]) ∧ under(EVENT[9]) = ENTITY[7] ∧ in(EVENT[9]) = GROUP[3]))

# ::id 54_nonfiction_GENIA-1999;99102590,6;NE
# ::snt We further show that subdominant latent cycle reactivities to epitopes in the latent membrane protein LMP2 , though rarely undetectable in LCL-stimulated populations , can be reactivated by DC stimulation and selectively expanded as polyclonal CTL lines ;
∃ ATTRIB[12] ATTRIB[10] ATTRIB[9] ATTRIB[6] ATTRIB[5] ATTRIB[4] REF1[1] EVENT[2] ENTITY[8] GROUP[7] GROUP[11] GROUP[3] (
 REF1[1] = we ∧
  subdominant(ATTRIB[4]) ∧
   latent(ATTRIB[5]) ∧
    cycle(ATTRIB[6]) ∧
     latent(ATTRIB[9]) ∧
      is_membrane_protein_ATTRIBUTE(ENTITY[8], ATTRIB[9]) ∧
       is_-ENTITY-_namely(ENTITY[LMP2], ENTITY[8]) ∧
        is_epitopes_in(GROUP[7], ENTITY[LMP2]) ∧
         is_reactivities_to(GROUP[3], GROUP[7]) ∧ is_reactivities_ATTRIBUTE(GROUP[3], ATTRIB[6]) ∧ is_reactivities_ATTRIBUTE(GROUP[3], ATTRIB[5]) ∧
          is_reactivities_ATTRIBUTE(GROUP[3], ATTRIB[4]) ∧
          lcl-stimulated(ATTRIB[12]) ∧
           is_populations_ATTRIBUTE(GROUP[11], ATTRIB[12]) ∧
            is_rarely_undetectable_in(ATTRIB[10], GROUP[11]) ∧
             ADV_further(EVENT[2]) ∧
              show(EVENT[2], REF1[1],
               MD_can(∃ ATTRIB[16] EVENT[14] EVENT[17] ENTITY[13] GROUP[15] (
                     DC_stimulation(ENTITY[13]) ∧
                      polyclonal(ATTRIB[16]) ∧
                       is_CTL_lines_ATTRIBUTE(GROUP[15], ATTRIB[16]) ∧
                        ADV_selectively(EVENT[17]) ∧
                         CONJ_and(reactivated(EVENT[14], ENTITY[13], GROUP[3]) ∧ though(EVENT[14]) = ATTRIB[10],
                          be_expanded(EVENT[17], GROUP[3]) ∧ as(EVENT[17]) = GROUP[15] ∧
                           though(EVENT[17]) = ATTRIB[10])))))

# ::id 55_nonfiction_GENIA-1999;99102590,6;NE
# ::snt the adoptive transfer of such preparations may be of value in targeting certain EBV-positive malignancies .
∃ ATTRIB[4] ATTRIB[2] GROUP[3] ENTITY[1] (
 adoptive(ATTRIB[2]) ∧
  such(ATTRIB[4]) ∧
   is_preparations_ATTRIBUTE(GROUP[3], ATTRIB[4]) ∧
    is_transfer_of(ENTITY[1], GROUP[3]) ∧ is_transfer_ATTRIBUTE(ENTITY[1], ATTRIB[2]) ∧
     MD_may(∃ ATTRIB[9] ATTRIB[8] SITUATION[6] EVENT[10] EVENT[11] GROUP[7] ENTITY[5] (
           value(ENTITY[5]) ∧
            certain(ATTRIB[8]) ∧
             ebv-positive(ATTRIB[9]) ∧
              is_malignancies_ATTRIBUTE(GROUP[7], ATTRIB[9]) ∧ is_malignancies_ATTRIBUTE(GROUP[7], ATTRIB[8]) ∧
               is_FACT_THAT(SITUATION[6], targeting(EVENT[10], ENTITY[1], GROUP[7])) ∧
                copula(EVENT[11], ENTITY[1]) ∧ in(EVENT[11]) = SITUATION[6] ∧
                 of(EVENT[11]) = ENTITY[5])))

# ::id 56_nonfiction_GENIA-1999;99103960,1;NE
# ::snt Differential monocyte adhesion and adhesion molecule expression in venous and arterial endothelial cells .
∃ EVENT[13] GROUP[6] GROUP[2] ENTITY[1] (
 ∃ ATTRIB[4] ENTITY[3] (differential(ATTRIB[4]) ∧ is_monocyte_adhesion_ATTRIBUTE(ENTITY[3], ATTRIB[4]) ∧ is_element_of(ENTITY[3], GROUP[2])) ∧
  ∃ ENTITY[5] (adhesion_molecule_expression(ENTITY[5]) ∧ is_element_of(ENTITY[5], GROUP[2])) ∧
  ∃ ATTRIB[9] ATTRIB[8] GROUP[7] (
   venous(ATTRIB[8]) ∧
    endothelial(ATTRIB[9]) ∧
     is_cells_ATTRIBUTE(GROUP[7], ATTRIB[9]) ∧ is_cells_ATTRIBUTE(GROUP[7], ATTRIB[8]) ∧ is_subset_of_or_equal_to(GROUP[7], GROUP[6])) ∧
   ∃ ATTRIB[12] ATTRIB[11] GROUP[10] (
    arterial(ATTRIB[11]) ∧
     endothelial(ATTRIB[12]) ∧
      is_cells_ATTRIBUTE(GROUP[10], ATTRIB[12]) ∧ is_cells_ATTRIBUTE(GROUP[10], ATTRIB[11]) ∧ is_subset_of_or_equal_to(GROUP[10], GROUP[6])) ∧
   is_in(ENTITY[1], GROUP[6]) ∧ is_equals(ENTITY[1], GROUP[2]) ∧
    xxx(EVENT[13]) ∧ LINK(EVENT[13]) = ENTITY[1])

# ::id 57_nonfiction_GENIA-1999;99103960,2;NE
# ::snt We compared U-937 cell adhesion and adhesion molecule expression in human umbilical venous -LRB- HUVECs -RRB- and arterial -LRB- HUAECs -RRB- endothelial cells exposed to tumor necrosis factor -LRB- TNF -RRB- , interleukin-1 , and lipopolysaccharide -LRB- LPS -RRB- .
∃ REF1[1] EVENT[19] EVENT[20] GROUP[16] GROUP[5] GROUP[14] GROUP[2] (
 REF1[1] = we ∧
  ∃ ENTITY[3] (U-937_cell_adhesion(ENTITY[3]) ∧ is_element_of(ENTITY[3], GROUP[2])) ∧
   ∃ ENTITY[4] (adhesion_molecule_expression(ENTITY[4]) ∧ is_element_of(ENTITY[4], GROUP[2])) ∧
   ∃ ENTITY[17] (tumor_necrosis_factor(ENTITY[17]) ∧ is_-ENTITY-_namely(ENTITY[17], ENTITY[TNF]) ∧ is_element_of(ENTITY[17], GROUP[16])) ∧
    is_element_of(ENTITY[interleukin-1], GROUP[16]) ∧
    ∃ ENTITY[18] (lipopolysaccharide(ENTITY[18]) ∧ is_-ENTITY-_namely(ENTITY[18], ENTITY[LPS]) ∧ is_element_of(ENTITY[18], GROUP[16])) ∧
    exposed(EVENT[19], _, GROUP[14]) ∧ to(EVENT[19]) = GROUP[16] ∧ cells(GROUP[14]) ∧
     ∃ ATTRIB[10] ATTRIB[9] ATTRIB[8] ENTITY[6] ENTITY[7] (
      human(ATTRIB[8]) ∧
       umbilical(ATTRIB[9]) ∧
        venous(ATTRIB[10]) ∧
         is_ATTRIBUTE(ENTITY[7], ATTRIB[10]) ∧ is_ATTRIBUTE(ENTITY[7], ATTRIB[9]) ∧ is_ATTRIBUTE(ENTITY[7], ATTRIB[8]) ∧
          HUVECs(ENTITY[6]) ∧ is_-ENTITY-_namely(ENTITY[7], ENTITY[6]) ∧ is_element_of(ENTITY[7], GROUP[5])) ∧
      ∃ ATTRIB[13] ENTITY[11] ENTITY[12] (
       arterial(ATTRIB[13]) ∧
        is_endothelial_ATTRIBUTE(ENTITY[12], ATTRIB[13]) ∧
         HUAECs(ENTITY[11]) ∧ is_-ENTITY-_namely(ENTITY[12], ENTITY[11]) ∧ is_element_of(ENTITY[12], GROUP[5])) ∧
      is_-GROUP-_namely(GROUP[14], GROUP[5]) ∧
       past(EVENT[20]) ∧ compared(EVENT[20], REF1[1], GROUP[2]) ∧ in(EVENT[20]) = GROUP[14])

# ::id 58_nonfiction_GENIA-1999;99103960,3;NE
# ::snt TNF and LPS stimulated vascular cell adhesion molecule -LRB- VCAM -RRB- -1 surface expression and adhesion of U-937 monocyte-like cells to HUVECs but not to HUAECs .
∃ EVENT[11] GROUP[2] GROUP[1] (
 is_element_of(ENTITY[TNF], GROUP[1]) ∧ is_element_of(ENTITY[LPS], GROUP[1]) ∧
  ∃ ATTRIB[5] ENTITY[3] ENTITY[4] (
   vascular(ATTRIB[5]) ∧
    is_cell_adhesion_molecule-1_surface_expression_ATTRIBUTE(ENTITY[4], ATTRIB[5]) ∧
     VCAM(ENTITY[3]) ∧ is_-ENTITY-_namely(ENTITY[4], ENTITY[3]) ∧ is_element_of(ENTITY[4], GROUP[2])) ∧
   ∃ GROUP[8] GROUP[10] GROUP[7] ENTITY[6] (
    U-937_monocyte-like_cells(GROUP[7]) ∧
     HUVECs(GROUP[8]) ∧
      HUAECs(GROUP[10]) ∧
       CONJ_but(is_adhesion_to(ENTITY[6], GROUP[8]) ∧ is_adhesion_of(ENTITY[6], GROUP[7]),
        NOT ENTITY[9] (is_element_of(ENTITY[9], GROUP[10]), is_adhesion_to(ENTITY[6], ENTITY[9]) ∧ is_adhesion_of(ENTITY[6], GROUP[7]))) ∧
        is_element_of(ENTITY[6], GROUP[2])) ∧ past(EVENT[11]) ∧ stimulated(EVENT[11], GROUP[1], GROUP[2]))

# ::id 59_nonfiction_GENIA-1999;99103960,4;NE
# ::snt Antibody studies demonstrated that in HUVECs at least 75 % of the adhesion response is VCAM-1 mediated .
∃ ATTRIB[7] EVENT[8] EVENT[2] ENTITY[4] GROUP[3] GROUP[1] ENTITY[6] (
 adhesion_response(ENTITY[6]) ∧
  Antibody_studies(GROUP[1]) ∧
   HUVECs(GROUP[3]) ∧
    (CD_75(ENTITY[4]), LEAST ENTITY[5] (is%of(ENTITY[4], ENTITY[6]) ∧ is%at(ENTITY[4], ENTITY[5]))) ∧
     is_mediated_comp(ATTRIB[7], ENTITY[VCAM-1]) ∧
      past(EVENT[2]) ∧
       demonstrated(EVENT[2], GROUP[1], copula(EVENT[8], ENTITY[4], ATTRIB[7]) ∧ in(EVENT[8]) = GROUP[3]))

# ::id 60_nonfiction_GENIA-1999;99103960,5;NE
# ::snt Interleukin-1 stimulated U-937 cell adhesion to and VCAM-1 surface expression in both HUVECs and HUAECs .
∃ EVENT[12] GROUP[1] (
 ∃ ENTITY[2] (
  BOTH GROUP[4] group[3] (
   (∃ GROUP[5] (HUVECs(GROUP[5]) ∧ is_subset_of_or_equal_to(GROUP[5], GROUP[4])) ∧
      ∃ GROUP[6] (HUAECs(GROUP[6]) ∧ is_subset_of_or_equal_to(GROUP[6], GROUP[4])) ∧ is_equals(group[3], GROUP[4])),
   is_U-937_cell_adhesion_to(ENTITY[2], group[3])) ∧ is_element_of(ENTITY[2], GROUP[1])) ∧
  ∃ ENTITY[7] (
   BOTH GROUP[9] group[8] (
    (∃ GROUP[10] (HUVECs(GROUP[10]) ∧ is_subset_of_or_equal_to(GROUP[10], GROUP[9])) ∧
       ∃ GROUP[11] (HUAECs(GROUP[11]) ∧ is_subset_of_or_equal_to(GROUP[11], GROUP[9])) ∧ is_equals(group[8], GROUP[9])),
    is_VCAM-1_surface_expression_in(ENTITY[7], group[8])) ∧ is_element_of(ENTITY[7], GROUP[1])) ∧
  past(EVENT[12]) ∧ stimulated(EVENT[12], ENTITY[Interleukin-1], GROUP[1]))

# ::id 61_nonfiction_GENIA-1999;99103960,6;NE
# ::snt Pyrrolidinedithiocarbamate and the proteasome inhibitor MG-132 blocked TNF- and LPS- stimulated U-937 cell adhesion to HUVECs .
∃ ATTRIB[4] EVENT[7] GROUP[5] GROUP[6] ENTITY[3] GROUP[1] (
 is_element_of(ENTITY[Pyrrolidinedithiocarbamate], GROUP[1]) ∧
  ∃ ENTITY[2] (proteasome_inhibitor(ENTITY[2]) ∧ is_-ENTITY-_namely(ENTITY[MG-132], ENTITY[2]) ∧ is_element_of(ENTITY[MG-132], GROUP[1])) ∧
  is_element_of(ENTITY[TNF-], GROUP[5]) ∧ is_element_of(ENTITY[LPS-], GROUP[5]) ∧
   is_stimulated_comp(ATTRIB[4], GROUP[5]) ∧
    HUVECs(GROUP[6]) ∧
     is_U-937_cell_adhesion_to(ENTITY[3], GROUP[6]) ∧ is_U-937_cell_adhesion_ATTRIBUTE(ENTITY[3], ATTRIB[4]) ∧
      past(EVENT[7]) ∧ blocked(EVENT[7], GROUP[1], ENTITY[3]))

# ::id 62_nonfiction_GENIA-1999;99103960,7;NE
# ::snt These agents also significantly decreased TNF- and LPS- stimulated increases in HUVEC surface VCAM-1 .
∃ ATTRIB[3] EVENT[6] GROUP[4] ENTITY[5] GROUP[2] GROUP[1] (
 agents(GROUP[1]) ∧
  is_element_of(ENTITY[TNF-], GROUP[4]) ∧ is_element_of(ENTITY[LPS-], GROUP[4]) ∧
   is_stimulated_comp(ATTRIB[3], GROUP[4]) ∧
    HUVEC_surface(ENTITY[5]) ∧
     is_-ENTITY-_namely(ENTITY[VCAM-1], ENTITY[5]) ∧
      is_increases_in(GROUP[2], ENTITY[VCAM-1]) ∧ is_increases_ATTRIBUTE(GROUP[2], ATTRIB[3]) ∧
       ADV_also(EVENT[6]) ∧ ADV_significantly(EVENT[6]) ∧ past(EVENT[6]) ∧ decreased(EVENT[6], GROUP[1], GROUP[2]))

# ::id 63_nonfiction_GENIA-1999;99103960,8;NE
# ::snt TNF increased VCAM-1 protein and mRNA in HUVECs that was blocked by pyrrolidinedithiocarbamate .
∃ EVENT[5] EVENT[6] GROUP[3] GROUP[1] (
 ∃ ENTITY[2] (VCAM-1_protein(ENTITY[2]) ∧ is_element_of(ENTITY[2], GROUP[1])) ∧ is_element_of(ENTITY[mRNA], GROUP[1]) ∧
  blocked(EVENT[5], ENTITY[pyrrolidinedithiocarbamate], GROUP[3]) ∧ HUVECs(GROUP[3]) ∧
   past(EVENT[5]) ∧
    past(EVENT[6]) ∧ increased(EVENT[6], ENTITY[TNF], GROUP[1]) ∧ in(EVENT[6]) = GROUP[3])

# ::id 64_nonfiction_GENIA-1999;99103960,9;NE
# ::snt However , neither TNF or LPS stimulated VCAM-1 expression in HUAECs .
∃ EVENT[4] GROUP[3] ENTITY[2] GROUP[1] (
 CONJ_neither_or(is_element_of(ENTITY[TNF], GROUP[1]), is_element_of(ENTITY[LPS], GROUP[1])) ∧
  HUAECs(GROUP[3]) ∧
   is_VCAM-1_expression_in(ENTITY[2], GROUP[3]) ∧
    ADV_however(EVENT[4]) ∧ past(EVENT[4]) ∧ stimulated(EVENT[4], GROUP[1], ENTITY[2]))

# ::id 65_nonfiction_GENIA-1999;99103960,10;NE
# ::snt TNF stimulated expression of both intercellular adhesion molecule-1 and E-selectin in HUVECs ,
∃ EVENT[7] ENTITY[1] (
 BOTH GROUP[3] group[2] (
  (∃ ATTRIB[5] ENTITY[4] (intercellular(ATTRIB[5]) ∧ is_adhesion_molecule-1_ATTRIBUTE(ENTITY[4], ATTRIB[5]) ∧ is_element_of(ENTITY[4], GROUP[3])) ∧
     is_element_of(ENTITY[E-selectin], GROUP[3]) ∧ is_equals(group[2], GROUP[3])),
  ∃ GROUP[6] (HUVECs(GROUP[6]) ∧ is_expression_in(ENTITY[1], GROUP[6]) ∧ is_expression_of(ENTITY[1], group[2]))) ∧
  past(EVENT[7]) ∧ stimulated(EVENT[7], ENTITY[TNF], ENTITY[1]))

# ::id 66_nonfiction_GENIA-1999;99103960,10;NE
# ::snt but in HUAECs , only intercellular adhesion molecule-1 was increased .
∃ ATTRIB[4] ENTITY[3] GROUP[1] (
 HUAECs(GROUP[1]) ∧
  intercellular(ATTRIB[4]) ∧
   is_adhesion_molecule-1_ATTRIBUTE(ENTITY[3], ATTRIB[4]) ∧
    ONLY ENTITY[2] (is_of(ENTITY[2], ENTITY[3]),
     ∃ EVENT[5] (past(EVENT[5]) ∧ increased(EVENT[5], _, ENTITY[2]) ∧ in(EVENT[5]) = GROUP[1])))

# ::id 67_nonfiction_GENIA-1999;99103960,11;NE
# ::snt Electrophoretic mobility shift assays demonstrated no difference in the pattern of TNF- stimulated nuclear factor -kappaB activation between HUVECs and HUAECs .
∃ ATTRIB[2] ATTRIB[7] ATTRIB[6] GROUP[1] ENTITY[5] ENTITY[4] (
 is_stimulated_comp(ATTRIB[6], ENTITY[TNF-]) ∧
  nuclear(ATTRIB[7]) ∧
   is_factor-kappaB_activation_ATTRIBUTE(ENTITY[5], ATTRIB[7]) ∧ is_factor-kappaB_activation_ATTRIBUTE(ENTITY[5], ATTRIB[6]) ∧
    is_pattern_of(ENTITY[4], ENTITY[5]) ∧
     electrophoretic(ATTRIB[2]) ∧
      is_mobility_shift_assays_ATTRIBUTE(GROUP[1], ATTRIB[2]) ∧
       ¬ ∃ EVENT[11] GROUP[8] ENTITY[3] (
             ∃ GROUP[9] (HUVECs(GROUP[9]) ∧ is_subset_of_or_equal_to(GROUP[9], GROUP[8])) ∧
              ∃ GROUP[10] (HUAECs(GROUP[10]) ∧ is_subset_of_or_equal_to(GROUP[10], GROUP[8])) ∧
              is_difference_between(ENTITY[3], GROUP[8]) ∧ is_difference_in(ENTITY[3], ENTITY[4]) ∧
               past(EVENT[11]) ∧ demonstrated(EVENT[11], GROUP[1], ENTITY[3])))

# ::id 68_nonfiction_GENIA-1999;99103960,12;NE
# ::snt These studies demonstrate a novel and striking insensitivity of arterial endothelium to the effects of TNF and LPS and indicate a dissociation between the ability of HUAECs to upregulate nuclear factor -kappaB and VCAM-1 .
∃ ATTRIB[6] ATTRIB[4] ATTRIB[6] ATTRIB[3] ATTRIB[15] EVENT[9] EVENT[17] ENTITY[5] ENTITY[5] ENTITY[2] ENTITY[10] EVENT[16] GROUP[8] GROUP[7] GROUP[8] GROUP[7] ENTITY[14] GROUP[13] GROUP[12] ENTITY[11] GROUP[1] (
 studies(GROUP[1]) ∧
  is_element_of(ENTITY[TNF], GROUP[8]) ∧ is_element_of(ENTITY[LPS], GROUP[8]) ∧
   is_effects_of(GROUP[7], GROUP[8]) ∧
    is_element_of(ENTITY[TNF], GROUP[8]) ∧ is_element_of(ENTITY[LPS], GROUP[8]) ∧
     is_effects_of(GROUP[7], GROUP[8]) ∧
      HUAECs(GROUP[12]) ∧
       nuclear(ATTRIB[15]) ∧
        is_factor-kappaB_ATTRIBUTE(ENTITY[14], ATTRIB[15]) ∧
         is_element_of(ENTITY[14], GROUP[13]) ∧ is_element_of(ENTITY[VCAM-1], GROUP[13]) ∧
          is_ability_of(ENTITY[11], GROUP[12]) ∧ is_ability_to(ENTITY[11], upregulate(EVENT[16], _, GROUP[13])) ∧
           novel(ATTRIB[3]) ∧
            arterial(ATTRIB[6]) ∧
             is_endothelium_ATTRIBUTE(ENTITY[5], ATTRIB[6]) ∧
              striking(ATTRIB[4]) ∧
               arterial(ATTRIB[6]) ∧
                is_endothelium_ATTRIBUTE(ENTITY[5], ATTRIB[6]) ∧
                 CONJ_and(is_insensitivity_to(ENTITY[2], GROUP[7]) ∧ is_insensitivity_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
                       is_insensitivity_of(ENTITY[2], ENTITY[5]),
                  is_insensitivity_to(ENTITY[2], GROUP[7]) ∧ is_insensitivity_ATTRIBUTE(ENTITY[2], ATTRIB[4]) ∧
                   is_insensitivity_of(ENTITY[2], ENTITY[5])) ∧
                  is_dissociation_between(ENTITY[10], ENTITY[11]) ∧
                   CONJ_and(demonstrate(EVENT[9], GROUP[1], ENTITY[2]), indicate(EVENT[17], GROUP[1], ENTITY[10])))

# ::id 69_nonfiction_GENIA-1999;99106021,1;NE
# ::snt Tissue factor expression of human monocytes is suppressed by lysophosphatidylcholine .
∃ ATTRIB[3] EVENT[4] GROUP[2] ENTITY[1] (
 human(ATTRIB[3]) ∧
  is_monocytes_ATTRIBUTE(GROUP[2], ATTRIB[3]) ∧ is_Tissue_factor_expression_of(ENTITY[1], GROUP[2]) ∧ suppressed(EVENT[4], ENTITY[lysophosphatidylcholine], ENTITY[1]))

# ::id 70_nonfiction_GENIA-1999;99106021,2;NE
# ::snt The expression of tissue factor -LRB- TF -RRB- , the principal initiator of coagulation , is increased during inflammation and atherosclerosis .
∃ ATTRIB[3] EVENT[9] GROUP[6] ENTITY[4] ENTITY[2] ENTITY[5] ENTITY[1] (
 tissue_factor(ENTITY[5]) ∧
  is_-ENTITY-_namely(ENTITY[5], ENTITY[TF]) ∧
   principal(ATTRIB[3]) ∧
    coagulation(ENTITY[4]) ∧
     is_initiator_of(ENTITY[2], ENTITY[4]) ∧ is_initiator_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
      is_-ENTITY-_namely(ENTITY[5], ENTITY[2]) ∧
       is_expression_of(ENTITY[1], ENTITY[5]) ∧
        ∃ ENTITY[7] (inflammation(ENTITY[7]) ∧ is_element_of(ENTITY[7], GROUP[6])) ∧
         ∃ ENTITY[8] (atherosclerosis(ENTITY[8]) ∧ is_element_of(ENTITY[8], GROUP[6])) ∧
         increased(EVENT[9], _, ENTITY[1]) ∧ during(EVENT[9]) = GROUP[6])

# ::id 71_nonfiction_GENIA-1999;99106021,3;NE
# ::snt Both conditions are promoted by lysophosphatidylcholine -LRB- lysoPC -RRB- .
BOTH GROUP[1] (conditions(GROUP[1]), ∃ EVENT[2] (is_-ENTITY-_namely(ENTITY[lysophosphatidylcholine], ENTITY[lysoPC]) ∧ promoted(EVENT[2], ENTITY[lysophosphatidylcholine], GROUP[1])))

# ::id 72_nonfiction_GENIA-1999;99106021,4;NE
# ::snt We observed in the present study that lysoPC -LRB- 1 to 10 micromol/L -RRB- dose-dependently reduced TF activity in human monocytes , as elicited by lipopolysaccharide -LRB- LPS -RRB- .
∃ SITUATION[12] SITUATION[9] ATTRIB[8] REF1[1] ATTRIB[3] EVENT[10] EVENT[11] EVENT[4] GROUP[7] ENTITY[6] DEGREE[5] ENTITY[2] (
 present(ATTRIB[3]) ∧
  is_study_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
   REF1[1] = we ∧
    (CD_1_to_10(DEGREE[5]), micromol__slash__L(DEGREE[5])) ∧
     human(ATTRIB[8]) ∧
      is_monocytes_ATTRIBUTE(GROUP[7], ATTRIB[8]) ∧
       is_TF_activity_in(ENTITY[6], GROUP[7]) ∧
        is_-ENTITY-_namely(ENTITY[lipopolysaccharide], ENTITY[LPS]) ∧
         is_FACT_THAT(SITUATION[9], elicited(EVENT[10], ENTITY[lipopolysaccharide], ENTITY[6])) ∧
          ADV_dose-dependently(SITUATION[12]) ∧
           is_before(EVENT[11], EVENT[4]) ∧
            past(EVENT[4]) ∧
             observed(EVENT[4], REF1[1],
              is_FACT_THAT(SITUATION[12],
               reduced(EVENT[11], ENTITY[lysoPC], ENTITY[6]) ∧ as(EVENT[11]) = SITUATION[9] ∧
                MSR(EVENT[11]) = DEGREE[5])) ∧ in(EVENT[4]) = ENTITY[2])

# ::id 73_nonfiction_GENIA-1999;99106021,5;NE
# ::snt Lysophosphatidylethanolamine -LRB- lysoPE -RRB- and other lysophospholipids did not affect LPS-induced TF activity of human monocytes .
∃ GROUP[1] (
 ∃ ENTITY[2] (lysoPE(ENTITY[2]) ∧ is_-ENTITY-_namely(ENTITY[Lysophosphatidylethanolamine], ENTITY[2]) ∧ is_element_of(ENTITY[Lysophosphatidylethanolamine], GROUP[1])) ∧
  ∃ ATTRIB[4] GROUP[3] (other(ATTRIB[4]) ∧ is_lysophospholipids_ATTRIBUTE(GROUP[3], ATTRIB[4]) ∧ is_subset_of_or_equal_to(GROUP[3], GROUP[1])) ∧
  ¬ ∃ ATTRIB[8] ATTRIB[6] EVENT[9] GROUP[7] ENTITY[5] (
        lps-induced(ATTRIB[6]) ∧
         human(ATTRIB[8]) ∧
          is_monocytes_ATTRIBUTE(GROUP[7], ATTRIB[8]) ∧
           is_TF_activity_of(ENTITY[5], GROUP[7]) ∧ is_TF_activity_ATTRIBUTE(ENTITY[5], ATTRIB[6]) ∧
            past(EVENT[9]) ∧ did_affect(EVENT[9], GROUP[1], ENTITY[5])))

# ::id 74_nonfiction_GENIA-1999;99106021,6;NE
# ::snt TF antigen expression as elicited by LPS was also lowered by lysoPC .
∃ SITUATION[2] EVENT[3] EVENT[4] ENTITY[1] (
 TF_antigen_expression(ENTITY[1]) ∧
  is_FACT_THAT(SITUATION[2], elicited(EVENT[3], ENTITY[LPS], ENTITY[1])) ∧
   ADV_also(EVENT[4]) ∧
    past(EVENT[4]) ∧ lowered(EVENT[4], ENTITY[lysoPC], ENTITY[1]) ∧ as(EVENT[4]) = SITUATION[2])

# ::id 75_nonfiction_GENIA-1999;99106021,7;NE
# ::snt Phospholipid analyses indicated a selective increase in the lysoPC content of the monocytes after preincubation with the lysophospholipid .
∃ ATTRIB[3] EVENT[8] ENTITY[6] ENTITY[2] GROUP[1] GROUP[5] ENTITY[7] ENTITY[4] (
 monocytes(GROUP[5]) ∧
  is_lysoPC_content_of(ENTITY[4], GROUP[5]) ∧
   lysophospholipid(ENTITY[7]) ∧
    Phospholipid_analyses(GROUP[1]) ∧
     selective(ATTRIB[3]) ∧
      is_preincubation_with(ENTITY[6], ENTITY[7]) ∧
       is_increase_after(ENTITY[2], ENTITY[6]) ∧ is_increase_in(ENTITY[2], ENTITY[4]) ∧ is_increase_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
        past(EVENT[8]) ∧ indicated(EVENT[8], GROUP[1], ENTITY[2]))

# ::id 76_nonfiction_GENIA-1999;99106021,8;NE
# ::snt LysoPC inhibited the TF activity of Mono Mac-6 cells to a similar extent as in the monocytes .
∃ ATTRIB[4] EVENT[6] GROUP[5] ENTITY[3] GROUP[2] ENTITY[1] (
 Mono_Mac-6_cells(GROUP[2]) ∧
  similar(ATTRIB[4]) ∧
   is_extent_ATTRIBUTE(ENTITY[3], ATTRIB[4]) ∧
    monocytes(GROUP[5]) ∧
     is_TF_activity_as_in(ENTITY[1], GROUP[5]) ∧ is_TF_activity_to(ENTITY[1], ENTITY[3]) ∧ is_TF_activity_of(ENTITY[1], GROUP[2]) ∧
      past(EVENT[6]) ∧ inhibited(EVENT[6], ENTITY[LysoPC], ENTITY[1]))

# ::id 77_nonfiction_GENIA-1999;99106021,9;NE
# ::snt LPS binding to plasma membrane receptors and internalization of LPS into monocytes were not affected by lysoPC .
∃ GROUP[1] (
 ∃ GROUP[3] ENTITY[2] (plasma_membrane_receptors(GROUP[3]) ∧ is_LPS_binding_to(ENTITY[2], GROUP[3]) ∧ is_element_of(ENTITY[2], GROUP[1])) ∧
  ∃ GROUP[5] ENTITY[4] (
   monocytes(GROUP[5]) ∧
    is_internalization_into(ENTITY[4], GROUP[5]) ∧ is_internalization_of(ENTITY[4], ENTITY[LPS]) ∧ is_element_of(ENTITY[4], GROUP[1])) ∧
  ¬ ∃ EVENT[6] (past(EVENT[6]) ∧ affected(EVENT[6], ENTITY[lysoPC], GROUP[1])))

# ::id 78_nonfiction_GENIA-1999;99106021,10;NE
# ::snt In contrast , LPS-mediated nuclear binding of nuclear factor -kappaB/Rel to a TF-specific kappaB site was inhibited by lysoPC .
∃ ATTRIB[8] ATTRIB[6] ATTRIB[4] ATTRIB[3] EVENT[9] ENTITY[7] ENTITY[5] ENTITY[2] ENTITY[1] (
 contrast(ENTITY[1]) ∧
  lps-mediated(ATTRIB[3]) ∧
   nuclear(ATTRIB[4]) ∧
    nuclear(ATTRIB[6]) ∧
     is_factor-kappaB__slash__Rel_ATTRIBUTE(ENTITY[5], ATTRIB[6]) ∧
      tf-specific(ATTRIB[8]) ∧
       is_kappaB_site_ATTRIBUTE(ENTITY[7], ATTRIB[8]) ∧
        is_binding_to(ENTITY[2], ENTITY[7]) ∧ is_binding_of(ENTITY[2], ENTITY[5]) ∧ is_binding_ATTRIBUTE(ENTITY[2], ATTRIB[4]) ∧
         is_binding_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
         past(EVENT[9]) ∧ inhibited(EVENT[9], ENTITY[lysoPC], ENTITY[2]) ∧ In(EVENT[9]) = ENTITY[1])

# ::id 79_nonfiction_GENIA-1999;99106021,11;NE
# ::snt Induction of TF mRNA expression by LPS tended to be partially reduced by the lysophospholipid .
∃ EVENT[4] EVENT[3] ENTITY[2] ENTITY[1] (
 TF_mRNA_expression(ENTITY[2]) ∧
  is_Induction_by(ENTITY[1], ENTITY[LPS]) ∧ is_Induction_of(ENTITY[1], ENTITY[2]) ∧
   ADV_partially(EVENT[4]) ∧ past(EVENT[3]) ∧ tended(EVENT[3], ENTITY[1], reduced(EVENT[4], ENTITY[lysophospholipid], ENTITY[1])))

# ::id 80_nonfiction_GENIA-1999;99106021,12;NE
# ::snt Preincubation with lysoPC increased monocytic cAMP levels .
∃ ATTRIB[3] EVENT[4] GROUP[2] ENTITY[1] (
 is_Preincubation_with(ENTITY[1], ENTITY[lysoPC]) ∧
  monocytic(ATTRIB[3]) ∧ is_cAMP_levels_ATTRIBUTE(GROUP[2], ATTRIB[3]) ∧ past(EVENT[4]) ∧ increased(EVENT[4], ENTITY[1], GROUP[2]))

# ::id 81_nonfiction_GENIA-1999;99106021,13;NE
# ::snt Inhibition of adenylyl cyclase by pretreatment with 2'-deoxy-3'-adenosine monophosphate partially reversed the inhibition of TF activity promoted by lysoPC .
∃ ATTRIB[6] ATTRIB[3] EVENT[11] ENTITY[5] ENTITY[4] ENTITY[2] ENTITY[1] EVENT[10] ENTITY[8] ENTITY[7] (
 promoted(EVENT[10], ENTITY[lysoPC], ENTITY[8]) ∧ TF_activity(ENTITY[8]) ∧
  is_inhibition_of(ENTITY[7], ENTITY[8]) ∧
   adenylyl(ATTRIB[3]) ∧
    is_cyclase_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
     2'dash__deoxy-3'dash__adenosine(ATTRIB[6]) ∧
      is_monophosphate_ATTRIBUTE(ENTITY[5], ATTRIB[6]) ∧
       is_pretreatment_with(ENTITY[4], ENTITY[5]) ∧
        is_Inhibition_of(ENTITY[1], ENTITY[2]) ∧ is_Inhibition_by(ENTITY[1], ENTITY[4]) ∧
         ADV_partially(EVENT[11]) ∧ past(EVENT[11]) ∧ reversed(EVENT[11], ENTITY[1], ENTITY[7]))

# ::id 82_nonfiction_GENIA-1999;99106021,14;NE
# ::snt In conclusion , lysoPC markedly decreases LPS-mediated TF expression of human monocytes , the effect probably being mediated by both transcriptional and posttranscriptional mechanisms .
∃ SITUATION[15] ATTRIB[5] ATTRIB[3] EVENT[14] EVENT[12] GROUP[4] GROUP[7] ENTITY[2] ENTITY[1] ENTITY[6] (
 effect(ENTITY[6]) ∧
  conclusion(ENTITY[1]) ∧
   lps-mediated(ATTRIB[3]) ∧
    human(ATTRIB[5]) ∧
     is_monocytes_ATTRIBUTE(GROUP[4], ATTRIB[5]) ∧
      is_TF_expression_of(ENTITY[2], GROUP[4]) ∧ is_TF_expression_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
       ∃ ATTRIB[9] GROUP[8] (transcriptional(ATTRIB[9]) ∧ is_mechanisms_ATTRIBUTE(GROUP[8], ATTRIB[9]) ∧ is_subset_of_or_equal_to(GROUP[8], GROUP[7])) ∧
        ∃ ATTRIB[11] GROUP[10] (posttranscriptional(ATTRIB[11]) ∧ is_mechanisms_ATTRIBUTE(GROUP[10], ATTRIB[11]) ∧ is_subset_of_or_equal_to(GROUP[10], GROUP[7])) ∧
        ADV_markedly(SITUATION[15]) ∧
         ADV_probably(EVENT[12]) ∧
          is_FACT_THAT(SITUATION[15],
           CONJ_and(decreases(EVENT[14], ENTITY[lysoPC], ENTITY[2]) ∧ In(EVENT[14]) = ENTITY[1],
            being_mediated(EVENT[12], ENTITY[6]) ∧ by(EVENT[12]) = GROUP[7])))

# ::id 83_nonfiction_GENIA-1999;99106021,15;NE
# ::snt LysoPC may thus attenuate activation of coagulation during inflammation and atherosclerosis .
∃ ENTITY[1] (
 LysoPC(ENTITY[1]) ∧
  MD_may(∃ EVENT[7] ENTITY[3] GROUP[4] ENTITY[2] (
        coagulation(ENTITY[3]) ∧
         is_activation_of(ENTITY[2], ENTITY[3]) ∧
          ∃ ENTITY[5] (inflammation(ENTITY[5]) ∧ is_element_of(ENTITY[5], GROUP[4])) ∧
           ∃ ENTITY[6] (atherosclerosis(ENTITY[6]) ∧ is_element_of(ENTITY[6], GROUP[4])) ∧
           ADV_thus(EVENT[7]) ∧ attenuate(EVENT[7], ENTITY[1], ENTITY[2]) ∧ during(EVENT[7]) = GROUP[4])))

# ::id 84_nonfiction_GENIA-1999;99107757,1;NE
# ::snt Intranuclear targeted delivery of functional NF-kappaB by 70 kDa heat shock protein .
∃ ATTRIB[5] ATTRIB[3] ATTRIB[2] EVENT[7] ENTITY[6] ENTITY[4] ENTITY[1] (
 intranuclear(ATTRIB[2]) ∧
  targeted(ATTRIB[3]) ∧
   functional(ATTRIB[5]) ∧
    is_NF-kappaB_ATTRIBUTE(ENTITY[4], ATTRIB[5]) ∧
     70_kDa_heat_shock_protein(ENTITY[6]) ∧
      is_delivery_by(ENTITY[1], ENTITY[6]) ∧ is_delivery_of(ENTITY[1], ENTITY[4]) ∧ is_delivery_ATTRIBUTE(ENTITY[1], ATTRIB[3]) ∧
       is_delivery_ATTRIBUTE(ENTITY[1], ATTRIB[2]) ∧ xxx(EVENT[7]) ∧ LINK(EVENT[7]) = ENTITY[1])

# ::id 85_nonfiction_GENIA-1999;99107757,2;NE
# ::snt The 70 kDa heat shock protein -LRB- Hsp70 -RRB- is a highly conserved , ubiquitous protein involved in chaperoning proteins to various cellular organelles .
∃ ATTRIB[10] ATTRIB[9] SITUATION[6] ATTRIB[4] ATTRIB[3] EVENT[11] EVENT[12] EVENT[13] GROUP[8] GROUP[7] ENTITY[2] ENTITY[1] (
 70_kDa_heat_shock_protein(ENTITY[1]) ∧
  is_-ENTITY-_namely(ENTITY[1], ENTITY[Hsp70]) ∧
   highly_conserved(ATTRIB[3]) ∧
    ubiquitous(ATTRIB[4]) ∧
     proteins(GROUP[7]) ∧
      various(ATTRIB[9]) ∧
       cellular(ATTRIB[10]) ∧
        is_organelles_ATTRIBUTE(GROUP[8], ATTRIB[10]) ∧ is_organelles_ATTRIBUTE(GROUP[8], ATTRIB[9]) ∧
         is_FACT_THAT(SITUATION[6], chaperoning(EVENT[11], ENTITY[2], GROUP[7]) ∧ to(EVENT[11]) = GROUP[8]) ∧
          involved(EVENT[12], ENTITY[2]) ∧ in(EVENT[12]) = SITUATION[6] ∧
           is_protein_ATTRIBUTE(ENTITY[2], ATTRIB[4]) ∧ is_protein_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
           past(EVENT[12]) ∧ copula(EVENT[13], ENTITY[1], ENTITY[2]))

# ::id 86_nonfiction_GENIA-1999;99107757,3;NE
# ::snt Here we show that when added exogenously to cells , Hsp70 is readily imported into both cytoplasmic and nuclear compartments in a cell-type-specific fashion .
∃ REF1[1] EVENT[2] (
 REF1[1] = we ∧
  LOC_here(EVENT[2]) ∧
   show(EVENT[2], REF1[1],
    ∀ EVENT[4] GROUP[3] CND_when(
        cells(GROUP[3]) ∧ ADV_exogenously(EVENT[4]) ∧
         added(EVENT[4], ENTITY[Hsp70]) ∧ to(EVENT[4]) = GROUP[3],
        ∃ ATTRIB[12] EVENT[13] ENTITY[11] GROUP[6] (
         ∃ ATTRIB[8] GROUP[7] (cytoplasmic(ATTRIB[8]) ∧ is_compartments_ATTRIBUTE(GROUP[7], ATTRIB[8]) ∧ is_subset_of_or_equal_to(GROUP[7], GROUP[6])) ∧
          ∃ ATTRIB[10] GROUP[9] (nuclear(ATTRIB[10]) ∧ is_compartments_ATTRIBUTE(GROUP[9], ATTRIB[10]) ∧ is_subset_of_or_equal_to(GROUP[9], GROUP[6])) ∧
          cell-type-specific(ATTRIB[12]) ∧
           is_fashion_ATTRIBUTE(ENTITY[11], ATTRIB[12]) ∧
            ADV_readily(EVENT[13]) ∧
             is_imported(EVENT[13], ENTITY[Hsp70]) ∧ in(EVENT[13]) = ENTITY[11] ∧
              into(EVENT[13]) = GROUP[6]))))

# ::id 87_nonfiction_GENIA-1999;99107757,4;NE
# ::snt We exploited this ability of Hsp70 to deliver NF-kappaB , a key transcriptional regulator of inflammatory responses .
∃ REF1[1] ATTRIB[7] ATTRIB[5] ATTRIB[4] EVENT[9] EVENT[8] GROUP[6] ENTITY[3] ENTITY[2] (
 key(ATTRIB[4]) ∧
  transcriptional(ATTRIB[5]) ∧
   inflammatory(ATTRIB[7]) ∧
    is_responses_ATTRIBUTE(GROUP[6], ATTRIB[7]) ∧
     is_regulator_of(ENTITY[3], GROUP[6]) ∧ is_regulator_ATTRIBUTE(ENTITY[3], ATTRIB[5]) ∧ is_regulator_ATTRIBUTE(ENTITY[3], ATTRIB[4]) ∧
      is_-ENTITY-_namely(ENTITY[NF-kappaB], ENTITY[3]) ∧
       is_ability_of(ENTITY[2], ENTITY[Hsp70]) ∧ is_ability_to(ENTITY[2], deliver(EVENT[8], _, ENTITY[NF-kappaB])) ∧
        REF1[1] = we ∧ past(EVENT[9]) ∧ exploited(EVENT[9], REF1[1], ENTITY[2]))

# ::id 88_nonfiction_GENIA-1999;99107757,5;NE
# ::snt We demonstrate that a fusion protein composed of a C-terminal Hsp70 peptide and the p50 subunit of NF-kappaB was directed into the nucleus of cells , could bind DNA specifically , and activated Igkappa expression and TNFalpha production .
∃ REF1[1] EVENT[8] EVENT[11] EVENT[18] EVENT[2] GROUP[5] GROUP[15] ENTITY[3] ENTITY[7] GROUP[10] ENTITY[9] (
 is_p50_subunit_of(ENTITY[7], ENTITY[NF-kappaB]) ∧
  cells(GROUP[10]) ∧
   is_nucleus_of(ENTITY[9], GROUP[10]) ∧
    REF1[1] = we ∧
     ∃ ENTITY[6] (C-terminal_Hsp70_peptide(ENTITY[6]) ∧ is_element_of(ENTITY[6], GROUP[5])) ∧ is_element_of(ENTITY[7], GROUP[5]) ∧
      composed(EVENT[8], _, ENTITY[3]) ∧ of(EVENT[8]) = GROUP[5] ∧ fusion_protein(ENTITY[3]) ∧
       ∃ ENTITY[16] (Igkappa_expression(ENTITY[16]) ∧ is_element_of(ENTITY[16], GROUP[15])) ∧
        ∃ ENTITY[17] (TNFalpha_production(ENTITY[17]) ∧ is_element_of(ENTITY[17], GROUP[15])) ∧
        is_before(EVENT[11], EVENT[2]) ∧
         is_before(EVENT[18], EVENT[2]) ∧
          demonstrate(EVENT[2], REF1[1],
           CONJ_and(directed(EVENT[11], _, ENTITY[3]) ∧ into(EVENT[11]) = ENTITY[9],
            MD_could(∃ EVENT[13] ENTITY[12] (DNA(ENTITY[12]) ∧ ADV_specifically(EVENT[13]) ∧ bind(EVENT[13], ENTITY[3], ENTITY[12]))),
            activated(EVENT[18], ENTITY[3], GROUP[15]))))

# ::id 89_nonfiction_GENIA-1999;99107757,6;NE
# ::snt We therefore propose that Hsp70 can be used as a vehicle for intracytoplasmic and intranuclear delivery of proteins or DNA to modulate gene expression and thereby control immune responses .
∃ REF1[1] EVENT[2] (
 REF1[1] = we ∧
  ADV_therefore(EVENT[2]) ∧
   propose(EVENT[2], REF1[1],
    MD_can(∃ ATTRIB[17] EVENT[15] EVENT[18] EVENT[13] GROUP[10] GROUP[5] ENTITY[4] ENTITY[14] GROUP[16] ENTITY[3] (
          ∃ ATTRIB[7] ENTITY[6] (intracytoplasmic(ATTRIB[7]) ∧ is_delivery_ATTRIBUTE(ENTITY[6], ATTRIB[7]) ∧ is_element_of(ENTITY[6], GROUP[5])) ∧
           ∃ ATTRIB[9] ENTITY[8] (intranuclear(ATTRIB[9]) ∧ is_delivery_ATTRIBUTE(ENTITY[8], ATTRIB[9]) ∧ is_element_of(ENTITY[8], GROUP[5])) ∧
           CONJ_or(∃ GROUP[11] (proteins(GROUP[11]) ∧ is_subset_of_or_equal_to(GROUP[11], GROUP[10])),
            ∃ ENTITY[12] (DNA(ENTITY[12]) ∧ is_element_of(ENTITY[12], GROUP[10]))) ∧
            is_element_of(ENTITY[4], GROUP[10]) ∧ is_equals(ENTITY[4], GROUP[5]) ∧
             is_vehicle_for(ENTITY[3], ENTITY[4]) ∧
              gene_expression(ENTITY[14]) ∧
               immune(ATTRIB[17]) ∧
                is_responses_ATTRIBUTE(GROUP[16], ATTRIB[17]) ∧
                 ADV_thereby(EVENT[18]) ∧
                  used(EVENT[13], _, ENTITY[Hsp70],
                   CONJ_and(modulate(EVENT[15], ENTITY[Hsp70], ENTITY[14]), control(EVENT[18], ENTITY[Hsp70], GROUP[16]))) ∧
                   as(EVENT[13]) = ENTITY[3]))))

# ::id 90_nonfiction_GENIA-1999;99107758,1;NE
# ::snt Regulation of IL-4 expression by the transcription factor JunB during T helper cell differentiation .
∃ EVENT[5] ENTITY[3] ENTITY[4] ENTITY[2] ENTITY[1] (
 IL-4_expression(ENTITY[2]) ∧
  transcription_factor(ENTITY[3]) ∧
   is_-ENTITY-_namely(ENTITY[JunB], ENTITY[3]) ∧
    T_helper_cell_differentiation(ENTITY[4]) ∧
     is_Regulation_during(ENTITY[1], ENTITY[4]) ∧ is_Regulation_by(ENTITY[1], ENTITY[JunB]) ∧ is_Regulation_of(ENTITY[1], ENTITY[2]) ∧
      xxx(EVENT[5]) ∧ LINK(EVENT[5]) = ENTITY[1])

# ::id 91_nonfiction_GENIA-1999;99107758,2;NE
# ::snt The molecular basis for restricted cytokine expression by T helper 1 -LRB- Th1 -RRB- and T helper 2 -LRB- Th2 -RRB- cells is unclear .
∃ ATTRIB[7] ATTRIB[4] ATTRIB[2] EVENT[8] GROUP[5] GROUP[6] ENTITY[3] ENTITY[1] (
 molecular(ATTRIB[2]) ∧
  restricted(ATTRIB[4]) ∧
   cells(GROUP[6]) ∧
    is_-ENTITY-_namely(ENTITY[T_helper_1], ENTITY[Th1]) ∧
     is_-ENTITY-_namely(ENTITY[T_helper_2], ENTITY[Th2]) ∧
      is_element_of(ENTITY[T_helper_1], GROUP[5]) ∧ is_element_of(ENTITY[T_helper_2], GROUP[5]) ∧
       is_-GROUP-_namely(GROUP[6], GROUP[5]) ∧
        is_cytokine_expression_ATTRIBUTE(ENTITY[3], ATTRIB[4]) ∧ is_cytokine_expression_by(ENTITY[3], GROUP[6]) ∧
         is_basis_for(ENTITY[1], ENTITY[3]) ∧ is_basis_ATTRIBUTE(ENTITY[1], ATTRIB[2]) ∧
          unclear(ATTRIB[7]) ∧ copula(EVENT[8], ENTITY[1], ATTRIB[7]))

# ::id 92_nonfiction_GENIA-1999;99107758,3;NE
# ::snt Previous studies found that P1 , an element of the interleukin 4 -LRB- IL-4 -RRB- promoter that binds AP-1 , is important for Th2-restricted IL-4 expression .
∃ ATTRIB[10] ATTRIB[8] ATTRIB[2] EVENT[11] EVENT[3] ENTITY[4] ENTITY[9] GROUP[1] EVENT[7] ENTITY[5] (
 binds(EVENT[7], ENTITY[5], ENTITY[AP-1]) ∧ interleukin_4_promoter(ENTITY[5]) ∧
  is_-ENTITY-_namely(ENTITY[5], ENTITY[IL-4]) ∧
   previous(ATTRIB[2]) ∧
    is_studies_ATTRIBUTE(GROUP[1], ATTRIB[2]) ∧
     is_element_of(ENTITY[4], ENTITY[5]) ∧
      is_-ENTITY-_namely(ENTITY[P1], ENTITY[4]) ∧
       th2-restricted(ATTRIB[10]) ∧
        is_IL-4_expression_ATTRIBUTE(ENTITY[9], ATTRIB[10]) ∧
         is_important_for(ATTRIB[8], ENTITY[9]) ∧
          past(EVENT[3]) ∧
           found(EVENT[3], GROUP[1], copula(EVENT[11], ENTITY[P1]) ∧ ATTRIBUTE(EVENT[11]) = ATTRIB[8]))

# ::id 93_nonfiction_GENIA-1999;99107758,4;NE
# ::snt Here we show that JunB , but not the other Jun family members , was selectively induced in Th2 cells and not in Th1 cells during differentiation .
∃ SITUATION[11] REF1[1] EVENT[9] EVENT[2] ENTITY[8] GROUP[5] GROUP[7] GROUP[3] (
 REF1[1] = we ∧
  CONJ_but(is_element_of(ENTITY[JunB], GROUP[3]), NOT GROUP[4] (other_Jun_family_members(GROUP[4]), is_subset_of_or_equal_to(GROUP[4], GROUP[3]))) ∧
   Th2_cells(GROUP[5]) ∧
    differentiation(ENTITY[8]) ∧
     Th1_cells(GROUP[7]) ∧
      LOC_here(SITUATION[11]) ∧
       ADV_selectively(EVENT[9]) ∧
        is_before(EVENT[9], EVENT[2]) ∧
         is_FACT_THAT(SITUATION[11],
          show(EVENT[2], REF1[1],
           CONJ_and(induced(EVENT[9], _, GROUP[3]) ∧ during(EVENT[9]) = ENTITY[8] ∧
                 in(EVENT[9]) = GROUP[5],
            NOT ENTITY[6] (is_element_of(ENTITY[6], GROUP[7]),
             ∃ EVENT[9] ENTITY[8] (
              differentiation(ENTITY[8]) ∧
               is_before(EVENT[9], EVENT[2]) ∧
                induced(EVENT[9], _, GROUP[3]) ∧ during(EVENT[9]) = ENTITY[8] ∧
                 in(EVENT[9]) = ENTITY[6]))))))

# ::id 94_nonfiction_GENIA-1999;99107758,5;NE
# ::snt JunB has previously been considered to be a negative regulator of transcription .
∃ SITUATION[6] ATTRIB[3] EVENT[5] EVENT[1] ENTITY[4] ENTITY[2] (
 negative(ATTRIB[3]) ∧
  transcription(ENTITY[4]) ∧
   is_regulator_of(ENTITY[2], ENTITY[4]) ∧ is_regulator_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
    TMP_previously(SITUATION[6]) ∧
     is_FACT_THAT(SITUATION[6], has_considered(EVENT[1], _, ENTITY[JunB], copula(EVENT[5], ENTITY[JunB], ENTITY[2]))))

# ::id 95_nonfiction_GENIA-1999;99107758,6;NE
# ::snt However , we show that JunB binds directly to the P1 site and synergizes with c-Maf to activate an IL-4 luciferase reporter gene .
∃ SITUATION[10] PRP[6] REF1[1] EVENT[4] EVENT[8] EVENT[9] EVENT[2] ENTITY[7] ENTITY[3] (
 P1_site(ENTITY[3]) ∧
  REF1[1] = we ∧
   IL-4_luciferase_reporter_gene(ENTITY[7]) ∧
    is_FACT_THAT(PRP[6], activate(EVENT[8], ENTITY[JunB], ENTITY[7])) ∧
     ADV_however(SITUATION[10]) ∧
      ADV_directly(EVENT[4]) ∧
       is_FACT_THAT(SITUATION[10],
        show(EVENT[2], REF1[1],
         CONJ_and(binds(EVENT[4], ENTITY[JunB]) ∧ to(EVENT[4]) = ENTITY[3],
          synergizes(EVENT[9], ENTITY[JunB]) ∧ PRP(EVENT[9]) = PRP[6] ∧
           with(EVENT[9]) = ENTITY[c-Maf]))))

# ::id 96_nonfiction_GENIA-1999;99107758,7;NE
# ::snt JunB -control of IL-4 expression is mediated by the phosphorylation of JunB at Thr102 and -104 by JNK MAP kinase .
∃ EVENT[6] ENTITY[2] ENTITY[1] ENTITY[5] GROUP[4] ENTITY[3] (
 is_element_of(ENTITY[Thr102], GROUP[4]) ∧ is_element_of(ENTITY[-104], GROUP[4]) ∧
  JNK_MAP_kinase(ENTITY[5]) ∧
   is_phosphorylation_by(ENTITY[3], ENTITY[5]) ∧ is_phosphorylation_at(ENTITY[3], GROUP[4]) ∧ is_phosphorylation_of(ENTITY[3], ENTITY[JunB]) ∧
    IL-4_expression(ENTITY[2]) ∧
     is_JunB-control_of(ENTITY[1], ENTITY[2]) ∧ is_mediated(EVENT[6], ENTITY[1]) ∧ by(EVENT[6]) = ENTITY[3])

# ::id 97_nonfiction_GENIA-1999;99107758,8;NE
# ::snt The synergy between c-Maf and JunB can be attributed to cooperative DNA binding , which is facilitated by JunB phosphorylation .
∃ GROUP[2] ENTITY[1] (
 is_element_of(ENTITY[c-Maf], GROUP[2]) ∧ is_element_of(ENTITY[JunB], GROUP[2]) ∧
  is_synergy_between(ENTITY[1], GROUP[2]) ∧
   MD_can(∃ ATTRIB[4] EVENT[7] EVENT[8] ENTITY[6] ENTITY[3] (
         cooperative(ATTRIB[4]) ∧
          JunB_phosphorylation(ENTITY[6]) ∧
           is_facilitated(EVENT[7], ENTITY[3]) ∧ by(EVENT[7]) = ENTITY[6] ∧ is_DNA_binding_ATTRIBUTE(ENTITY[3], ATTRIB[4]) ∧
            attributed(EVENT[8], _, ENTITY[1]) ∧ to(EVENT[8]) = ENTITY[3])))

# ::id 98_nonfiction_GENIA-1999;99107758,9;NE
# ::snt In transgenic mice , elevated JunB levels caused increased expression of several Th2 cytokines in developing Th1 cells .
∃ ATTRIB[5] ATTRIB[2] EVENT[8] ENTITY[4] GROUP[3] GROUP[1] (
 transgenic(ATTRIB[2]) ∧
  is_mice_ATTRIBUTE(GROUP[1], ATTRIB[2]) ∧
   elevated_JunB_levels(GROUP[3]) ∧
    increased(ATTRIB[5]) ∧
     SEVERAL GROUP[6] (Th2_cytokines(GROUP[6]),
      ∃ GROUP[7] (
       developing_Th1_cells(GROUP[7]) ∧
        is_expression_in(ENTITY[4], GROUP[7]) ∧ is_expression_of(ENTITY[4], GROUP[6]) ∧ is_expression_ATTRIBUTE(ENTITY[4], ATTRIB[5]))) ∧
      past(EVENT[8]) ∧ caused(EVENT[8], GROUP[3], ENTITY[4]) ∧ In(EVENT[8]) = GROUP[1])

# ::id 99_nonfiction_GENIA-1999;99107758,10;NE
# ::snt JunB also upregulated IL-4 expression in response to immunization .
∃ EVENT[4] ENTITY[3] ENTITY[2] ENTITY[1] (
 immunization(ENTITY[3]) ∧
  is_response_to(ENTITY[2], ENTITY[3]) ∧
   is_IL-4_expression_in(ENTITY[1], ENTITY[2]) ∧
    ADV_also(EVENT[4]) ∧ past(EVENT[4]) ∧ upregulated(EVENT[4], ENTITY[JunB], ENTITY[1]))

# ::id 100_nonfiction_GENIA-1999;99107758,11;NE
# ::snt Thus , the early increase of JunB protein in Th2 cells can provide the specificity for c-Maf in IL-4 expression during T cell development and directs thereby Th2 differentiation .
∃ ATTRIB[2] EVENT[10] ENTITY[9] GROUP[4] ENTITY[3] ENTITY[6] ENTITY[5] ENTITY[1] (
 early(ATTRIB[2]) ∧
  JunB_protein(ENTITY[3]) ∧
   Th2_cells(GROUP[4]) ∧
    is_increase_in(ENTITY[1], GROUP[4]) ∧ is_increase_of(ENTITY[1], ENTITY[3]) ∧ is_increase_ATTRIBUTE(ENTITY[1], ATTRIB[2]) ∧
     IL-4_expression(ENTITY[6]) ∧
      is_specificity_in(ENTITY[5], ENTITY[6]) ∧ is_specificity_for(ENTITY[5], ENTITY[c-Maf]) ∧
       Th2_differentiation(ENTITY[9]) ∧
        ADV_thus(EVENT[10]) ∧
         ADV_thereby(EVENT[10]) ∧
          CONJ_and(MD_can(∃ EVENT[8] ENTITY[7] (
                     T_cell_development(ENTITY[7]) ∧
                      provide(EVENT[8], ENTITY[1], ENTITY[5]) ∧ during(EVENT[8]) = ENTITY[7])),
           directs(EVENT[10], ENTITY[1], ENTITY[9])))

# ::id 101_nonfiction_GENIA-1999;99111186,1;NE
# ::snt Immunohistochemical study of c-fos-positive lymphocytes infiltrated into human squamous cell carcinomas of the head and neck during radiation therapy and its clinical significance .
∃ EVENT[19] GROUP[1] ENTITY[12] ENTITY[13] GROUP[11] ENTITY[10] (
 head(ENTITY[12]) ∧
  neck(ENTITY[13]) ∧
   is_element_of(ENTITY[12], GROUP[11]) ∧ is_element_of(ENTITY[13], GROUP[11]) ∧
    is_equals(ENTITY[10], GROUP[11]) ∧
     ∃ ATTRIB[9] ATTRIB[8] ATTRIB[5] ATTRIB[3] EVENT[15] ENTITY[14] GROUP[7] GROUP[4] ENTITY[2] (
      immunohistochemical(ATTRIB[3]) ∧
       c-fos-positive(ATTRIB[5]) ∧
        human(ATTRIB[8]) ∧
         squamous(ATTRIB[9]) ∧
          is_cell_carcinomas_of(GROUP[7], ENTITY[10]) ∧ is_cell_carcinomas_ATTRIBUTE(GROUP[7], ATTRIB[9]) ∧ is_cell_carcinomas_ATTRIBUTE(GROUP[7], ATTRIB[8]) ∧
           radiation_therapy(ENTITY[14]) ∧
            infiltrated(EVENT[15], GROUP[4]) ∧ during(EVENT[15]) = ENTITY[14] ∧
             into(EVENT[15]) = GROUP[7] ∧ is_lymphocytes_ATTRIBUTE(GROUP[4], ATTRIB[5]) ∧
             is_study_of(ENTITY[2], GROUP[4]) ∧ is_study_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧ is_element_of(ENTITY[2], GROUP[1])) ∧
      ∃ ATTRIB[18] REF1[17] ENTITY[16] (
       REF1[17] = its ∧
        clinical(ATTRIB[18]) ∧
         is_significance_ATTRIBUTE(ENTITY[16], ATTRIB[18]) ∧ is_significance_POS(ENTITY[16], REF1[17]) ∧ is_element_of(ENTITY[16], GROUP[1])) ∧
      xxx(EVENT[19]) ∧ LINK(EVENT[19]) = GROUP[1])

# ::id 102_nonfiction_GENIA-1999;99111186,2;NE
# ::snt C-fos has been reported to be one of the immediate early genes in signal transduction systems after many kinds of stresses , including ionizing radiation .
∃ ATTRIB[5] ATTRIB[4] EVENT[1] ENTITY[2] GROUP[6] GROUP[3] (
 immediate(ATTRIB[4]) ∧
  early(ATTRIB[5]) ∧
   signal_transduction_systems(GROUP[6]) ∧
    is_genes_in(GROUP[3], GROUP[6]) ∧ is_genes_ATTRIBUTE(GROUP[3], ATTRIB[5]) ∧ is_genes_ATTRIBUTE(GROUP[3], ATTRIB[4]) ∧
     (CD_one(ENTITY[2]), is_element_of(ENTITY[2], GROUP[3])) ∧
      has_reported(EVENT[1], _, ENTITY[C-fos],
       MANY ATTRIB[11] EVENT[12] ENTITY[10] GROUP[8] GROUP[7] (
        (stresses(GROUP[8]) ∧ ionizing(ATTRIB[11]) ∧ is_radiation_ATTRIBUTE(ENTITY[10], ATTRIB[11]) ∧
         including(EVENT[12], GROUP[7], ENTITY[10]) ∧ is_kinds_of(GROUP[7], GROUP[8])),
        ∃ EVENT[13] (copula(EVENT[13], ENTITY[C-fos], ENTITY[2]) ∧ after(EVENT[13]) = GROUP[7]))))

# ::id 103_nonfiction_GENIA-1999;99111186,3;NE
# ::snt Changes in c-fos expression induced by radiation therapy in tumor tissues have not yet been reported .
∃ EVENT[6] GROUP[5] ENTITY[4] ENTITY[2] GROUP[1] (
 radiation_therapy(ENTITY[4]) ∧
  tumor_tissues(GROUP[5]) ∧
   induced(EVENT[6], ENTITY[2]) ∧ in(EVENT[6]) = GROUP[5] ∧ by(EVENT[6]) = ENTITY[4] ∧
    c-fos_expression(ENTITY[2]) ∧
    is_Changes_in(GROUP[1], ENTITY[2]) ∧ ¬ ∃ EVENT[7] (TMP_yet(EVENT[7]) ∧ have_reported(EVENT[7], _, GROUP[1])))

# ::id 104_nonfiction_GENIA-1999;99111186,4;NE
# ::snt In this study , we have attempted to determine whether c-fos expression is induced by radiotherapy in human squamous cell carcinomas of the head and neck and to establish a possible correlation between c-fos expression and the therapeutic effects of radiation therapy .
∃ ATTRIB[16] REF1[2] ATTRIB[20] EVENT[4] EVENT[22] EVENT[3] GROUP[17] ENTITY[15] ENTITY[12] ENTITY[13] GROUP[11] ENTITY[10] ENTITY[21] GROUP[19] ENTITY[1] (
 study(ENTITY[1]) ∧
  head(ENTITY[12]) ∧
   neck(ENTITY[13]) ∧
    is_element_of(ENTITY[12], GROUP[11]) ∧ is_element_of(ENTITY[13], GROUP[11]) ∧
     is_equals(ENTITY[10], GROUP[11]) ∧
      therapeutic(ATTRIB[20]) ∧
       radiation_therapy(ENTITY[21]) ∧
        is_effects_of(GROUP[19], ENTITY[21]) ∧ is_effects_ATTRIBUTE(GROUP[19], ATTRIB[20]) ∧
         REF1[2] = we ∧
          possible(ATTRIB[16]) ∧
           ∃ ENTITY[18] (c-fos_expression(ENTITY[18]) ∧ is_element_of(ENTITY[18], GROUP[17])) ∧ is_subset_of_or_equal_to(GROUP[19], GROUP[17]) ∧
            is_correlation_between(ENTITY[15], GROUP[17]) ∧ is_correlation_ATTRIBUTE(ENTITY[15], ATTRIB[16]) ∧
             have_attempted(EVENT[3], REF1[2],
              CONJ_and(determine(EVENT[4], REF1[2],
                    QUEST(∃ ATTRIB[9] ATTRIB[8] EVENT[14] GROUP[7] ENTITY[6] ENTITY[5] (
                          c-fos_expression(ENTITY[5]) ∧
                           radiotherapy(ENTITY[6]) ∧
                            human(ATTRIB[8]) ∧
                             squamous(ATTRIB[9]) ∧
                              is_cell_carcinomas_of(GROUP[7], ENTITY[10]) ∧ is_cell_carcinomas_ATTRIBUTE(GROUP[7], ATTRIB[9]) ∧
                               is_cell_carcinomas_ATTRIBUTE(GROUP[7], ATTRIB[8]) ∧
                               is_induced(EVENT[14], ENTITY[5]) ∧ in(EVENT[14]) = GROUP[7] ∧
                                by(EVENT[14]) = ENTITY[6]))),
               establish(EVENT[22], REF1[2], ENTITY[15]))) ∧ In(EVENT[3]) = ENTITY[1])

# ::id 105_nonfiction_GENIA-1999;99111186,5;NE
# ::snt Twenty-seven patients with tumors of the oral cavity , oropharynx , and maxillary sinus were examined , all of which were confirmed as squamous cell carcinomas .
∃ ATTRIB[9] ATTRIB[6] EVENT[15] GROUP[2] GROUP[1] ENTITY[5] ENTITY[7] ENTITY[8] GROUP[4] ENTITY[3] (
 oral(ATTRIB[6]) ∧
  is_cavity_ATTRIBUTE(ENTITY[5], ATTRIB[6]) ∧
   oropharynx(ENTITY[7]) ∧
    maxillary(ATTRIB[9]) ∧
     is_sinus_ATTRIBUTE(ENTITY[8], ATTRIB[9]) ∧
      is_element_of(ENTITY[5], GROUP[4]) ∧ is_element_of(ENTITY[7], GROUP[4]) ∧ is_element_of(ENTITY[8], GROUP[4]) ∧
       is_equals(ENTITY[3], GROUP[4]) ∧
        ALL ENTITY[10] (is_element_of(ENTITY[10], GROUP[2]),
         ∃ ATTRIB[13] EVENT[14] GROUP[12] (
          squamous(ATTRIB[13]) ∧
           is_cell_carcinomas_ATTRIBUTE(GROUP[12], ATTRIB[13]) ∧
            past(EVENT[14]) ∧
             confirmed(EVENT[14], _, ENTITY[10]) ∧ as(EVENT[14]) = GROUP[12])) ∧
         is_tumors_of(GROUP[2], ENTITY[3]) ∧
         (CD_twenty-seven(GROUP[1]), is_patients_with(GROUP[1], GROUP[2])) ∧
          past(EVENT[15]) ∧ examined(EVENT[15], _, GROUP[1]))

# ::id 106_nonfiction_GENIA-1999;99111186,6;NE
# ::snt After obtaining the patients ' informed consent , biopsies were performed before treatment and at doses of 4 , 10 , and 20 Gy of radiotherapy .
∃ ATTRIB[4] EVENT[5] EVENT[10] EVENT[10] ENTITY[2] ENTITY[6] ENTITY[9] ENTITY[8] GROUP[7] GROUP[1] GROUP[3] (
 patients(GROUP[3]) ∧
  biopsies(GROUP[1]) ∧
   informed(ATTRIB[4]) ∧
    is_consent_ATTRIBUTE(ENTITY[2], ATTRIB[4]) ∧ is_consent_POS(ENTITY[2], GROUP[3]) ∧
     treatment(ENTITY[6]) ∧
      radiotherapy(ENTITY[9]) ∧
       (CD_4,10,and_20(ENTITY[8]), is_Gy_of(ENTITY[8], ENTITY[9])) ∧
        is_doses_of(GROUP[7], ENTITY[8]) ∧
         past(EVENT[10]) ∧
          past(EVENT[10]) ∧
           CRD_After(obtaining(EVENT[5], GROUP[1], ENTITY[2]),
            CONJ_and(performed(EVENT[10], _, GROUP[1]) ∧ before(EVENT[10]) = ENTITY[6],
             performed(EVENT[10], _, GROUP[1]) ∧ at(EVENT[10]) = GROUP[7])))

# ::id 107_nonfiction_GENIA-1999;99111186,6;NE
# ::snt and the specimens were preserved in liquid nitrogen for further examination ,
∃ ATTRIB[5] ATTRIB[3] EVENT[6] ENTITY[4] ENTITY[2] GROUP[1] (
 specimens(GROUP[1]) ∧
  liquid(ATTRIB[3]) ∧
   is_nitrogen_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
    further(ATTRIB[5]) ∧
     is_examination_ATTRIBUTE(ENTITY[4], ATTRIB[5]) ∧
      past(EVENT[6]) ∧
       preserved(EVENT[6], _, GROUP[1]) ∧ for(EVENT[6]) = ENTITY[4] ∧ in(EVENT[6]) = ENTITY[2])

# ::id 108_nonfiction_GENIA-1999;99111186,7;NE
# ::snt Serial sectioning of 6 micrometer was performed using a cryostat ,
∃ ATTRIB[2] EVENT[6] EVENT[5] ENTITY[3] ENTITY[4] ENTITY[1] (
 serial(ATTRIB[2]) ∧
  (CD_6(ENTITY[3]), micrometer(ENTITY[3])) ∧
   is_sectioning_of(ENTITY[1], ENTITY[3]) ∧ is_sectioning_ATTRIBUTE(ENTITY[1], ATTRIB[2]) ∧
    cryostat(ENTITY[4]) ∧
     past(EVENT[6]) ∧ CONJ_and(performed(EVENT[6], _, ENTITY[1]), using(EVENT[5], ENTITY[1], ENTITY[4])))

# ::id 109_nonfiction_GENIA-1999;99111186,7;NE
# ::snt and samples were immunohistochemically stained using the streptoavidin-biotin peroxidase method and a monoclonal antibody against c-fos .
∃ SITUATION[9] ATTRIB[4] EVENT[8] EVENT[7] GROUP[2] GROUP[1] ENTITY[3] (
 streptoavidin-biotin(ATTRIB[4]) ∧
  is_peroxidase_method_ATTRIBUTE(ENTITY[3], ATTRIB[4]) ∧
   samples(GROUP[1]) ∧
    is_element_of(ENTITY[3], GROUP[2]) ∧
     ∃ ATTRIB[6] ENTITY[5] (
      monoclonal(ATTRIB[6]) ∧
       is_antibody_ATTRIBUTE(ENTITY[5], ATTRIB[6]) ∧ is_antibody_against(ENTITY[5], ENTITY[c-fos]) ∧ is_element_of(ENTITY[5], GROUP[2])) ∧
     ADV_immunohistochemically(SITUATION[9]) ∧
      past(EVENT[8]) ∧
       is_FACT_THAT(SITUATION[9], CONJ_and(stained(EVENT[8], _, GROUP[1]), using(EVENT[7], GROUP[1], GROUP[2]))))

# ::id 110_nonfiction_GENIA-1999;99111186,8;NE
# ::snt Three of the 27 patients with squamous cell carcinoma showed slight expression of c-fos in their tumor cells before and/or at 4 or 10 Gy of radiotherapy .
∃ REF1[6] ATTRIB[4] EVENT[11] EVENT[11] ENTITY[8] ENTITY[7] ENTITY[10] ENTITY[9] GROUP[5] ENTITY[3] ENTITY[1] GROUP[2] (
 (CD_27(GROUP[2]), patients(GROUP[2])) ∧
  (CD_three(ENTITY[1]), is_element_of(ENTITY[1], GROUP[2]) ∧ is_with(ENTITY[1], ENTITY[squamous_cell_carcinoma])) ∧
   slight(ATTRIB[4]) ∧
    is_expression_of(ENTITY[3], ENTITY[c-fos]) ∧ is_expression_ATTRIBUTE(ENTITY[3], ATTRIB[4]) ∧
     REF1[6] = their ∧
      is_tumor_cells_POS(GROUP[5], REF1[6]) ∧
       radiotherapy(ENTITY[8]) ∧
        (CD_4_or_10(ENTITY[7]), is_Gy_of(ENTITY[7], ENTITY[8])) ∧
         radiotherapy(ENTITY[10]) ∧
          (CD_4_or_10(ENTITY[9]), is_Gy_of(ENTITY[9], ENTITY[10])) ∧
           past(EVENT[11]) ∧
            past(EVENT[11]) ∧
             CONJ_and_slash_or(showed(EVENT[11], ENTITY[1], ENTITY[3]) ∧ before(EVENT[11]) = ENTITY[7] ∧
                   in(EVENT[11]) = GROUP[5],
              showed(EVENT[11], ENTITY[1], ENTITY[3]) ∧ at(EVENT[11]) = ENTITY[9] ∧
               in(EVENT[11]) = GROUP[5]))

# ::id 111_nonfiction_GENIA-1999;99111186,9;NE
# ::snt The tumors showed high radiosensitivity .
∃ ATTRIB[3] EVENT[4] ENTITY[2] GROUP[1] (
 tumors(GROUP[1]) ∧
  high(ATTRIB[3]) ∧ is_radiosensitivity_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧ past(EVENT[4]) ∧ showed(EVENT[4], GROUP[1], ENTITY[2]))

# ::id 112_nonfiction_GENIA-1999;99111186,10;NE
# ::snt Concerning tumor-infiltrating lymphocytes , the rate of moderate or remarkable grades of c-fos-positive lymphocytes before radiotherapy and at radiation doses of 4 , 10 , and 20 Gy was 8.0 , 29.2 , 4.8 , and 0 % , respectively .
∃ ATTRIB[17] ATTRIB[9] ATTRIB[7] ATTRIB[5] EVENT[18] EVENT[24] GROUP[16] GROUP[19] GROUP[4] GROUP[6] GROUP[8] GROUP[3] ENTITY[10] ENTITY[13] ENTITY[14] ENTITY[15] GROUP[12] GROUP[11] ENTITY[2] ENTITY[1] (
 moderate(ATTRIB[5]) ∧
  is_grades_ATTRIBUTE(GROUP[4], ATTRIB[5]) ∧
   remarkable(ATTRIB[7]) ∧
    is_grades_ATTRIBUTE(GROUP[6], ATTRIB[7]) ∧
     CONJ_or(is_subset_of_or_equal_to(GROUP[4], GROUP[3]), is_subset_of_or_equal_to(GROUP[6], GROUP[3])) ∧
      c-fos-positive(ATTRIB[9]) ∧
       is_lymphocytes_ATTRIBUTE(GROUP[8], ATTRIB[9]) ∧
        is_element_of(ENTITY[2], GROUP[8]) ∧ is_equals(ENTITY[2], GROUP[3]) ∧
         radiotherapy(ENTITY[10]) ∧
          (CD_4(ENTITY[13]), Gy(ENTITY[13])) ∧
           (CD_10(ENTITY[14]), Gy(ENTITY[14])) ∧
            (CD_20(ENTITY[15]), Gy(ENTITY[15])) ∧
             is_element_of(ENTITY[13], GROUP[12]) ∧ is_element_of(ENTITY[14], GROUP[12]) ∧ is_element_of(ENTITY[15], GROUP[12]) ∧
              is_radiation_doses_of(GROUP[11], GROUP[12]) ∧
               CONJ_and(is_rate_before(ENTITY[1], ENTITY[10]) ∧ is_rate_of(ENTITY[1], ENTITY[2]),
                is_rate_at(ENTITY[1], GROUP[11]) ∧ is_rate_of(ENTITY[1], ENTITY[2])) ∧
                tumor-infiltrating(ATTRIB[17]) ∧
                 is_lymphocytes_ATTRIBUTE(GROUP[16], ATTRIB[17]) ∧
                  ∃ ENTITY[20] ((CD_8.0(ENTITY[20]), %(ENTITY[20])) ∧ is_element_of(ENTITY[20], GROUP[19])) ∧
                   ∃ ENTITY[21] ((CD_29.2(ENTITY[21]), %(ENTITY[21])) ∧ is_element_of(ENTITY[21], GROUP[19])) ∧
                   ∃ ENTITY[22] ((CD_4.8(ENTITY[22]), %(ENTITY[22])) ∧ is_element_of(ENTITY[22], GROUP[19])) ∧
                   ∃ ENTITY[23] ((CD_0(ENTITY[23]), %(ENTITY[23])) ∧ is_element_of(ENTITY[23], GROUP[19])) ∧
                   ADV_respectively(EVENT[24]) ∧
                    past(EVENT[24]) ∧
                     CONJ_and(concerning(EVENT[18], ENTITY[1], GROUP[16]), copula(EVENT[24], ENTITY[1], GROUP[19])))

# ::id 113_nonfiction_GENIA-1999;99111186,11;NE
# ::snt The relationship between the immunohistochemical findings and the antitumor effect at a radiation dose of 20 Gy was examined on the corresponding H & E -stained sections .
∃ ATTRIB[10] ATTRIB[9] ATTRIB[4] EVENT[12] GROUP[3] ENTITY[7] ENTITY[6] ENTITY[5] GROUP[2] GROUP[11] GROUP[8] ENTITY[1] (
 immunohistochemical(ATTRIB[4]) ∧
  is_findings_ATTRIBUTE(GROUP[3], ATTRIB[4]) ∧
   (CD_20(ENTITY[7]), Gy(ENTITY[7])) ∧
    is_radiation_dose_of(ENTITY[6], ENTITY[7]) ∧
     is_antitumor_effect_at(ENTITY[5], ENTITY[6]) ∧
      is_subset_of_or_equal_to(GROUP[3], GROUP[2]) ∧ is_element_of(ENTITY[5], GROUP[2]) ∧
       is_relationship_between(ENTITY[1], GROUP[2]) ∧
        corresponding(ATTRIB[9]) ∧
         is_element_of(ENTITY[H], GROUP[11]) ∧ is_element_of(ENTITY[E], GROUP[11]) ∧
          is-stained_comp(ATTRIB[10], GROUP[11]) ∧
           is_sections_ATTRIBUTE(GROUP[8], ATTRIB[10]) ∧ is_sections_ATTRIBUTE(GROUP[8], ATTRIB[9]) ∧
            past(EVENT[12]) ∧ examined(EVENT[12], _, ENTITY[1]) ∧ on(EVENT[12]) = GROUP[8])

# ::id 114_nonfiction_GENIA-1999;99111186,12;NE
# ::snt In patients whose infiltration of c-fos-positive lymphocytes into tumor tissues were moderate or remarkable at 4 Gy of radiotherapy , the tumors responded significantly well to radiation therapy -LRB- P < 0.025 , chi2 test -RRB- ,
∃ ATTRIB[8] ATTRIB[7] ATTRIB[5] EVENT[11] EVENT[11] EVENT[14] GROUP[6] GROUP[4] ENTITY[10] ENTITY[9] ENTITY[10] ENTITY[9] ENTITY[2] ENTITY[13] GROUP[1] GROUP[12] (
 tumors(GROUP[12]) ∧
  c-fos-positive(ATTRIB[5]) ∧
   is_lymphocytes_ATTRIBUTE(GROUP[4], ATTRIB[5]) ∧
    tumor_tissues(GROUP[6]) ∧
     is_infiltration_into(ENTITY[2], GROUP[6]) ∧ is_infiltration_of(ENTITY[2], GROUP[4]) ∧ is_infiltration_POS(ENTITY[2], GROUP[1]) ∧
      moderate(ATTRIB[7]) ∧
       radiotherapy(ENTITY[10]) ∧
        (CD_4(ENTITY[9]), is_Gy_of(ENTITY[9], ENTITY[10])) ∧
         remarkable(ATTRIB[8]) ∧
          radiotherapy(ENTITY[10]) ∧
           (CD_4(ENTITY[9]), is_Gy_of(ENTITY[9], ENTITY[10])) ∧
            CONJ_or(copula(EVENT[11], ENTITY[2], ATTRIB[7]) ∧ at(EVENT[11]) = ENTITY[9],
             copula(EVENT[11], ENTITY[2], ATTRIB[8]) ∧ at(EVENT[11]) = ENTITY[9]) ∧
             patients(GROUP[1]) ∧
             radiation_therapy(ENTITY[13]) ∧
              past(EVENT[11]) ∧
               past(EVENT[11]) ∧
                ADV_significantly_well(EVENT[14]) ∧
                 past(EVENT[14]) ∧
                  responded(EVENT[14], GROUP[12]) ∧ to(EVENT[14]) = ENTITY[13] ∧
                   In(EVENT[14]) = GROUP[1])

# ::id 115_nonfiction_GENIA-1999;99111186,12;NE
# ::snt and the patients took a significantly favorable clinical course -LRB- P < 0.05 , chi2 test -RRB- .
∃ ATTRIB[4] ATTRIB[3] EVENT[5] ENTITY[2] GROUP[1] (
 patients(GROUP[1]) ∧
  significantly_favorable(ATTRIB[3]) ∧
   clinical(ATTRIB[4]) ∧
    is_course_ATTRIBUTE(ENTITY[2], ATTRIB[4]) ∧ is_course_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
     past(EVENT[5]) ∧ took(EVENT[5], GROUP[1], ENTITY[2]))

# ::id 116_nonfiction_GENIA-1999;99111186,13;NE
# ::snt In a sample from one of the patients , c-fos-positive lymphocytes were identified as CD4 positive and CD8 negative .
∃ ATTRIB[5] EVENT[7] ENTITY[2] GROUP[6] GROUP[4] ENTITY[1] GROUP[3] (
 patients(GROUP[3]) ∧
  (CD_one(ENTITY[2]), is_element_of(ENTITY[2], GROUP[3])) ∧
   is_sample_from(ENTITY[1], ENTITY[2]) ∧
    c-fos-positive(ATTRIB[5]) ∧
     is_lymphocytes_ATTRIBUTE(GROUP[4], ATTRIB[5]) ∧
      is_element_of(ENTITY[CD4_positive], GROUP[6]) ∧ is_element_of(ENTITY[CD8_negative], GROUP[6]) ∧
       past(EVENT[7]) ∧
        identified(EVENT[7], _, GROUP[4]) ∧ as(EVENT[7]) = GROUP[6] ∧ In(EVENT[7]) = ENTITY[1])

# ::id 117_nonfiction_GENIA-1999;99111186,14;NE
# ::snt Therefore , the high radiosensitivity of squamous cell carcinomas in our samples could be explained by an overexpression of c-fos in the tumor-infiltrating lymphocytes induced by small doses of radiation therapy ,
∃ SITUATION[16] ATTRIB[9] REF1[6] ATTRIB[4] ATTRIB[2] GROUP[5] GROUP[3] GROUP[8] ENTITY[1] (
 high(ATTRIB[2]) ∧
  squamous(ATTRIB[4]) ∧
   REF1[6] = our ∧
    is_samples_POS(GROUP[5], REF1[6]) ∧
     is_cell_carcinomas_ATTRIBUTE(GROUP[3], ATTRIB[4]) ∧ is_cell_carcinomas_in(GROUP[3], GROUP[5]) ∧
      is_radiosensitivity_of(ENTITY[1], GROUP[3]) ∧ is_radiosensitivity_ATTRIBUTE(ENTITY[1], ATTRIB[2]) ∧
       tumor-infiltrating(ATTRIB[9]) ∧
        is_lymphocytes_ATTRIBUTE(GROUP[8], ATTRIB[9]) ∧
         ADV_therefore(SITUATION[16]) ∧
          is_FACT_THAT(SITUATION[16],
           MD_could(∃ ATTRIB[12] EVENT[14] EVENT[15] ENTITY[13] GROUP[11] ENTITY[7] (
                 small(ATTRIB[12]) ∧
                  radiation_therapy(ENTITY[13]) ∧
                   is_doses_of(GROUP[11], ENTITY[13]) ∧ is_doses_ATTRIBUTE(GROUP[11], ATTRIB[12]) ∧
                    induced(EVENT[14], ENTITY[7]) ∧ by(EVENT[14]) = GROUP[11] ∧
                     is_overexpression_in(ENTITY[7], GROUP[8]) ∧ is_overexpression_of(ENTITY[7], ENTITY[c-fos]) ∧
                     explained(EVENT[15], ENTITY[7], ENTITY[1])))))

# ::id 118_nonfiction_GENIA-1999;99111186,14;NE
# ::snt and these activated lymphocytes exerted a cytotoxic effect against the cancer cells .
∃ ATTRIB[4] ATTRIB[2] EVENT[6] ENTITY[3] GROUP[5] GROUP[1] (
 activated(ATTRIB[2]) ∧
  is_lymphocytes_ATTRIBUTE(GROUP[1], ATTRIB[2]) ∧
   cancer_cells(GROUP[5]) ∧
    cytotoxic(ATTRIB[4]) ∧
     is_effect_ATTRIBUTE(ENTITY[3], ATTRIB[4]) ∧
      past(EVENT[6]) ∧ exerted(EVENT[6], GROUP[1], ENTITY[3]) ∧ against(EVENT[6]) = GROUP[5])

# ::id 119_nonfiction_GENIA-1999;99111421,1;NE
# ::snt CD2 signalling induces phosphorylation of CREB in primary lymphocytes .
∃ ATTRIB[4] EVENT[5] GROUP[3] ENTITY[2] ENTITY[1] (
 CD2_signalling(ENTITY[1]) ∧
  is_phosphorylation_of(ENTITY[2], ENTITY[CREB]) ∧
   primary(ATTRIB[4]) ∧
    is_lymphocytes_ATTRIBUTE(GROUP[3], ATTRIB[4]) ∧ induces(EVENT[5], ENTITY[1], ENTITY[2]) ∧ in(EVENT[5]) = GROUP[3])

# ::id 120_nonfiction_GENIA-1999;99111421,2;NE
# ::snt Promoter sequences responsive to cyclic AMP -LRB- cAMP -RRB- are found in a number of cellular genes , and bind transcription factors of the cAMP response element binding protein -LRB- CREB -RRB- / activating transcription factor-1 -LRB- ATF-1 -RRB- family .
∃ ATTRIB[8] ATTRIB[5] ATTRIB[2] ATTRIB[14] EVENT[9] EVENT[16] ENTITY[3] ENTITY[4] GROUP[7] ENTITY[6] GROUP[10] GROUP[1] ENTITY[13] ENTITY[12] ENTITY[11] ENTITY[15] (
 cAMP_response_element_binding_protein(ENTITY[15]) ∧
  is_-ENTITY-_namely(ENTITY[15], ENTITY[CREB]) ∧
   activating(ATTRIB[14]) ∧
    is_transcription_factor-1_ATTRIBUTE(ENTITY[13], ATTRIB[14]) ∧
     is_-ENTITY-_namely(ENTITY[15], ENTITY[13]) ∧
      family(ENTITY[12]) ∧
       is_-ENTITY-_namely(ENTITY[15], ENTITY[12]) ∧
        ATF-1(ENTITY[11]) ∧
         is_-ENTITY-_namely(ENTITY[15], ENTITY[11]) ∧
          cyclic(ATTRIB[5]) ∧
           is_AMP_ATTRIBUTE(ENTITY[4], ATTRIB[5]) ∧
            cAMP(ENTITY[3]) ∧
             is_-ENTITY-_namely(ENTITY[4], ENTITY[3]) ∧
              is_responsive_to(ATTRIB[2], ENTITY[4]) ∧
               is_Promoter_sequences_ATTRIBUTE(GROUP[1], ATTRIB[2]) ∧
                cellular(ATTRIB[8]) ∧
                 is_genes_ATTRIBUTE(GROUP[7], ATTRIB[8]) ∧
                  is_number_of(ENTITY[6], GROUP[7]) ∧
                   is_transcription_factors_of(GROUP[10], ENTITY[15]) ∧
                    CONJ_and(are_found(EVENT[9], GROUP[1]) ∧ in(EVENT[9]) = ENTITY[6],
                     bind(EVENT[16], GROUP[1], GROUP[10])))

# ::id 121_nonfiction_GENIA-1999;99111421,3;NE
# ::snt We have used a human T-lymphotropic virus type 1 -LRB- HTLV-1 -RRB- model of cAMP response element -LRB- CRE -RRB- transcription to investigate the influence of lymphocyte activation on transcription from homologous regions in the viral promoter .
∃ ATTRIB[5] ATTRIB[4] REF1[1] ATTRIB[15] ATTRIB[13] EVENT[16] EVENT[8] ENTITY[6] ENTITY[7] ENTITY[2] ENTITY[3] ENTITY[14] GROUP[12] ENTITY[11] ENTITY[10] ENTITY[9] (
 lymphocyte_activation(ENTITY[10]) ∧
  homologous(ATTRIB[13]) ∧
   viral(ATTRIB[15]) ∧
    is_promoter_ATTRIBUTE(ENTITY[14], ATTRIB[15]) ∧
     is_regions_in(GROUP[12], ENTITY[14]) ∧ is_regions_ATTRIBUTE(GROUP[12], ATTRIB[13]) ∧
      is_transcription_from(ENTITY[11], GROUP[12]) ∧
       is_influence_on(ENTITY[9], ENTITY[11]) ∧ is_influence_of(ENTITY[9], ENTITY[10]) ∧
        REF1[1] = we ∧
         human(ATTRIB[4]) ∧
          t-lymphotropic(ATTRIB[5]) ∧
           cAMP_response_element_transcription(ENTITY[7]) ∧
            CRE(ENTITY[6]) ∧
             is_-ENTITY-_namely(ENTITY[7], ENTITY[6]) ∧
              is_virus_type_1_model_of(ENTITY[3], ENTITY[7]) ∧ is_virus_type_1_model_ATTRIBUTE(ENTITY[3], ATTRIB[5]) ∧ is_virus_type_1_model_ATTRIBUTE(ENTITY[3], ATTRIB[4]) ∧
               HTLV-1(ENTITY[2]) ∧
                is_-ENTITY-_namely(ENTITY[3], ENTITY[2]) ∧
                 have_used(EVENT[8], REF1[1], ENTITY[3], investigate(EVENT[16], ENTITY[3], ENTITY[9])))

# ::id 122_nonfiction_GENIA-1999;99111421,4;NE
# ::snt We previously demonstrated increased HTLV-1 transcription following CD2 but not CD3 receptor cross-linking .
∃ SITUATION[8] REF1[1] EVENT[6] EVENT[7] GROUP[4] ENTITY[5] ENTITY[2] (
 REF1[1] = we ∧
  receptor_cross-linking(ENTITY[5]) ∧
   CONJ_but(is_element_of(ENTITY[CD2], GROUP[4]), ¬ is_element_of(ENTITY[CD3], GROUP[4])) ∧
    is_-ENTITY-_namely(ENTITY[5], GROUP[4]) ∧
     following(EVENT[6], ENTITY[2], ENTITY[5]) ∧ increased_HTLV-1_transcription(ENTITY[2]) ∧
      TMP_previously(SITUATION[8]) ∧ past(EVENT[7]) ∧ is_FACT_THAT(SITUATION[8], demonstrated(EVENT[7], REF1[1], ENTITY[2])))

# ::id 123_nonfiction_GENIA-1999;99111421,5;NE
# ::snt We hypothesized that this increased viral transcription was mediated , in part , through the phosphorylation of CREB .
∃ REF1[1] ATTRIB[5] ATTRIB[4] EVENT[8] EVENT[2] ENTITY[6] ENTITY[7] ENTITY[3] (
 increased(ATTRIB[4]) ∧
  viral(ATTRIB[5]) ∧
   is_transcription_ATTRIBUTE(ENTITY[3], ATTRIB[5]) ∧ is_transcription_ATTRIBUTE(ENTITY[3], ATTRIB[4]) ∧
    is_phosphorylation_of(ENTITY[7], ENTITY[CREB]) ∧
     REF1[1] = we ∧
      part(ENTITY[6]) ∧
       is_before(EVENT[8], EVENT[2]) ∧
        past(EVENT[2]) ∧
         hypothesized(EVENT[2], REF1[1],
          was_mediated(EVENT[8], ENTITY[3]) ∧ through(EVENT[8]) = ENTITY[7] ∧ in(EVENT[8]) = ENTITY[6]))

# ::id 124_nonfiction_GENIA-1999;99111421,6;NE
# ::snt Therefore , we investigated CD2 and CD3 receptor-mediated signalling in primary human peripheral blood mononuclear cells -LRB- PBMC -RRB- .
∃ ATTRIB[7] ATTRIB[6] ATTRIB[4] REF1[1] EVENT[8] GROUP[2] GROUP[5] ENTITY[3] (
 REF1[1] = we ∧
  receptor-mediated(ATTRIB[4]) ∧
   is_signalling_ATTRIBUTE(ENTITY[3], ATTRIB[4]) ∧
    is_element_of(ENTITY[CD2], GROUP[2]) ∧ is_element_of(ENTITY[CD3], GROUP[2]) ∧
     is_-ENTITY-_namely(ENTITY[3], GROUP[2]) ∧
      primary(ATTRIB[6]) ∧
       human(ATTRIB[7]) ∧
        is_peripheral_blood_mononuclear_cells_ATTRIBUTE(GROUP[5], ATTRIB[7]) ∧ is_peripheral_blood_mononuclear_cells_ATTRIBUTE(GROUP[5], ATTRIB[6]) ∧
         is_-GROUP-_namely(GROUP[5], ENTITY[PBMC]) ∧
          ADV_therefore(EVENT[8]) ∧
           past(EVENT[8]) ∧ investigated(EVENT[8], REF1[1], ENTITY[3]) ∧ in(EVENT[8]) = GROUP[5])

# ::id 125_nonfiction_GENIA-1999;99111421,7;NE
# ::snt CD2 , but not CD3 , cross-linking increased cAMP detected by competitive enzyme-linked immunosorbent assay -LRB- ELISA -RRB- approximately fourfold .
∃ ATTRIB[6] ATTRIB[5] EVENT[7] EVENT[8] GROUP[1] ENTITY[4] ENTITY[2] (
 cross-linking(ENTITY[2]) ∧
  CONJ_but(is_element_of(ENTITY[CD2], GROUP[1]), ¬ is_element_of(ENTITY[CD3], GROUP[1])) ∧
   is_-ENTITY-_namely(ENTITY[2], GROUP[1]) ∧
    competitive(ATTRIB[5]) ∧
     enzyme-linked(ATTRIB[6]) ∧
      is_immunosorbent_assay_ATTRIBUTE(ENTITY[4], ATTRIB[6]) ∧ is_immunosorbent_assay_ATTRIBUTE(ENTITY[4], ATTRIB[5]) ∧
       is_-ENTITY-_namely(ENTITY[4], ENTITY[ELISA]) ∧
        detected(EVENT[7], ENTITY[4], ENTITY[cAMP]) ∧
         fourfold(EVENT[8]) ∧ ADV_approximately(EVENT[8]) ∧
          past(EVENT[8]) ∧ increased(EVENT[8], ENTITY[2], ENTITY[cAMP]))

# ::id 126_nonfiction_GENIA-1999;99111421,8;NE
# ::snt CD2 cross-linking concurrently increased phosphorylation of CREB detected by immunoblot assay eightfold .
∃ SITUATION[8] EVENT[5] EVENT[6] ENTITY[4] ENTITY[2] ENTITY[1] (
 CD2_cross-linking(ENTITY[1]) ∧
  immunoblot_assay(ENTITY[4]) ∧
   detected(EVENT[5], ENTITY[4], ENTITY[2]) ∧ is_phosphorylation_of(ENTITY[2], ENTITY[CREB]) ∧
    ADV_concurrently(SITUATION[8]) ∧
     ADV_eightfold(EVENT[6]) ∧ past(EVENT[6]) ∧ is_FACT_THAT(SITUATION[8], increased(EVENT[6], ENTITY[1], ENTITY[2])))

# ::id 127_nonfiction_GENIA-1999;99111421,9;NE
# ::snt Consistent with post-translational regulation , no change in total level of CREB protein was observed .
¬ ∃ ATTRIB[7] ATTRIB[5] ATTRIB[3] EVENT[9] EVENT[8] ENTITY[4] ENTITY[2] ENTITY[6] ENTITY[1] (
      total(ATTRIB[3]) ∧
       CREB_protein(ENTITY[4]) ∧
        is_level_of(ENTITY[2], ENTITY[4]) ∧ is_level_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
         is_change_in(ENTITY[1], ENTITY[2]) ∧
          post-translational(ATTRIB[7]) ∧
           is_regulation_ATTRIBUTE(ENTITY[6], ATTRIB[7]) ∧
            is_consistent_with(ATTRIB[5], ENTITY[6]) ∧
             past(EVENT[9]) ∧
              CONJ_and(observed(EVENT[9], _, ENTITY[1]),
               xxx(EVENT[8], ENTITY[1]) ∧ ATTRIBUTE(EVENT[8]) = ATTRIB[5]))

# ::id 128_nonfiction_GENIA-1999;99111421,10;NE
# ::snt Phosphorylation of CREB occurred through a herbimycin A and Rp-cAMP -sensitive pathway , suggesting phosphorylation required antecedent activation of both protein tyrosine kinases -LRB- PTK -RRB- and protein kinase A -LRB- PKA -RRB- .
∃ ATTRIB[8] ATTRIB[3] EVENT[14] EVENT[13] EVENT[5] GROUP[4] ENTITY[7] ENTITY[6] ENTITY[2] ENTITY[1] (
 is_Phosphorylation_of(ENTITY[1], ENTITY[CREB]) ∧
  is_element_of(ENTITY[herbimycin_A], GROUP[4]) ∧ is_element_of(ENTITY[Rp-cAMP], GROUP[4]) ∧
   is-sensitive_comp(ATTRIB[3], GROUP[4]) ∧
    is_pathway_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
     phosphorylation(ENTITY[6]) ∧
      antecedent(ATTRIB[8]) ∧
       BOTH GROUP[10] group[9] (
        (∃ ENTITY[11] GROUP[12] (
           protein_tyrosine_kinases(GROUP[12]) ∧
            PTK(ENTITY[11]) ∧ is_-GROUP-_namely(GROUP[12], ENTITY[11]) ∧ is_subset_of_or_equal_to(GROUP[12], GROUP[10])) ∧
           is_-ENTITY-_namely(ENTITY[protein_kinase_A], ENTITY[PKA]) ∧ is_element_of(ENTITY[protein_kinase_A], GROUP[10]) ∧ is_equals(group[9], GROUP[10])),
        is_activation_of(ENTITY[7], group[9]) ∧ is_activation_ATTRIBUTE(ENTITY[7], ATTRIB[8])) ∧
        past(EVENT[14]) ∧
         is_before(EVENT[13], EVENT[5]) ∧
          CONJ_and(occurred(EVENT[14], ENTITY[1]) ∧ through(EVENT[14]) = ENTITY[2],
           suggesting(EVENT[5], ENTITY[1], required(EVENT[13], ENTITY[6], ENTITY[7]))))

# ::id 129_nonfiction_GENIA-1999;99111421,11;NE
# ::snt Both CD2 and CD3 cross-linking increased binding of nuclear proteins to a radiolabelled CRE oligonucleotide probe in electrophoretic mobility shift assays suggesting that lymphocyte activation enhances binding independently of phosphorylation of CREB at serine 133 .
∃ ATTRIB[9] ATTRIB[7] ATTRIB[5] EVENT[16] EVENT[14] EVENT[10] GROUP[1] GROUP[8] ENTITY[6] GROUP[4] ENTITY[13] ENTITY[12] ENTITY[11] ENTITY[3] ENTITY[2] (
 cross-linking(ENTITY[2]) ∧
  is_element_of(ENTITY[CD2], GROUP[1]) ∧ is_element_of(ENTITY[CD3], GROUP[1]) ∧
   is_-ENTITY-_namely(ENTITY[2], GROUP[1]) ∧
    nuclear(ATTRIB[5]) ∧
     is_proteins_ATTRIBUTE(GROUP[4], ATTRIB[5]) ∧
      radiolabelled(ATTRIB[7]) ∧
       is_CRE_oligonucleotide_probe_ATTRIBUTE(ENTITY[6], ATTRIB[7]) ∧
        electrophoretic(ATTRIB[9]) ∧
         is_mobility_shift_assays_ATTRIBUTE(GROUP[8], ATTRIB[9]) ∧
          is_binding_in(ENTITY[3], GROUP[8]) ∧ is_binding_to(ENTITY[3], ENTITY[6]) ∧ is_binding_of(ENTITY[3], GROUP[4]) ∧
           lymphocyte_activation(ENTITY[11]) ∧
            binding(ENTITY[12]) ∧
             is_phosphorylation_at(ENTITY[13], ENTITY[serine_133]) ∧ is_phosphorylation_of(ENTITY[13], ENTITY[CREB]) ∧
              past(EVENT[16]) ∧
               is_ADV_independently_of(EVENT[14], ENTITY[13]) ∧
                CONJ_and(increased(EVENT[16], ENTITY[2], ENTITY[3]),
                 suggesting(EVENT[10], ENTITY[3], enhances(EVENT[14], ENTITY[11], ENTITY[12]))))

# ::id 130_nonfiction_GENIA-1999;99111421,12;NE
# ::snt These data indicate specific modulation of the CREB/ATF-1 family of transcription factors by the CD2 signalling pathway and suggest CD2 receptor modulation of CRE-mediated transcription following ligand engagement -LRB- e.g. cell-to-cell contact -RRB- .
∃ ATTRIB[12] ATTRIB[10] ATTRIB[3] EVENT[7] EVENT[15] EVENT[16] ENTITY[2] ENTITY[14] ENTITY[11] ENTITY[9] ENTITY[8] GROUP[5] ENTITY[6] ENTITY[4] GROUP[1] (
 data(GROUP[1]) ∧
  transcription_factors(GROUP[5]) ∧
   is_CREB__slash__ATF-1_family_of(ENTITY[4], GROUP[5]) ∧
    CD2_signalling_pathway(ENTITY[6]) ∧
     specific(ATTRIB[3]) ∧
      is_modulation_by(ENTITY[2], ENTITY[6]) ∧ is_modulation_of(ENTITY[2], ENTITY[4]) ∧ is_modulation_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
       cre-mediated(ATTRIB[10]) ∧
        is_transcription_ATTRIBUTE(ENTITY[9], ATTRIB[10]) ∧
         cell-to-cell(ATTRIB[12]) ∧
          is_contact_ATTRIBUTE(ENTITY[11], ATTRIB[12]) ∧
           ligand_engagement(ENTITY[14]) ∧
            following(EVENT[15], ENTITY[8], ENTITY[14]) ∧
             is_CD2_receptor_modulation_of(ENTITY[8], ENTITY[9]) ∧ is_CD2_receptor_modulation_e.g.(ENTITY[8], ENTITY[11]) ∧
             CONJ_and(indicate(EVENT[7], GROUP[1], ENTITY[2]), suggest(EVENT[16], GROUP[1], ENTITY[8])))

# ::id 131_nonfiction_GENIA-1999;99113717,1;NE
# ::snt Protective effects of notch-1 on TCR-induced apoptosis .
∃ ATTRIB[4] ATTRIB[2] EVENT[5] ENTITY[3] GROUP[1] (
 protective(ATTRIB[2]) ∧
  tcr-induced(ATTRIB[4]) ∧
   is_apoptosis_ATTRIBUTE(ENTITY[3], ATTRIB[4]) ∧
    is_effects_on(GROUP[1], ENTITY[3]) ∧ is_effects_of(GROUP[1], ENTITY[notch-1]) ∧ is_effects_ATTRIBUTE(GROUP[1], ATTRIB[2]) ∧
     xxx(EVENT[5]) ∧ LINK(EVENT[5]) = GROUP[1])

# ::id 132_nonfiction_GENIA-1999;99113717,2;NE
# ::snt The Notch receptor protein was originally identified in Drosophila and is known to mediate cell to cell communication and influence cell fate decisions .
∃ ATTRIB[6] ENTITY[5] GROUP[8] EVENT[2] EVENT[7] EVENT[9] EVENT[4] ENTITY[1] (
 Notch_receptor_protein(ENTITY[1]) ∧
  ADV_originally(EVENT[2]) ∧
   past(EVENT[2]) ∧
    to(ATTRIB[6]) ∧ cell_cell(ATTRIB[6]) ∧
     is_communication_ATTRIBUTE(ENTITY[5], ATTRIB[6]) ∧
      cell_fate_decisions(GROUP[8]) ∧
       CONJ_and(identified(EVENT[2], _, ENTITY[1]) ∧ in(EVENT[2]) = ENTITY[Drosophila],
        is_known(EVENT[4], ENTITY[1],
         CONJ_and(mediate(EVENT[7], ENTITY[1], ENTITY[5]), influence(EVENT[9], ENTITY[1], GROUP[8])))))

# ::id 133_nonfiction_GENIA-1999;99113717,3;NE
# ::snt Members of this family have been isolated from invertebrates as well as vertebrates .
∃ EVENT[5] GROUP[4] GROUP[3] GROUP[1] ENTITY[2] (
 family(ENTITY[2]) ∧
  is_Members_of(GROUP[1], ENTITY[2]) ∧
   invertebrates(GROUP[3]) ∧
    vertebrates(GROUP[4]) ∧
     is_ADV_as_well_as(EVENT[5], GROUP[4]) ∧ have_isolated(EVENT[5], _, GROUP[1]) ∧ from(EVENT[5]) = GROUP[3])

# ::id 134_nonfiction_GENIA-1999;99113717,4;NE
# ::snt We isolated mouse Notch-1 in a yeast two-hybrid screen with Nur77 , which is a protein that has been shown previously to be required for apoptosis in T cell lines .
∃ SITUATION[10] REF1[1] EVENT[9] EVENT[6] EVENT[11] EVENT[12] GROUP[8] ENTITY[7] ENTITY[4] ENTITY[2] (
 REF1[1] = we ∧
  yeast_two-hybrid_screen(ENTITY[2]) ∧
   T_cell_lines(GROUP[8]) ∧
    is_apoptosis_in(ENTITY[7], GROUP[8]) ∧
     is_FACT_THAT(SITUATION[10],
      has_shown(EVENT[6], _, ENTITY[4],
       required(EVENT[9], _, ENTITY[4]) ∧ for(EVENT[9]) = ENTITY[7])) ∧ protein(ENTITY[4]) ∧
      copula(EVENT[11], ENTITY[Nur77], ENTITY[4]) ∧
       TMP_previously(SITUATION[10]) ∧
        past(EVENT[12]) ∧
         isolated(EVENT[12], REF1[1], ENTITY[mouse_Notch-1]) ∧ with(EVENT[12]) = ENTITY[Nur77] ∧
          in(EVENT[12]) = ENTITY[2])

# ::id 135_nonfiction_GENIA-1999;99113717,5;NE
# ::snt The data presented below indicate that Notch-1 expression provides significant protection to T cell lines from TCR-mediated apoptosis .
∃ ATTRIB[10] ATTRIB[7] EVENT[11] EVENT[4] ENTITY[9] GROUP[8] ENTITY[6] ENTITY[5] GROUP[1] EVENT[3] (
 presented(EVENT[3], _, GROUP[1]) ∧ data(GROUP[1]) ∧
  Notch-1_expression(ENTITY[5]) ∧
   significant(ATTRIB[7]) ∧
    is_protection_ATTRIBUTE(ENTITY[6], ATTRIB[7]) ∧
     T_cell_lines(GROUP[8]) ∧
      tcr-mediated(ATTRIB[10]) ∧
       is_apoptosis_ATTRIBUTE(ENTITY[9], ATTRIB[10]) ∧
        indicate(EVENT[4], GROUP[1],
         provides(EVENT[11], ENTITY[5], ENTITY[6]) ∧ from(EVENT[11]) = ENTITY[9] ∧
          to(EVENT[11]) = GROUP[8]))

# ::id 136_nonfiction_GENIA-1999;99113717,6;NE
# ::snt These data demonstrate a new antiapoptotic role for Notch-1 , providing evidence that , in addition to regulating cell fate decisions , Notch-1 can play a critical role in controlling levels of cell death in T cells .
∃ SITUATION[7] ATTRIB[4] ATTRIB[3] EVENT[19] EVENT[9] EVENT[18] GROUP[8] ENTITY[6] ENTITY[5] ENTITY[2] GROUP[1] (
 data(GROUP[1]) ∧
  new(ATTRIB[3]) ∧
   antiapoptotic(ATTRIB[4]) ∧
    is_role_for(ENTITY[2], ENTITY[Notch-1]) ∧ is_role_ATTRIBUTE(ENTITY[2], ATTRIB[4]) ∧ is_role_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
     cell_fate_decisions(GROUP[8]) ∧
      is_FACT_THAT(SITUATION[7], regulating(EVENT[9], _, GROUP[8])) ∧
       is_addition_to(ENTITY[6], SITUATION[7]) ∧
        is_evidence_THAT(ENTITY[5],
         MD_can(∃ SITUATION[12] ATTRIB[11] EVENT[16] EVENT[17] GROUP[15] ENTITY[14] GROUP[13] ENTITY[10] (
               critical(ATTRIB[11]) ∧
                cell_death(ENTITY[14]) ∧
                 T_cells(GROUP[15]) ∧
                  is_levels_in(GROUP[13], GROUP[15]) ∧ is_levels_of(GROUP[13], ENTITY[14]) ∧
                   is_FACT_THAT(SITUATION[12], controlling(EVENT[16], _, GROUP[13])) ∧
                    is_role_in(ENTITY[10], SITUATION[12]) ∧ is_role_ATTRIBUTE(ENTITY[10], ATTRIB[11]) ∧
                     play(EVENT[17], ENTITY[Notch-1], ENTITY[10]) ∧ in(EVENT[17]) = ENTITY[6]))) ∧
         CONJ_and(demonstrate(EVENT[19], GROUP[1], ENTITY[2]), providing(EVENT[18], ENTITY[2], ENTITY[5])))

# ::id 137_nonfiction_GENIA-1999;99113747,1;NE
# ::snt T cell priming enhances IL-4 gene expression by increasing nuclear factor of activated T cells .
∃ ATTRIB[4] EVENT[6] EVENT[7] GROUP[5] ENTITY[3] ENTITY[2] ENTITY[1] (
 T_cell_priming(ENTITY[1]) ∧
  IL-4_gene_expression(ENTITY[2]) ∧
   nuclear(ATTRIB[4]) ∧
    activated_T_cells(GROUP[5]) ∧
     is_factor_of(ENTITY[3], GROUP[5]) ∧ is_factor_ATTRIBUTE(ENTITY[3], ATTRIB[4]) ∧
      CRD_by(increasing(EVENT[6], ENTITY[2], ENTITY[3]), enhances(EVENT[7], ENTITY[1], ENTITY[2])))

# ::id 138_nonfiction_GENIA-1999;99113747,2;NE
# ::snt The repetitive activation of T cells -LRB- priming -RRB- enhances the expression of many cytokines , such as IL-4 , but not others , such as IL-2 .
∃ ATTRIB[10] ATTRIB[3] EVENT[11] GROUP[4] ENTITY[1] GROUP[6] ENTITY[5] ENTITY[2] (
 repetitive(ATTRIB[3]) ∧
  T_cells(GROUP[4]) ∧
   is_activation_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧ is_activation_of(ENTITY[2], GROUP[4]) ∧
    priming(ENTITY[1]) ∧
     is_-ENTITY-_namely(ENTITY[2], ENTITY[1]) ∧
      is_such_as(ATTRIB[10], ENTITY[IL-2]) ∧
       CONJ_but(MANY ATTRIB[8] GROUP[7] ((is_such_as(ATTRIB[8], ENTITY[IL-4]) ∧ is_cytokines_ATTRIBUTE(GROUP[7], ATTRIB[8])), is_subset_of_or_equal_to(GROUP[7], GROUP[6])),
        NOT GROUP[9] (is_others_ATTRIBUTE(GROUP[9], ATTRIB[10]), is_subset_of_or_equal_to(GROUP[9], GROUP[6]))) ∧
        is_expression_of(ENTITY[5], GROUP[6]) ∧ enhances(EVENT[11], ENTITY[2], ENTITY[5]))

# ::id 139_nonfiction_GENIA-1999;99113747,3;NE
# ::snt Molecular mechanisms underlying selective expression of cytokines by T cells remain poorly understood .
∃ ATTRIB[9] ATTRIB[5] ATTRIB[2] EVENT[8] EVENT[10] GROUP[7] GROUP[6] ENTITY[4] GROUP[1] (
 molecular(ATTRIB[2]) ∧
  selective(ATTRIB[5]) ∧
   cytokines(GROUP[6]) ∧
    T_cells(GROUP[7]) ∧
     is_expression_by(ENTITY[4], GROUP[7]) ∧ is_expression_of(ENTITY[4], GROUP[6]) ∧ is_expression_ATTRIBUTE(ENTITY[4], ATTRIB[5]) ∧
      underlying(EVENT[8], GROUP[1], ENTITY[4]) ∧ is_mechanisms_ATTRIBUTE(GROUP[1], ATTRIB[2]) ∧
       poorly_understood(ATTRIB[9]) ∧ remain(EVENT[10], GROUP[1], ATTRIB[9]))

# ::id 140_nonfiction_GENIA-1999;99113747,4;NE
# ::snt Here we show that priming of CD4 T cells selectively enhances IL-4 expression relative to IL-2 expression by a transcriptional mechanism involving nuclear factor of activated T cells -LRB- NFAT -RRB- proteins .
∃ SITUATION[17] SITUATION[18] ATTRIB[13] ATTRIB[9] ATTRIB[6] REF1[1] EVENT[15] EVENT[16] EVENT[2] GROUP[4] ENTITY[7] GROUP[14] ENTITY[11] GROUP[12] ENTITY[8] ENTITY[5] ENTITY[3] (
 REF1[1] = we ∧
  CD4_T_cells(GROUP[4]) ∧
   is_priming_of(ENTITY[3], GROUP[4]) ∧
    IL-2_expression(ENTITY[7]) ∧
     is_relative_to(ATTRIB[6], ENTITY[7]) ∧
      is_IL-4_expression_ATTRIBUTE(ENTITY[5], ATTRIB[6]) ∧
       transcriptional(ATTRIB[9]) ∧
        nuclear(ATTRIB[13]) ∧
         activated_T_cells(GROUP[14]) ∧
          is_factor_proteins_of(GROUP[12], GROUP[14]) ∧ is_factor_proteins_ATTRIBUTE(GROUP[12], ATTRIB[13]) ∧
           NFAT(ENTITY[11]) ∧
            is_-GROUP-_namely(GROUP[12], ENTITY[11]) ∧
             involving(EVENT[15], ENTITY[8], GROUP[12]) ∧ is_mechanism_ATTRIBUTE(ENTITY[8], ATTRIB[9]) ∧
              LOC_here(SITUATION[18]) ∧
               ADV_selectively(SITUATION[17]) ∧
                is_FACT_THAT(SITUATION[18],
                 show(EVENT[2], REF1[1],
                  is_FACT_THAT(SITUATION[17],
                   enhances(EVENT[16], ENTITY[3], ENTITY[5]) ∧ by(EVENT[16]) = ENTITY[8]))))

# ::id 141_nonfiction_GENIA-1999;99113747,5;NE
# ::snt As detected by in vivo footprinting , priming markedly increases the activation-dependent engagement of the P0 and P1 NFAT -binding elements of the IL-4 promoter .
∃ ATTRIB[3] ATTRIB[8] ATTRIB[6] EVENT[4] EVENT[12] ENTITY[2] ENTITY[1] GROUP[9] ENTITY[10] ENTITY[11] GROUP[7] ENTITY[5] (
 activation-dependent(ATTRIB[6]) ∧
  NFAT(ENTITY[10]) ∧
   is_element_of(ENTITY[P0], GROUP[9]) ∧ is_element_of(ENTITY[P1], GROUP[9]) ∧
    is_-ENTITY-_namely(ENTITY[10], GROUP[9]) ∧
     is-binding_comp(ATTRIB[8], ENTITY[10]) ∧
      IL-4_promoter(ENTITY[11]) ∧
       is_elements_of(GROUP[7], ENTITY[11]) ∧ is_elements_ATTRIBUTE(GROUP[7], ATTRIB[8]) ∧
        is_engagement_of(ENTITY[5], GROUP[7]) ∧ is_engagement_ATTRIBUTE(ENTITY[5], ATTRIB[6]) ∧
         priming(ENTITY[1]) ∧
          in_vivo(ATTRIB[3]) ∧
           is_footprinting_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
            ADV_markedly(EVENT[12]) ∧
             CRD_As(detected(EVENT[4], ENTITY[2], ENTITY[1]), increases(EVENT[12], ENTITY[1], ENTITY[5])))

# ::id 142_nonfiction_GENIA-1999;99113747,6;NE
# ::snt Moreover , each proximal P element is essential for optimal IL-4 promoter activity .
∃ SITUATION[5] (
 ADV_moreover(SITUATION[5]) ∧
  is_FACT_THAT(SITUATION[5],
   EACH ENTITY[1] (proximal_P__element(ENTITY[1]),
    ∃ ATTRIB[2] EVENT[4] ENTITY[3] (optimal_IL-4_promoter_activity(ENTITY[3]) ∧ is_essential_for(ATTRIB[2], ENTITY[3]) ∧ copula(EVENT[4], ENTITY[1], ATTRIB[2])))))

# ::id 143_nonfiction_GENIA-1999;99113747,7;NE
# ::snt Activated primed CD4 T cells contain more NFAT1 and support greater NFAT-directed transcription than unprimed CD4 T cells , while activator protein 1 binding and activator protein 1-mediated transcription by both cell types is similar .
∃ ATTRIB[15] ATTRIB[13] ATTRIB[8] ATTRIB[2] EVENT[9] EVENT[16] GROUP[3] ENTITY[14] GROUP[1] (
 activated_primed(ATTRIB[2]) ∧
  is_CD4_T_cells_ATTRIBUTE(GROUP[1], ATTRIB[2]) ∧
   ∃ ENTITY[4] (BOTH GROUP[5] (cell_types(GROUP[5]), is_activator_protein_1_binding_by(ENTITY[4], GROUP[5])) ∧ is_element_of(ENTITY[4], GROUP[3])) ∧
    ∃ ENTITY[6] (BOTH GROUP[7] (cell_types(GROUP[7]), is_activator_protein_1-mediated_transcription_by(ENTITY[6], GROUP[7])) ∧ is_element_of(ENTITY[6], GROUP[3])) ∧
    similar(ATTRIB[8]) ∧
     nfat-directed(ATTRIB[15]) ∧
      is_transcription_ATTRIBUTE(ENTITY[14], ATTRIB[15]) ∧
       is_greater_comp(ATTRIB[13], ENTITY[14]) ∧
        CRD_while(copula(EVENT[9], GROUP[3], ATTRIB[8]),
         CONJ_and(MORE GROUP[11] ENTITY[10] ((unprimed_CD4_T_cells(GROUP[11]) ∧ is_NFAT1_than(ENTITY[10], GROUP[11])),
               ∃ EVENT[12] contain(EVENT[12], GROUP[1], ENTITY[10])),
          support(EVENT[16], GROUP[1]) ∧ ATTRIBUTE(EVENT[16]) = ATTRIB[13])))

# ::id 144_nonfiction_GENIA-1999;99113747,8;NE
# ::snt Increased expression of wild-type NFAT1 substantially increases IL-4 promoter activity in unprimed CD4 T cells , suggesting NFAT1 may be limiting for IL-4 gene expression in this cell type .
∃ SITUATION[13] ATTRIB[4] ATTRIB[2] EVENT[12] EVENT[7] ENTITY[3] ENTITY[8] GROUP[6] ENTITY[5] ENTITY[1] ENTITY[10] (
 cell_type(ENTITY[10]) ∧
  increased(ATTRIB[2]) ∧
   wild-type(ATTRIB[4]) ∧
    is_NFAT1_ATTRIBUTE(ENTITY[3], ATTRIB[4]) ∧
     is_expression_of(ENTITY[1], ENTITY[3]) ∧ is_expression_ATTRIBUTE(ENTITY[1], ATTRIB[2]) ∧
      IL-4_promoter_activity(ENTITY[5]) ∧
       unprimed_CD4_T_cells(GROUP[6]) ∧
        NFAT1(ENTITY[8]) ∧
         ADV_substantially(SITUATION[13]) ∧
          is_FACT_THAT(SITUATION[13],
           CONJ_and(increases(EVENT[12], ENTITY[1], ENTITY[5]) ∧ in(EVENT[12]) = GROUP[6],
            suggesting(EVENT[7], ENTITY[5],
             MD_may(∃ EVENT[11] ENTITY[9] (
                   is_IL-4_gene_expression_in(ENTITY[9], ENTITY[10]) ∧
                    be_limiting(EVENT[11], ENTITY[8]) ∧ for(EVENT[11]) = ENTITY[9]))))))

# ::id 145_nonfiction_GENIA-1999;99113747,9;NE
# ::snt Furthermore , a truncated form of NFAT1 acts as a dominant-negative , reducing IL-4 promoter activity in primed CD4 T cells and confirming the importance of endogenous NFAT to increased IL-4 gene expression by effector T cells .
∃ SITUATION[16] ATTRIB[5] ATTRIB[2] ATTRIB[11] EVENT[15] EVENT[8] EVENT[14] ENTITY[3] GROUP[7] ENTITY[6] ENTITY[4] ENTITY[1] GROUP[13] ENTITY[12] ENTITY[10] ENTITY[9] (
 endogenous(ATTRIB[11]) ∧
  is_NFAT_ATTRIBUTE(ENTITY[10], ATTRIB[11]) ∧
   effector_T_cells(GROUP[13]) ∧
    is_increased_IL-4_gene_expression_by(ENTITY[12], GROUP[13]) ∧
     is_importance_to(ENTITY[9], ENTITY[12]) ∧ is_importance_of(ENTITY[9], ENTITY[10]) ∧
      truncated(ATTRIB[2]) ∧
       NFAT1(ENTITY[3]) ∧
        is_form_ATTRIBUTE(ENTITY[1], ATTRIB[2]) ∧ is_form_of(ENTITY[1], ENTITY[3]) ∧
         dominant-negative(ATTRIB[5]) ∧
          is_ATTRIBUTE(ENTITY[4], ATTRIB[5]) ∧
           IL-4_promoter_activity(ENTITY[6]) ∧
            primed_CD4_T_cells(GROUP[7]) ∧
             ADV_furthermore(SITUATION[16]) ∧
              is_FACT_THAT(SITUATION[16],
               CONJ_and(acts(EVENT[15], ENTITY[1]) ∧ as(EVENT[15]) = ENTITY[4],
                CONJ_and(reducing(EVENT[8], ENTITY[1], ENTITY[6]) ∧ in(EVENT[8]) = GROUP[7],
                 confirming(EVENT[14], ENTITY[1], ENTITY[9])))))

# ::id 146_nonfiction_GENIA-1999;99113747,10;NE
# ::snt NFAT1 appears to be the major NFAT family member responsible for the initial increased expression of IL-4 by primed CD4 T cells .
∃ ATTRIB[7] ATTRIB[6] ATTRIB[4] EVENT[9] EVENT[2] ENTITY[1] GROUP[8] ENTITY[5] ENTITY[3] (
 initial(ATTRIB[6]) ∧
  increased(ATTRIB[7]) ∧
   primed_CD4_T_cells(GROUP[8]) ∧
    is_expression_by(ENTITY[5], GROUP[8]) ∧ is_expression_of(ENTITY[5], ENTITY[IL-4]) ∧ is_expression_ATTRIBUTE(ENTITY[5], ATTRIB[7]) ∧
     is_expression_ATTRIBUTE(ENTITY[5], ATTRIB[6]) ∧
     is_responsible_for(ATTRIB[4], ENTITY[5]) ∧
      is_major_NFAT_family_member_ATTRIBUTE(ENTITY[3], ATTRIB[4]) ∧
       NFAT1(ENTITY[1]) ∧ appears(EVENT[2], copula(EVENT[9], ENTITY[1], ENTITY[3])))

# ::id 147_nonfiction_GENIA-1999;99115412,1;NE
# ::snt Anoxia/reoxygenation-induced tolerance with respect to polymorphonuclear leukocyte adhesion to cultured endothelial cells .
∃ ATTRIB[8] ATTRIB[7] ATTRIB[5] ATTRIB[2] EVENT[9] GROUP[6] ENTITY[4] ENTITY[3] ENTITY[1] (
 anoxia__slash__reoxygenation-induced(ATTRIB[2]) ∧
  polymorphonuclear(ATTRIB[5]) ∧
   cultured(ATTRIB[7]) ∧
    endothelial(ATTRIB[8]) ∧
     is_cells_ATTRIBUTE(GROUP[6], ATTRIB[8]) ∧ is_cells_ATTRIBUTE(GROUP[6], ATTRIB[7]) ∧
      is_leukocyte_adhesion_to(ENTITY[4], GROUP[6]) ∧ is_leukocyte_adhesion_ATTRIBUTE(ENTITY[4], ATTRIB[5]) ∧
       is_respect_to(ENTITY[3], ENTITY[4]) ∧
        is_tolerance_with(ENTITY[1], ENTITY[3]) ∧ is_tolerance_ATTRIBUTE(ENTITY[1], ATTRIB[2]) ∧
         xxx(EVENT[9]) ∧ LINK(EVENT[9]) = ENTITY[1])

# ::id 148_nonfiction_GENIA-1999;99115412,2;NE
# ::snt A nuclear factor -kappaB -mediated phenomenon .
∃ ATTRIB[4] ATTRIB[2] EVENT[5] ENTITY[3] ENTITY[1] (
 nuclear(ATTRIB[4]) ∧
  is_factor-kappaB_ATTRIBUTE(ENTITY[3], ATTRIB[4]) ∧
   is-mediated_comp(ATTRIB[2], ENTITY[3]) ∧
    is_phenomenon_ATTRIBUTE(ENTITY[1], ATTRIB[2]) ∧ xxx(EVENT[5]) ∧ LINK(EVENT[5]) = ENTITY[1])

# ::id 149_nonfiction_GENIA-1999;99115412,3;NE
# ::snt Exposing human umbilical vein endothelial cells -LRB- HUVECs -RRB- to anoxia/reoxygenation -LRB- A/R -RRB- results in an increase in polymorphonuclear leukocyte -LRB- PMN -RRB- adhesion to HUVECs .
∃ ATTRIB[10] ATTRIB[5] ATTRIB[4] SITUATION[1] EVENT[6] EVENT[12] ENTITY[2] GROUP[3] GROUP[11] ENTITY[8] ENTITY[9] ENTITY[7] (
 human(ATTRIB[4]) ∧
  umbilical(ATTRIB[5]) ∧
   is_vein_endothelial_cells_ATTRIBUTE(GROUP[3], ATTRIB[5]) ∧ is_vein_endothelial_cells_ATTRIBUTE(GROUP[3], ATTRIB[4]) ∧
    HUVECs(ENTITY[2]) ∧
     is_-GROUP-_namely(GROUP[3], ENTITY[2]) ∧
      is_-ENTITY-_namely(ENTITY[anoxia__slash__reoxygenation], ENTITY[A__slash__R]) ∧
       is_FACT_THAT(SITUATION[1], exposing(EVENT[6], _, GROUP[3]) ∧ to(EVENT[6]) = ENTITY[anoxia__slash__reoxygenation]) ∧
        polymorphonuclear(ATTRIB[10]) ∧
         HUVECs(GROUP[11]) ∧
          is_leukocyte_adhesion_to(ENTITY[9], GROUP[11]) ∧ is_leukocyte_adhesion_ATTRIBUTE(ENTITY[9], ATTRIB[10]) ∧
           PMN(ENTITY[8]) ∧
            is_-ENTITY-_namely(ENTITY[9], ENTITY[8]) ∧
             is_increase_in(ENTITY[7], ENTITY[9]) ∧ results(EVENT[12], SITUATION[1]) ∧ in(EVENT[12]) = ENTITY[7])

# ::id 150_nonfiction_GENIA-1999;99115412,4;NE
# ::snt This A/R-induced hyperadhesion is completely prevented by a previous -LRB- 24 hours earlier -RRB- exposure of HUVECs to A/R .
∃ ATTRIB[4] ATTRIB[2] EVENT[7] GROUP[5] GROUP[6] ENTITY[3] ENTITY[1] (
 a__slash__r-induced(ATTRIB[2]) ∧
  is_hyperadhesion_ATTRIBUTE(ENTITY[1], ATTRIB[2]) ∧
   previous(ATTRIB[4]) ∧
    (CD_24(GROUP[5]), hours(GROUP[5])) ∧
     HUVECs(GROUP[6]) ∧
      is_TMP_earlier_TMP(ENTITY[3], GROUP[5]) ∧
       is_exposure_to(ENTITY[3], ENTITY[A__slash__R]) ∧ is_exposure_of(ENTITY[3], GROUP[6]) ∧ is_exposure_ATTRIBUTE(ENTITY[3], ATTRIB[4]) ∧
       ADV_completely(EVENT[7]) ∧ prevented(EVENT[7], ENTITY[3], ENTITY[1]))

# ::id 151_nonfiction_GENIA-1999;99115412,5;NE
# ::snt This phenomenon has been termed " A/R tolerance . "
∃ EVENT[3] ENTITY[2] ENTITY[1] (phenomenon(ENTITY[1]) ∧ A__slash__R_tolerance(ENTITY[2]) ∧ has_termed(EVENT[3], _, ENTITY[2], ENTITY[1]))

# ::id 152_nonfiction_GENIA-1999;99115412,6;NE
# ::snt Exposing HUVECs to A/R induces an increase in nuclear factor kappaB -LRB- NF-kappaB -RRB- in HUVEC nuclei within 4 hours .
∃ ATTRIB[6] SITUATION[1] EVENT[3] EVENT[9] GROUP[2] GROUP[7] ENTITY[5] GROUP[8] ENTITY[4] (
 HUVECs(GROUP[2]) ∧
  is_FACT_THAT(SITUATION[1], exposing(EVENT[3], _, GROUP[2]) ∧ to(EVENT[3]) = ENTITY[A__slash__R]) ∧
   nuclear(ATTRIB[6]) ∧
    is_factor_kappaB_ATTRIBUTE(ENTITY[5], ATTRIB[6]) ∧
     is_-ENTITY-_namely(ENTITY[5], ENTITY[NF-kappaB]) ∧
      HUVEC_nuclei(GROUP[7]) ∧
       is_increase_in(ENTITY[4], GROUP[7]) ∧ is_increase_in(ENTITY[4], ENTITY[5]) ∧
        (CD_4(GROUP[8]), hours(GROUP[8])) ∧
         induces(EVENT[9], SITUATION[1], ENTITY[4]) ∧ within(EVENT[9]) = GROUP[8])

# ::id 153_nonfiction_GENIA-1999;99115412,7;NE
# ::snt Interfering with either NF-kappaB activation -LRB- proteasome inhibitor -RRB- or translocation -LRB- double-stranded oligonucleotides containing NF-kappaB binding sequence -RRB- prevents the development of A/R tolerance
∃ SITUATION[1] EVENT[11] EVENT[14] GROUP[2] ENTITY[13] ENTITY[12] (
 A__slash__R_tolerance(ENTITY[13]) ∧
  is_development_of(ENTITY[12], ENTITY[13]) ∧
   CONJ_either_or(∃ ENTITY[3] ENTITY[4] (
         NF-kappaB_activation(ENTITY[4]) ∧
          proteasome_inhibitor(ENTITY[3]) ∧ is_-ENTITY-_namely(ENTITY[4], ENTITY[3]) ∧ is_element_of(ENTITY[4], GROUP[2])),
    ∃ ATTRIB[6] EVENT[9] ENTITY[8] ENTITY[5] ENTITY[10] (
     translocation(ENTITY[10]) ∧
      double-stranded(ATTRIB[6]) ∧
       NF-kappaB_binding_sequence(ENTITY[8]) ∧
        containing(EVENT[9], ENTITY[5], ENTITY[8]) ∧ is_oligonucleotides_ATTRIBUTE(ENTITY[5], ATTRIB[6]) ∧
         is_-ENTITY-_namely(ENTITY[10], ENTITY[5]) ∧ is_element_of(ENTITY[10], GROUP[2]))) ∧
    is_FACT_THAT(SITUATION[1], interfering(EVENT[11]) ∧ with(EVENT[11]) = GROUP[2]) ∧
     prevents(EVENT[14], SITUATION[1], ENTITY[12]))

# ::id 154_nonfiction_GENIA-1999;99115412,7;NE
# ::snt -LRB- ie , the increase in A/R-induced PMN adhesion to HUVECs is the same after the first and second A/R challenges -RRB- .
∃ ATTRIB[6] ATTRIB[3] EVENT[11] GROUP[4] ENTITY[2] GROUP[9] GROUP[10] GROUP[8] ENTITY[7] ENTITY[5] ENTITY[1] (
 a__slash__r-induced(ATTRIB[3]) ∧
  HUVECs(GROUP[4]) ∧
   is_PMN_adhesion_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧ is_PMN_adhesion_to(ENTITY[2], GROUP[4]) ∧
    is_increase_in(ENTITY[1], ENTITY[2]) ∧
     same(ATTRIB[6]) ∧
      first_A__slash__R_challenges(GROUP[9]) ∧
       second_A__slash__R_challenges(GROUP[10]) ∧
        is_subset_of_or_equal_to(GROUP[9], GROUP[8]) ∧ is_subset_of_or_equal_to(GROUP[10], GROUP[8]) ∧
         is_equals(ENTITY[7], GROUP[8]) ∧
          is_after(ENTITY[5], ENTITY[7]) ∧ is_ATTRIBUTE(ENTITY[5], ATTRIB[6]) ∧ copula(EVENT[11], ENTITY[1], ENTITY[5]))

# ::id 155_nonfiction_GENIA-1999;99115412,8;NE
# ::snt NO production by HUVECs is increased after the second A/R challenge , but not after the first A/R challenge .
∃ EVENT[6] GROUP[2] ENTITY[1] ENTITY[3] ENTITY[5] (
 second_A__slash__R_challenge(ENTITY[3]) ∧
  first_A__slash__R_challenge(ENTITY[5]) ∧
   HUVECs(GROUP[2]) ∧
    is_NO_production_by(ENTITY[1], GROUP[2]) ∧
     CONJ_but(is_increased(EVENT[6], ENTITY[1]) ∧ after(EVENT[6]) = ENTITY[3],
      NOT ENTITY[4] (is_of(ENTITY[4], ENTITY[5]), ∃ EVENT[6] (is_increased(EVENT[6], ENTITY[1]) ∧ after(EVENT[6]) = ENTITY[4]))))

# ::id 156_nonfiction_GENIA-1999;99115412,9;NE
# ::snt Inhibition of NO synthase -LRB- NOS -RRB- during the second A/R challenge prevents the development of A/R tolerance with respect to PMN adhesion .
∃ EVENT[9] ENTITY[2] ENTITY[3] ENTITY[8] ENTITY[7] ENTITY[1] ENTITY[4] ENTITY[6] ENTITY[5] (
 second_A__slash__R_challenge(ENTITY[4]) ∧
  A__slash__R_tolerance(ENTITY[6]) ∧
   is_development_of(ENTITY[5], ENTITY[6]) ∧
    NO_synthase(ENTITY[3]) ∧
     NOS(ENTITY[2]) ∧
      is_-ENTITY-_namely(ENTITY[3], ENTITY[2]) ∧
       is_Inhibition_of(ENTITY[1], ENTITY[3]) ∧ is_Inhibition_during(ENTITY[1], ENTITY[4]) ∧
        PMN_adhesion(ENTITY[8]) ∧
         is_respect_to(ENTITY[7], ENTITY[8]) ∧ prevents(EVENT[9], ENTITY[1], ENTITY[5]) ∧ with(EVENT[9]) = ENTITY[7])

# ::id 157_nonfiction_GENIA-1999;99115412,10;NE
# ::snt However , while HUVECs contained endothelial NOS protein , no inducible NOS was detected in either tolerant or nontolerant cells .
∃ ATTRIB[3] EVENT[4] ENTITY[2] GROUP[1] (
 HUVECs(GROUP[1]) ∧
  endothelial(ATTRIB[3]) ∧
   is_NOS_protein_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
    ADV_however(EVENT[4]) ∧
     past(EVENT[4]) ∧
      CRD_while(contained(EVENT[4], GROUP[1], ENTITY[2]),
       ¬ ∃ ATTRIB[6] EVENT[12] GROUP[7] ENTITY[5] (
             inducible(ATTRIB[6]) ∧
              is_NOS_ATTRIBUTE(ENTITY[5], ATTRIB[6]) ∧
               CONJ_either_or(∃ ATTRIB[9] GROUP[8] (tolerant(ATTRIB[9]) ∧ is_cells_ATTRIBUTE(GROUP[8], ATTRIB[9]) ∧ is_subset_of_or_equal_to(GROUP[8], GROUP[7])),
                ∃ ATTRIB[11] GROUP[10] (
                 nontolerant(ATTRIB[11]) ∧ is_cells_ATTRIBUTE(GROUP[10], ATTRIB[11]) ∧ is_subset_of_or_equal_to(GROUP[10], GROUP[7]))) ∧
                past(EVENT[12]) ∧
                 detected(EVENT[12], _, ENTITY[5]) ∧ in(EVENT[12]) = GROUP[7])))

# ::id 158_nonfiction_GENIA-1999;99115412,11;NE
# ::snt Further studies indicated that inhibition of GTP-cyclohydrolase I -LRB- an enzyme involved in de novo synthesis of an important cofactor for NOS activity , tetrahydrobiopterin -RRB- prevented the generation of NO in A/R-tolerant cells .
∃ ATTRIB[10] ATTRIB[8] ATTRIB[2] ATTRIB[16] EVENT[12] EVENT[17] EVENT[3] ENTITY[11] ENTITY[9] ENTITY[7] ENTITY[5] ENTITY[4] GROUP[1] GROUP[15] ENTITY[14] ENTITY[13] (
 NO(ENTITY[14]) ∧
  a__slash__r-tolerant(ATTRIB[16]) ∧
   is_cells_ATTRIBUTE(GROUP[15], ATTRIB[16]) ∧
    is_generation_in(ENTITY[13], GROUP[15]) ∧ is_generation_of(ENTITY[13], ENTITY[14]) ∧
     further(ATTRIB[2]) ∧
      is_studies_ATTRIBUTE(GROUP[1], ATTRIB[2]) ∧
       de_novo(ATTRIB[8]) ∧
        important(ATTRIB[10]) ∧
         NOS_activity(ENTITY[11]) ∧
          is_cofactor_for(ENTITY[9], ENTITY[11]) ∧ is_cofactor_ATTRIBUTE(ENTITY[9], ATTRIB[10]) ∧
           is_-ENTITY-_namely(ENTITY[tetrahydrobiopterin], ENTITY[9]) ∧
            is_synthesis_of(ENTITY[7], ENTITY[tetrahydrobiopterin]) ∧ is_synthesis_ATTRIBUTE(ENTITY[7], ATTRIB[8]) ∧
             involved(EVENT[12], _, ENTITY[5]) ∧ in(EVENT[12]) = ENTITY[7] ∧ enzyme(ENTITY[5]) ∧
              is_-ENTITY-_namely(ENTITY[GTP-cyclohydrolase_I], ENTITY[5]) ∧
               is_inhibition_of(ENTITY[4], ENTITY[GTP-cyclohydrolase_I]) ∧
                is_before(EVENT[17], EVENT[3]) ∧
                 past(EVENT[3]) ∧ indicated(EVENT[3], GROUP[1], prevented(EVENT[17], ENTITY[4], ENTITY[13])))

# ::id 159_nonfiction_GENIA-1999;99115412,12;NE
# ::snt Extracellular generation of NO -LRB- NO donor -RRB- did not effect the hyperadhesion response induced by the initial A/R challenge .
∃ ATTRIB[2] ENTITY[3] ENTITY[4] ENTITY[1] EVENT[8] ENTITY[7] ENTITY[5] (
 initial_A__slash__R_challenge(ENTITY[7]) ∧
  induced(EVENT[8], ENTITY[5]) ∧ by(EVENT[8]) = ENTITY[7] ∧ hyperadhesion_response(ENTITY[5]) ∧
   extracellular(ATTRIB[2]) ∧
    NO(ENTITY[4]) ∧
     NO_donor(ENTITY[3]) ∧
      is_-ENTITY-_namely(ENTITY[4], ENTITY[3]) ∧
       is_generation_of(ENTITY[1], ENTITY[4]) ∧ is_generation_ATTRIBUTE(ENTITY[1], ATTRIB[2]) ∧
        ¬ ∃ EVENT[9] (past(EVENT[9]) ∧ did_effect(EVENT[9], ENTITY[1], ENTITY[5])))

# ::id 160_nonfiction_GENIA-1999;99115412,13;NE
# ::snt A/R also induced an oxidant stress in naive HUVECs , but not in A/R-tolerant HUVECs .
∃ ATTRIB[7] ATTRIB[4] ATTRIB[2] EVENT[8] GROUP[3] GROUP[6] ENTITY[1] (
 oxidant(ATTRIB[2]) ∧
  is_stress_ATTRIBUTE(ENTITY[1], ATTRIB[2]) ∧
   naive(ATTRIB[4]) ∧
    is_HUVECs_ATTRIBUTE(GROUP[3], ATTRIB[4]) ∧
     a__slash__r-tolerant(ATTRIB[7]) ∧
      is_HUVECs_ATTRIBUTE(GROUP[6], ATTRIB[7]) ∧
       ADV_also(EVENT[8]) ∧
        past(EVENT[8]) ∧
         CONJ_but(induced(EVENT[8], ENTITY[A__slash__R], ENTITY[1]) ∧ in(EVENT[8]) = GROUP[3],
          NOT ENTITY[5] (is_element_of(ENTITY[5], GROUP[6]),
           ∃ EVENT[8] (
            past(EVENT[8]) ∧
             induced(EVENT[8], ENTITY[A__slash__R], ENTITY[1]) ∧ in(EVENT[8]) = ENTITY[5]))))

# ::id 161_nonfiction_GENIA-1999;99115412,14;NE
# ::snt Inhibition of NOS during the second A/R insult results in the generation of an oxidant stress similar to that observed after the first A/R challenge .
∃ ATTRIB[7] ATTRIB[6] EVENT[12] ENTITY[2] ENTITY[1] EVENT[11] ENTITY[3] ENTITY[10] ENTITY[8] ENTITY[5] ENTITY[4] (
 second_A__slash__R_insult(ENTITY[3]) ∧
  oxidant(ATTRIB[6]) ∧
   first_A__slash__R_challenge(ENTITY[10]) ∧
    observed(EVENT[11], ENTITY[8]) ∧ after(EVENT[11]) = ENTITY[10] ∧
     is_similar_to(ATTRIB[7], ENTITY[8]) ∧
      is_stress_ATTRIBUTE(ENTITY[5], ATTRIB[7]) ∧ is_stress_ATTRIBUTE(ENTITY[5], ATTRIB[6]) ∧
       is_generation_of(ENTITY[4], ENTITY[5]) ∧
        NOS(ENTITY[2]) ∧
         is_Inhibition_of(ENTITY[1], ENTITY[2]) ∧ is_Inhibition_during(ENTITY[1], ENTITY[3]) ∧
          results(EVENT[12], ENTITY[1]) ∧ in(EVENT[12]) = ENTITY[4])

# ::id 162_nonfiction_GENIA-1999;99115412,15;NE
# ::snt Taken together , the findings of the present study are consistent with a role for NF-kappaB in the development of A/R tolerance -LRB- with respect to PMN adhesion -RRB- , perhaps by transcriptional regulation of GTP-cyclohydrolase .
∃ ATTRIB[6] ATTRIB[13] ATTRIB[3] ENTITY[7] EVENT[4] EVENT[14] ENTITY[2] ENTITY[11] ENTITY[12] ENTITY[10] ENTITY[9] ENTITY[8] GROUP[1] (
 present(ATTRIB[3]) ∧
  is_study_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
   is_findings_of(GROUP[1], ENTITY[2]) ∧
    PMN_adhesion(ENTITY[11]) ∧
     is_respect_to(ENTITY[10], ENTITY[11]) ∧
      transcriptional(ATTRIB[13]) ∧
       is_regulation_of(ENTITY[12], ENTITY[GTP-cyclohydrolase]) ∧ is_regulation_ATTRIBUTE(ENTITY[12], ATTRIB[13]) ∧
        is_A__slash__R_tolerance_perhaps_by(ENTITY[9], ENTITY[12]) ∧ is_A__slash__R_tolerance_with(ENTITY[9], ENTITY[10]) ∧
         is_development_of(ENTITY[8], ENTITY[9]) ∧
          ADV_together(EVENT[4]) ∧
           is_role_in(ENTITY[7], ENTITY[8]) ∧ is_role_for(ENTITY[7], ENTITY[NF-kappaB]) ∧
            is_consistent_with(ATTRIB[6], ENTITY[7]) ∧
             CONJ_and(taken(EVENT[4], GROUP[1]),
              copula(EVENT[14], GROUP[1]) ∧ ATTRIBUTE(EVENT[14]) = ATTRIB[6]))

# ::id 163_nonfiction_GENIA-1999;99115412,16;NE
# ::snt The increased NO production during the second A/R insult reduces PMN adhesion most likely by reducing the intracellular oxidant stress induced by A/R .
∃ SITUATION[13] SITUATION[5] ATTRIB[8] ATTRIB[7] ATTRIB[2] EVENT[11] EVENT[12] ENTITY[4] EVENT[10] ENTITY[3] ENTITY[6] ENTITY[1] (
 increased(ATTRIB[2]) ∧
  second_A__slash__R_insult(ENTITY[3]) ∧
   is_NO_production_during(ENTITY[1], ENTITY[3]) ∧ is_NO_production_ATTRIBUTE(ENTITY[1], ATTRIB[2]) ∧
    intracellular(ATTRIB[7]) ∧
     oxidant(ATTRIB[8]) ∧
      induced(EVENT[10], ENTITY[6]) ∧ by(EVENT[10]) = ENTITY[A__slash__R] ∧
       is_stress_ATTRIBUTE(ENTITY[6], ATTRIB[8]) ∧ is_stress_ATTRIBUTE(ENTITY[6], ATTRIB[7]) ∧
       PMN_adhesion(ENTITY[4]) ∧
        is_FACT_THAT(SITUATION[5], reducing(EVENT[11], _, ENTITY[6])) ∧
         is_ADV_most_likely_by(SITUATION[13], SITUATION[5]) ∧ is_FACT_THAT(SITUATION[13], reduces(EVENT[12], ENTITY[1], ENTITY[4])))

# ::id 164_nonfiction_GENIA-1999;99115544,1;NE
# ::snt Involvement of mitogen-activated protein kinase pathways in interleukin-8 production by human monocytes and polymorphonuclear cells stimulated with lipopolysaccharide or Mycoplasma fermentans membrane lipoproteins .
∃ ATTRIB[3] EVENT[15] GROUP[5] ENTITY[4] GROUP[2] ENTITY[1] (
 mitogen-activated(ATTRIB[3]) ∧
  is_protein_kinase_pathways_ATTRIBUTE(GROUP[2], ATTRIB[3]) ∧
   ∃ ATTRIB[7] GROUP[6] (human(ATTRIB[7]) ∧ is_monocytes_ATTRIBUTE(GROUP[6], ATTRIB[7]) ∧ is_subset_of_or_equal_to(GROUP[6], GROUP[5])) ∧
    ∃ ATTRIB[9] EVENT[14] GROUP[11] GROUP[8] (
     polymorphonuclear(ATTRIB[9]) ∧
      CONJ_or(∃ ENTITY[12] (lipopolysaccharide(ENTITY[12]) ∧ is_element_of(ENTITY[12], GROUP[11])),
       ∃ GROUP[13] (Mycoplasma_fermentans_membrane_lipoproteins(GROUP[13]) ∧ is_subset_of_or_equal_to(GROUP[13], GROUP[11]))) ∧
       stimulated(EVENT[14], _, GROUP[8]) ∧ with(EVENT[14]) = GROUP[11] ∧ is_cells_ATTRIBUTE(GROUP[8], ATTRIB[9]) ∧
        is_subset_of_or_equal_to(GROUP[8], GROUP[5])) ∧
    is_interleukin-8_production_by(ENTITY[4], GROUP[5]) ∧
     is_Involvement_in(ENTITY[1], ENTITY[4]) ∧ is_Involvement_of(ENTITY[1], GROUP[2]) ∧
      xxx(EVENT[15]) ∧ LINK(EVENT[15]) = ENTITY[1])

# ::id 165_nonfiction_GENIA-1999;99115544,2;NE
# ::snt Interleukin-8 -LRB- IL-8 -RRB- is a chemokine that belongs to the alpha-chemokine or CXC subfamily and is produced by a wide variety of human cells , including monocytes and polymorphonuclear cells -LRB- PMN -RRB- .
∃ ATTRIB[12] ATTRIB[10] EVENT[7] EVENT[8] EVENT[19] EVENT[20] ENTITY[1] GROUP[14] GROUP[11] ENTITY[9] ENTITY[5] ENTITY[6] GROUP[4] ENTITY[3] (
 alpha-chemokine_subfamily(ENTITY[5]) ∧
  CXC_subfamily(ENTITY[6]) ∧
   CONJ_or(is_element_of(ENTITY[5], GROUP[4]), is_element_of(ENTITY[6], GROUP[4])) ∧
    is_equals(ENTITY[3], GROUP[4]) ∧
     is_-ENTITY-_namely(ENTITY[Interleukin-8], ENTITY[IL-8]) ∧
      belongs(EVENT[7], ENTITY[1]) ∧ to(EVENT[7]) = ENTITY[3] ∧ chemokine(ENTITY[1]) ∧
       wide(ATTRIB[10]) ∧
        human(ATTRIB[12]) ∧
         ∃ GROUP[15] (monocytes(GROUP[15]) ∧ is_subset_of_or_equal_to(GROUP[15], GROUP[14])) ∧
          ∃ ATTRIB[18] ENTITY[16] GROUP[17] (
           polymorphonuclear(ATTRIB[18]) ∧
            is_cells_ATTRIBUTE(GROUP[17], ATTRIB[18]) ∧
             PMN(ENTITY[16]) ∧ is_-GROUP-_namely(GROUP[17], ENTITY[16]) ∧ is_subset_of_or_equal_to(GROUP[17], GROUP[14])) ∧
          including(EVENT[19], GROUP[11], GROUP[14]) ∧ is_cells_ATTRIBUTE(GROUP[11], ATTRIB[12]) ∧
           is_variety_of(ENTITY[9], GROUP[11]) ∧ is_variety_ATTRIBUTE(ENTITY[9], ATTRIB[10]) ∧
            CONJ_and(copula(EVENT[8], ENTITY[Interleukin-8], ENTITY[1]), produced(EVENT[20], ENTITY[9], ENTITY[Interleukin-8])))

# ::id 166_nonfiction_GENIA-1999;99115544,3;NE
# ::snt IL-8 is secreted in response to inflammatory stimuli , notably bacterial products such as lipopolysaccharide -LRB- LPS -RRB- ,
∃ ATTRIB[4] ATTRIB[3] ATTRIB[6] EVENT[7] ENTITY[2] GROUP[5] ENTITY[1] (
 inflammatory(ATTRIB[6]) ∧
  is_stimuli_ATTRIBUTE(GROUP[5], ATTRIB[6]) ∧
   bacterial(ATTRIB[3]) ∧
    is_-ENTITY-_namely(ENTITY[lipopolysaccharide], ENTITY[LPS]) ∧
     is_such_as(ATTRIB[4], ENTITY[lipopolysaccharide]) ∧
      ADV_notably(ENTITY[2]) ∧ is_products_ATTRIBUTE(ENTITY[2], ATTRIB[4]) ∧ is_products_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
       is_-GROUP-_namely(GROUP[5], ENTITY[2]) ∧
        is_response_to(ENTITY[1], GROUP[5]) ∧ is_secreted(EVENT[7], ENTITY[IL-8]) ∧ in(EVENT[7]) = ENTITY[1])

# ::id 167_nonfiction_GENIA-1999;99115544,3;NE
# ::snt but little is known about the mechanisms by which these agents mediate IL-8 induction .
∃ EVENT[6] ENTITY[5] GROUP[4] GROUP[2] (
 agents(GROUP[4]) ∧
  IL-8_induction(ENTITY[5]) ∧
   mediate(EVENT[6], GROUP[4], ENTITY[5]) ∧ by(EVENT[6]) = GROUP[2] ∧ mechanisms(GROUP[2]) ∧
    LITTLE ENTITY[1] ∃ EVENT[7] (known(EVENT[7], _, ENTITY[1]) ∧ about(EVENT[7]) = GROUP[2]))

# ::id 168_nonfiction_GENIA-1999;99115544,4;NE
# ::snt In this report , we show that Mycoplasma fermentans lipid-associated membrane proteins -LRB- LAMPf -RRB- induce the production of high levels of IL-8 by THP-1 -LRB- human monocyte -RRB- cells and PMN at the same extent as LPS .
∃ REF1[2] ATTRIB[14] ATTRIB[10] ATTRIB[7] EVENT[15] EVENT[3] GROUP[4] ENTITY[9] GROUP[11] GROUP[12] GROUP[8] GROUP[6] ENTITY[13] ENTITY[5] ENTITY[1] (
 report(ENTITY[1]) ∧
  high(ATTRIB[7]) ∧
   is_levels_ATTRIBUTE(GROUP[6], ATTRIB[7]) ∧ is_levels_of(GROUP[6], ENTITY[IL-8]) ∧
    THP-1_cells(GROUP[11]) ∧
     human(ATTRIB[10]) ∧
      is_monocyte_ATTRIBUTE(ENTITY[9], ATTRIB[10]) ∧
       is_-GROUP-_namely(GROUP[11], ENTITY[9]) ∧
        PMN(GROUP[12]) ∧
         is_subset_of_or_equal_to(GROUP[11], GROUP[8]) ∧ is_subset_of_or_equal_to(GROUP[12], GROUP[8]) ∧
          is_production_by(ENTITY[5], GROUP[8]) ∧ is_production_of(ENTITY[5], GROUP[6]) ∧
           same(ATTRIB[14]) ∧
            is_extent_as(ENTITY[13], ENTITY[LPS]) ∧ is_extent_ATTRIBUTE(ENTITY[13], ATTRIB[14]) ∧
             REF1[2] = we ∧
              Mycoplasma_fermentans_lipid-associated_membrane_proteins(GROUP[4]) ∧
               is_-GROUP-_namely(GROUP[4], ENTITY[LAMPf]) ∧
                show(EVENT[3], REF1[2],
                 induce(EVENT[15], GROUP[4], ENTITY[5]) ∧ at(EVENT[15]) = ENTITY[13]) ∧
                 In(EVENT[3]) = ENTITY[1])

# ::id 169_nonfiction_GENIA-1999;99115544,5;NE
# ::snt It was previously demonstrated that stimulation of monocytic cells with either LPS or LAMPf led to a series of common downstream signaling events , including the activation of protein tyrosine kinase and of mitogen-activated protein kinase cascades .
∃ ATTRIB[10] ATTRIB[9] ATTRIB[8] ATTRIB[4] SITUATION[1] ATTRIB[15] EVENT[16] EVENT[17] EVENT[18] GROUP[5] GROUP[3] GROUP[7] ENTITY[6] ENTITY[2] ENTITY[13] GROUP[14] ENTITY[12] (
 protein_tyrosine_kinase(ENTITY[13]) ∧
  mitogen-activated(ATTRIB[15]) ∧
   is_protein_kinase_cascades_ATTRIBUTE(GROUP[14], ATTRIB[15]) ∧
    CONJ_and(is_activation_of(ENTITY[12], ENTITY[13]), is_activation_of(ENTITY[12], GROUP[14])) ∧
     monocytic(ATTRIB[4]) ∧
      is_cells_ATTRIBUTE(GROUP[3], ATTRIB[4]) ∧
       CONJ_either_or(is_element_of(ENTITY[LPS], GROUP[5]), is_element_of(ENTITY[LAMPf], GROUP[5])) ∧
        is_stimulation_of(ENTITY[2], GROUP[3]) ∧ is_stimulation_with(ENTITY[2], GROUP[5]) ∧
         common(ATTRIB[8]) ∧
          downstream(ATTRIB[9]) ∧
           signaling(ATTRIB[10]) ∧
            including(EVENT[16], GROUP[7], ENTITY[12]) ∧
             is_events_ATTRIBUTE(GROUP[7], ATTRIB[10]) ∧ is_events_ATTRIBUTE(GROUP[7], ATTRIB[9]) ∧ is_events_ATTRIBUTE(GROUP[7], ATTRIB[8]) ∧
             is_series_of(ENTITY[6], GROUP[7]) ∧
              is_FACT_THAT(SITUATION[1], led(EVENT[17], ENTITY[2]) ∧ to(EVENT[17]) = ENTITY[6]) ∧
               past(EVENT[17]) ∧
                TMP_previously(EVENT[18]) ∧ past(EVENT[18]) ∧ demonstrated(EVENT[18], _, SITUATION[1]))

# ::id 170_nonfiction_GENIA-1999;99115544,6;NE
# ::snt By using PD-98059 and SB203580 , two potent and selective inhibitors of MEK1 -LRB- a kinase upstream of ERK1/2 -RRB- and p38 , respectively , we have demonstrated that both ERK1/2 and p38 cascades play a key role in the production of IL-8 by monocytes and PMN stimulated with bacterial fractions .
∃ ATTRIB[5] ATTRIB[4] SITUATION[2] REF1[1] ATTRIB[24] EVENT[10] EVENT[12] GROUP[9] GROUP[6] GROUP[6] ENTITY[3] ENTITY[8] EVENT[25] GROUP[20] GROUP[21] GROUP[23] GROUP[19] ENTITY[18] ENTITY[17] (
 monocytes(GROUP[20]) ∧
  PMN(GROUP[21]) ∧
   is_subset_of_or_equal_to(GROUP[20], GROUP[19]) ∧ is_subset_of_or_equal_to(GROUP[21], GROUP[19]) ∧
    bacterial(ATTRIB[24]) ∧
     is_fractions_ATTRIBUTE(GROUP[23], ATTRIB[24]) ∧
      stimulated(EVENT[25], _, ENTITY[18]) ∧ with(EVENT[25]) = GROUP[23] ∧ is_equals(ENTITY[18], GROUP[19]) ∧
       is_production_by(ENTITY[17], ENTITY[18]) ∧ is_production_of(ENTITY[17], ENTITY[IL-8]) ∧
        REF1[1] = we ∧
         is_element_of(ENTITY[PD-98059], GROUP[9]) ∧ is_element_of(ENTITY[SB203580], GROUP[9]) ∧
          is_equals(ENTITY[8], GROUP[9]) ∧
           potent(ATTRIB[4]) ∧
            ∃ ENTITY[7] (
             is_LOC_upstream_of(ENTITY[7], ENTITY[ERK1__slash__2]) ∧ kinase(ENTITY[7]) ∧
              is_-ENTITY-_namely(ENTITY[MEK1], ENTITY[7]) ∧ is_element_of(ENTITY[MEK1], GROUP[6])) ∧
             is_element_of(ENTITY[p38], GROUP[6]) ∧
             selective(ATTRIB[5]) ∧
              ∃ ENTITY[7] (
               is_LOC_upstream_of(ENTITY[7], ENTITY[ERK1__slash__2]) ∧ kinase(ENTITY[7]) ∧
                is_-ENTITY-_namely(ENTITY[MEK1], ENTITY[7]) ∧ is_element_of(ENTITY[MEK1], GROUP[6])) ∧
               is_element_of(ENTITY[p38], GROUP[6]) ∧
               (CD_two(ENTITY[3]),
                CONJ_and(is_inhibitors_of(ENTITY[3], GROUP[6]) ∧ is_inhibitors_ATTRIBUTE(ENTITY[3], ATTRIB[4]),
                 is_inhibitors_of(ENTITY[3], GROUP[6]) ∧ is_inhibitors_ATTRIBUTE(ENTITY[3], ATTRIB[5]))) ∧
                is_-ENTITY-_namely(ENTITY[8], ENTITY[3]) ∧
                 is_FACT_THAT(SITUATION[2], using(EVENT[10], REF1[1], ENTITY[8])) ∧
                  ADV_respectively(EVENT[10]) ∧
                   have_demonstrated(EVENT[12], REF1[1],
                    BOTH GROUP[14] group[13] (
                     (is_element_of(ENTITY[ERK1__slash__2], GROUP[14]) ∧ is_element_of(ENTITY[p38], GROUP[14]) ∧
                      is_cascades_equals(group[13], GROUP[14])),
                     ∃ ATTRIB[16] EVENT[26] ENTITY[15] (
                      key(ATTRIB[16]) ∧
                       is_role_in(ENTITY[15], ENTITY[17]) ∧ is_role_ATTRIBUTE(ENTITY[15], ATTRIB[16]) ∧
                        play(EVENT[26], group[13], ENTITY[15])))) ∧ By(EVENT[12]) = SITUATION[2])

# ::id 171_nonfiction_GENIA-1999;99115659,1;NE
# ::snt CD80 and CD86 are not equivalent in their ability to induce the tyrosine phosphorylation of CD28 .
∃ GROUP[1] ENTITY[5] (
 is_tyrosine_phosphorylation_of(ENTITY[5], ENTITY[CD28]) ∧
  is_element_of(ENTITY[CD80], GROUP[1]) ∧ is_element_of(ENTITY[CD86], GROUP[1]) ∧
   ¬ ∃ REF1[4] ATTRIB[2] EVENT[6] EVENT[7] ENTITY[3] (
         REF1[4] = their ∧
          is_ability_POS(ENTITY[3], REF1[4]) ∧ is_ability_to(ENTITY[3], induce(EVENT[6], _, ENTITY[5])) ∧
           is_equivalent_in(ATTRIB[2], ENTITY[3]) ∧ copula(EVENT[7], GROUP[1], ATTRIB[2])))

# ::id 172_nonfiction_GENIA-1999;99115659,2;NE
# ::snt Ligation of either CD80 -LRB- B7-1 -RRB- or CD86 -LRB- B7-2 -RRB- , two principal ligands for CD28 , is thought to skew the immune response toward Th1 or Th2 differentiation .
∃ ATTRIB[3] ATTRIB[8] EVENT[11] EVENT[6] GROUP[5] ENTITY[2] ENTITY[4] ENTITY[1] GROUP[9] ENTITY[10] ENTITY[7] (
 immune(ATTRIB[8]) ∧
  differentiation(ENTITY[10]) ∧
   CONJ_or(is_element_of(ENTITY[Th1], GROUP[9]), is_element_of(ENTITY[Th2], GROUP[9])) ∧
    is_-ENTITY-_namely(ENTITY[10], GROUP[9]) ∧
     is_response_toward(ENTITY[7], ENTITY[10]) ∧ is_response_ATTRIBUTE(ENTITY[7], ATTRIB[8]) ∧
      CONJ_either_or(is_-ENTITY-_namely(ENTITY[CD80], ENTITY[B7-1]) ∧ is_element_of(ENTITY[CD80], GROUP[5]),
       is_-ENTITY-_namely(ENTITY[CD86], ENTITY[B7-2]) ∧ is_element_of(ENTITY[CD86], GROUP[5])) ∧
       is_equals(ENTITY[4], GROUP[5]) ∧
        principal(ATTRIB[3]) ∧
         (CD_two(ENTITY[2]), is_ligands_for(ENTITY[2], ENTITY[CD28]) ∧ is_ligands_ATTRIBUTE(ENTITY[2], ATTRIB[3])) ∧
          is_-ENTITY-_namely(ENTITY[4], ENTITY[2]) ∧
           is_Ligation_of(ENTITY[1], ENTITY[4]) ∧
            thought(EVENT[6], _, ENTITY[1], skew(EVENT[11], ENTITY[1], ENTITY[7])))

# ::id 173_nonfiction_GENIA-1999;99115659,3;NE
# ::snt We have examined early signal transduction pathways recruited following T cell stimulation with either CD80 or CD86 .
∃ ATTRIB[3] REF1[1] EVENT[5] EVENT[9] EVENT[10] GROUP[8] ENTITY[7] GROUP[2] (
 REF1[1] = we ∧
  early(ATTRIB[3]) ∧
   CONJ_either_or(is_element_of(ENTITY[CD80], GROUP[8]), is_element_of(ENTITY[CD86], GROUP[8])) ∧
    is_T_cell_stimulation_with(ENTITY[7], GROUP[8]) ∧
     recruited(EVENT[5], _, GROUP[2]) ∧
      following(EVENT[9], GROUP[2], ENTITY[7]) ∧ is_signal_transduction_pathways_ATTRIBUTE(GROUP[2], ATTRIB[3]) ∧ have_examined(EVENT[10], REF1[1], GROUP[2]))

# ::id 174_nonfiction_GENIA-1999;99115659,4;NE
# ::snt Purified human peripheral T cells or Jurkat T cells were stimulated with Chinese hamster ovary -LRB- CHO -RRB- cells expressing either human CD80 -LRB- CHO-CD80 -RRB- or human CD86 -LRB- CHO-CD86 -RRB- or with anti-CD28 monoclonal antibody -LRB- mAb -RRB- .
∃ ATTRIB[14] ATTRIB[13] ATTRIB[7] EVENT[10] EVENT[15] EVENT[15] GROUP[9] ENTITY[5] GROUP[6] ENTITY[11] ENTITY[12] GROUP[1] (
 CONJ_or(∃ ATTRIB[3] GROUP[2] (human_peripheral(ATTRIB[3]) ∧ is_Purified_T_cells_ATTRIBUTE(GROUP[2], ATTRIB[3]) ∧ is_subset_of_or_equal_to(GROUP[2], GROUP[1])),
  ∃ GROUP[4] (Jurkat_T_cells(GROUP[4]) ∧ is_subset_of_or_equal_to(GROUP[4], GROUP[1]))) ∧
  chinese(ATTRIB[7]) ∧
   CONJ_either_or(is_-ENTITY-_namely(ENTITY[human_CD80], ENTITY[CHO-CD80]) ∧ is_element_of(ENTITY[human_CD80], GROUP[9]),
    is_-ENTITY-_namely(ENTITY[human_CD86], ENTITY[CHO-CD86]) ∧ is_element_of(ENTITY[human_CD86], GROUP[9])) ∧
    expressing(EVENT[10], GROUP[6], GROUP[9]) ∧ is_hamster_ovary_cells_ATTRIBUTE(GROUP[6], ATTRIB[7]) ∧
     CHO(ENTITY[5]) ∧
      is_-GROUP-_namely(GROUP[6], ENTITY[5]) ∧
       anti-cd28(ATTRIB[13]) ∧
        monoclonal(ATTRIB[14]) ∧
         is_antibody_ATTRIBUTE(ENTITY[12], ATTRIB[14]) ∧ is_antibody_ATTRIBUTE(ENTITY[12], ATTRIB[13]) ∧
          mAb(ENTITY[11]) ∧
           is_-ENTITY-_namely(ENTITY[12], ENTITY[11]) ∧
            past(EVENT[15]) ∧
             past(EVENT[15]) ∧
              CONJ_or(stimulated(EVENT[15], _, GROUP[1]) ∧ with(EVENT[15]) = GROUP[6],
               stimulated(EVENT[15], _, GROUP[1]) ∧ with(EVENT[15]) = ENTITY[12]))

# ::id 175_nonfiction_GENIA-1999;99115659,5;NE
# ::snt In the presence of phorbol 12-myristate 13-acetate , both CHO-CD80 and CHO-CD86 , like anti-CD28 mAb , were capable of stimulating cytokine production from both human peripheral T cells and Jurkat T cells .
∃ ENTITY[2] ENTITY[1] (
 phorbol_12-myristate_13-acetate(ENTITY[2]) ∧
  is_presence_of(ENTITY[1], ENTITY[2]) ∧
   BOTH GROUP[4] group[3] ((is_element_of(ENTITY[CHO-CD80], GROUP[4]) ∧ is_element_of(ENTITY[CHO-CD86], GROUP[4]) ∧ is_equals(group[3], GROUP[4])),
    ∃ ATTRIB[7] ATTRIB[5] SITUATION[10] ATTRIB[9] EVENT[17] EVENT[8] ENTITY[11] ENTITY[6] (
     cytokine_production(ENTITY[11]) ∧
      is_FACT_THAT(SITUATION[10],
       BOTH GROUP[13] group[12] (
        (∃ GROUP[14] (human_peripheral_T_cells(GROUP[14]) ∧ is_subset_of_or_equal_to(GROUP[14], GROUP[13])) ∧
           ∃ GROUP[15] (Jurkat_T_cells(GROUP[15]) ∧ is_subset_of_or_equal_to(GROUP[15], GROUP[13])) ∧ is_equals(group[12], GROUP[13])),
        ∃ EVENT[16] (stimulating(EVENT[16], _, ENTITY[11]) ∧ from(EVENT[16]) = group[12]))) ∧
       is_capable_of(ATTRIB[9], SITUATION[10]) ∧
        anti-cd28(ATTRIB[7]) ∧
         is_mAb_ATTRIBUTE(ENTITY[6], ATTRIB[7]) ∧
          is_like_comp(ATTRIB[5], ENTITY[6]) ∧
           past(EVENT[17]) ∧
            CONJ_and(copula(EVENT[17], group[3], ATTRIB[9]) ∧ In(EVENT[17]) = ENTITY[1],
             xxx(EVENT[8], group[3]) ∧ ATTRIBUTE(EVENT[8]) = ATTRIB[5]))))

# ::id 176_nonfiction_GENIA-1999;99115659,6;NE
# ::snt Both CHO-CD80 and CHO-CD86 , in the presence of anti-CD3 mAb , costimulated NFAT-dependent transcriptional activation .
∃ ATTRIB[8] ATTRIB[7] ATTRIB[5] EVENT[9] ENTITY[6] GROUP[1] ENTITY[4] ENTITY[3] (
 anti-cd3(ATTRIB[5]) ∧
  is_mAb_ATTRIBUTE(ENTITY[4], ATTRIB[5]) ∧
   is_presence_of(ENTITY[3], ENTITY[4]) ∧
    is_element_of(ENTITY[CHO-CD80], GROUP[1]) ∧ ∃ ENTITY[2] (CHO-CD86(ENTITY[2]) ∧ is_element_of(ENTITY[2], GROUP[1])) ∧
     nfat-dependent(ATTRIB[7]) ∧
      transcriptional(ATTRIB[8]) ∧
       is_activation_ATTRIBUTE(ENTITY[6], ATTRIB[8]) ∧ is_activation_ATTRIBUTE(ENTITY[6], ATTRIB[7]) ∧
        past(EVENT[9]) ∧ costimulated(EVENT[9], GROUP[1], ENTITY[6]) ∧ in(EVENT[9]) = ENTITY[3])

# ::id 177_nonfiction_GENIA-1999;99115659,7;NE
# ::snt Several intracellular signaling proteins , such as CBL and VAV , were phosphorylated on tyrosine in response to CD80 , CD86 , and anti-CD28 mAb .
SEVERAL ATTRIB[4] ATTRIB[3] ATTRIB[2] GROUP[5] GROUP[1] (
 (intracellular(ATTRIB[2]) ∧ signaling(ATTRIB[3]) ∧ is_element_of(ENTITY[CBL], GROUP[5]) ∧ is_element_of(ENTITY[VAV], GROUP[5]) ∧
  is_such_as(ATTRIB[4], GROUP[5]) ∧
  is_proteins_ATTRIBUTE(GROUP[1], ATTRIB[4]) ∧ is_proteins_ATTRIBUTE(GROUP[1], ATTRIB[3]) ∧ is_proteins_ATTRIBUTE(GROUP[1], ATTRIB[2])),
 ∃ EVENT[11] GROUP[8] ENTITY[7] ENTITY[6] (
  tyrosine(ENTITY[6]) ∧
   is_element_of(ENTITY[CD80], GROUP[8]) ∧ is_element_of(ENTITY[CD86], GROUP[8]) ∧
    ∃ ATTRIB[10] ENTITY[9] (anti-cd28(ATTRIB[10]) ∧ is_mAb_ATTRIBUTE(ENTITY[9], ATTRIB[10]) ∧ is_element_of(ENTITY[9], GROUP[8])) ∧
    is_response_to(ENTITY[7], GROUP[8]) ∧
     past(EVENT[11]) ∧
      were_phosphorylated(EVENT[11], GROUP[1]) ∧ in(EVENT[11]) = ENTITY[7] ∧ on(EVENT[11]) = ENTITY[6]))

# ::id 178_nonfiction_GENIA-1999;99115659,8;NE
# ::snt Surprisingly , although stimulation of Jurkat T cells with either CHO-CD80 or anti-CD28 mAb resulted in robust tyrosine phosphorylation of CD28 itself , ligation with CHO-CD86 was unable to induce detectable CD28 tyrosyl phosphorylation over a range of stimulation conditions .
∃ SITUATION[18] ATTRIB[12] REF1[9] ATTRIB[8] SITUATION[1] EVENT[10] EVENT[16] EVENT[17] GROUP[4] GROUP[3] ENTITY[7] ENTITY[2] GROUP[15] ENTITY[14] ENTITY[13] ENTITY[11] (
 Jurkat_T_cells(GROUP[3]) ∧
  CONJ_either_or(is_element_of(ENTITY[CHO-CD80], GROUP[4]),
   ∃ ATTRIB[6] ENTITY[5] (anti-cd28(ATTRIB[6]) ∧ is_mAb_ATTRIBUTE(ENTITY[5], ATTRIB[6]) ∧ is_element_of(ENTITY[5], GROUP[4]))) ∧
   is_stimulation_of(ENTITY[2], GROUP[3]) ∧ is_stimulation_with(ENTITY[2], GROUP[4]) ∧
    robust(ATTRIB[8]) ∧
     REF1[9] = itself ∧
      is_RFL(ENTITY[CD28], REF1[9]) ∧
       is_tyrosine_phosphorylation_of(ENTITY[7], ENTITY[CD28]) ∧ is_tyrosine_phosphorylation_ATTRIBUTE(ENTITY[7], ATTRIB[8]) ∧
        is_FACT_THAT(SITUATION[1], resulted(EVENT[10], ENTITY[2]) ∧ in(EVENT[10]) = ENTITY[7]) ∧
         is_ligation_with(ENTITY[11], ENTITY[CHO-CD86]) ∧
          detectable_CD28_tyrosyl_phosphorylation(ENTITY[13]) ∧
           stimulation_conditions(GROUP[15]) ∧
            is_range_of(ENTITY[14], GROUP[15]) ∧
             is_unable_to(ATTRIB[12], induce(EVENT[16], _, ENTITY[13]) ∧ over(EVENT[16]) = ENTITY[14]) ∧
              ADV_surprisingly(SITUATION[18]) ∧
               past(EVENT[10]) ∧
                past(EVENT[17]) ∧
                 is_FACT_THAT(SITUATION[18], copula(EVENT[17], ENTITY[11], ATTRIB[12]) ∧ although(EVENT[17]) = SITUATION[1]))

# ::id 179_nonfiction_GENIA-1999;99115659,9;NE
# ::snt In addition , the association of phosphoinositide 3-kinase with CD28 and enhanced tyrosine phosphorylation of phospholipase Cgamma were seen after anti-CD28 mAb and CHO-CD80 stimulation but to a much lesser extent after CHO-CD86 stimulation .
∃ ATTRIB[12] ATTRIB[5] EVENT[10] EVENT[14] GROUP[6] ENTITY[9] ENTITY[13] ENTITY[11] ENTITY[1] ENTITY[4] GROUP[3] ENTITY[2] (
 enhanced(ATTRIB[5]) ∧
  is_tyrosine_phosphorylation_ATTRIBUTE(ENTITY[4], ATTRIB[5]) ∧ is_tyrosine_phosphorylation_of(ENTITY[4], ENTITY[phospholipase_Cgamma]) ∧
   is_element_of(ENTITY[CD28], GROUP[3]) ∧ is_element_of(ENTITY[4], GROUP[3]) ∧
    is_association_with(ENTITY[2], GROUP[3]) ∧ is_association_of(ENTITY[2], ENTITY[phosphoinositide_3-kinase]) ∧
     addition(ENTITY[1]) ∧
      stimulation(ENTITY[9]) ∧
       ∃ ATTRIB[8] ENTITY[7] (anti-cd28(ATTRIB[8]) ∧ is_mAb_ATTRIBUTE(ENTITY[7], ATTRIB[8]) ∧ is_element_of(ENTITY[7], GROUP[6])) ∧
        is_element_of(ENTITY[CHO-CD80], GROUP[6]) ∧
        is_-ENTITY-_namely(ENTITY[9], GROUP[6]) ∧
         much_lesser(ATTRIB[12]) ∧
          is_extent_ATTRIBUTE(ENTITY[11], ATTRIB[12]) ∧
           CHO-CD86_stimulation(ENTITY[13]) ∧
            past(EVENT[10]) ∧
             past(EVENT[14]) ∧
              CONJ_but(seen(EVENT[10], _, ENTITY[2]) ∧ after(EVENT[10]) = ENTITY[9] ∧
                    In(EVENT[10]) = ENTITY[1],
               seen(EVENT[14], _, ENTITY[2]) ∧ after(EVENT[14]) = ENTITY[13] ∧
                to(EVENT[14]) = ENTITY[11] ∧ In(EVENT[14]) = ENTITY[1]))

# ::id 180_nonfiction_GENIA-1999;99115659,10;NE
# ::snt Thus , ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT-mediated transcriptional activation , and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .
∃ SITUATION[17] ATTRIB[11] ATTRIB[10] ATTRIB[6] ATTRIB[5] ATTRIB[4] ATTRIB[14] EVENT[16] EVENT[16] EVENT[16] GROUP[2] GROUP[3] ENTITY[9] ENTITY[1] GROUP[8] ENTITY[7] GROUP[15] ENTITY[13] ENTITY[12] (
 is_element_of(ENTITY[CBL], GROUP[8]) ∧ is_element_of(ENTITY[VAV], GROUP[8]) ∧
  is_tyrosine_phosphorylation_of(ENTITY[7], GROUP[8]) ∧
   is_element_of(ENTITY[interleukin-2], GROUP[15]) ∧ is_element_of(ENTITY[granulocyte-macrophage], GROUP[15]) ∧
    is_colony-stimulating_comp(ATTRIB[14], GROUP[15]) ∧
     is_factor_production_ATTRIBUTE(ENTITY[13], ATTRIB[14]) ∧
      is_costimulation_of(ENTITY[12], ENTITY[13]) ∧
       CONJ_either_or(is_element_of(ENTITY[CD80], GROUP[2]), is_element_of(ENTITY[CD86], GROUP[2])) ∧
        is_ligation_of(ENTITY[1], ENTITY[CD28]) ∧ is_ligation_with(ENTITY[1], GROUP[2]) ∧
         shared(ATTRIB[4]) ∧
          early(ATTRIB[5]) ∧
           is_such_as(ATTRIB[6], ENTITY[7]) ∧
            is_signal_transduction_events_ATTRIBUTE(GROUP[3], ATTRIB[6]) ∧ is_signal_transduction_events_ATTRIBUTE(GROUP[3], ATTRIB[5]) ∧ is_signal_transduction_events_ATTRIBUTE(GROUP[3], ATTRIB[4]) ∧
             nfat-mediated(ATTRIB[10]) ∧
              transcriptional(ATTRIB[11]) ∧
               is_activation_ATTRIBUTE(ENTITY[9], ATTRIB[11]) ∧ is_activation_ATTRIBUTE(ENTITY[9], ATTRIB[10]) ∧
                ADV_thus(SITUATION[17]) ∧
                 is_FACT_THAT(SITUATION[17],
                  CONJ_and(leads(EVENT[16], ENTITY[1]) ∧ to(EVENT[16]) = GROUP[3],
                   leads(EVENT[16], ENTITY[1]) ∧ to(EVENT[16]) = ENTITY[9],
                   leads(EVENT[16], ENTITY[1]) ∧ to(EVENT[16]) = ENTITY[12])))

# ::id 181_nonfiction_GENIA-1999;99115659,11;NE
# ::snt However , CD80 and CD86 also induce distinct signal transduction pathways including the tyrosine phosphorylation of CD28 and phospholipase Cgamma1 and the SH2-dependent association of phosphoinositide 3-kinase with CD28 .
∃ SITUATION[12] SITUATION[13] ATTRIB[3] ATTRIB[9] EVENT[10] EVENT[11] GROUP[5] GROUP[2] GROUP[1] GROUP[7] ENTITY[6] ENTITY[8] (
 is_element_of(ENTITY[CD28], GROUP[7]) ∧ is_element_of(ENTITY[phospholipase_Cgamma1], GROUP[7]) ∧
  is_tyrosine_phosphorylation_of(ENTITY[6], GROUP[7]) ∧
   sh2-dependent(ATTRIB[9]) ∧
    is_association_of(ENTITY[8], ENTITY[phosphoinositide_3-kinase]) ∧ is_association_with(ENTITY[8], ENTITY[CD28]) ∧ is_association_ATTRIBUTE(ENTITY[8], ATTRIB[9]) ∧
     is_element_of(ENTITY[CD80], GROUP[1]) ∧ is_element_of(ENTITY[CD86], GROUP[1]) ∧
      distinct(ATTRIB[3]) ∧
       is_element_of(ENTITY[6], GROUP[5]) ∧ is_element_of(ENTITY[8], GROUP[5]) ∧
        including(EVENT[10], GROUP[2], GROUP[5]) ∧ is_signal_transduction_pathways_ATTRIBUTE(GROUP[2], ATTRIB[3]) ∧
         ADV_however(SITUATION[13]) ∧
          ADV_also(SITUATION[12]) ∧ is_FACT_THAT(SITUATION[13], is_FACT_THAT(SITUATION[12], induce(EVENT[11], GROUP[1], GROUP[2]))))

# ::id 182_nonfiction_GENIA-1999;99115659,12;NE
# ::snt These quantitative , if not qualitative , differences between signaling initiated by these two ligands for CD28 may contribute to functional differences -LRB- e.g. Th1 or Th2 differentiation -RRB- in T cell responses .
∃ ATTRIB[3] ATTRIB[2] EVENT[7] GROUP[6] ENTITY[4] GROUP[1] (
 qualitative(ATTRIB[3]) ∧
  ¬ is_quantitative_if(ATTRIB[2], ATTRIB[3]) ∧
   (CD_two(GROUP[6]), ligands(GROUP[6])) ∧
    initiated(EVENT[7], GROUP[6], ENTITY[4]) ∧ for(EVENT[7]) = ENTITY[CD28] ∧ signaling(ENTITY[4]) ∧
     is_differences_ATTRIBUTE(GROUP[1], ATTRIB[2]) ∧ is_differences_between(GROUP[1], ENTITY[4]) ∧
      MD_may(∃ ATTRIB[9] EVENT[13] GROUP[10] ENTITY[11] GROUP[12] GROUP[8] (
            functional(ATTRIB[9]) ∧
             differentiation(ENTITY[11]) ∧
              CONJ_or(is_element_of(ENTITY[Th1], GROUP[10]), is_element_of(ENTITY[Th2], GROUP[10])) ∧
               is_-ENTITY-_namely(ENTITY[11], GROUP[10]) ∧
                is_differences_e.g.(GROUP[8], ENTITY[11]) ∧ is_differences_ATTRIBUTE(GROUP[8], ATTRIB[9]) ∧
                 T_cell_responses(GROUP[12]) ∧
                  contribute(EVENT[13], GROUP[1]) ∧ in(EVENT[13]) = GROUP[12] ∧
                   to(EVENT[13]) = GROUP[8])))

# ::id 183_nonfiction_GENIA-1999;99115672,1;NE
# ::snt Role of Egr-2 in up-regulation of Fas ligand in normal T cells and aberrant double-negative lpr and gld T cells .
∃ EVENT[11] GROUP[4] ENTITY[3] ENTITY[2] ENTITY[1] (
 Fas_ligand(ENTITY[3]) ∧
  ∃ GROUP[5] (normal_T_cells(GROUP[5]) ∧ is_subset_of_or_equal_to(GROUP[5], GROUP[4])) ∧
   ∃ GROUP[6] GROUP[10] (
    cells(GROUP[10]) ∧
     ∃ ATTRIB[9] ATTRIB[8] ENTITY[7] (
      aberrant(ATTRIB[8]) ∧
       double-negative(ATTRIB[9]) ∧
        is_lpr_ATTRIBUTE(ENTITY[7], ATTRIB[9]) ∧ is_lpr_ATTRIBUTE(ENTITY[7], ATTRIB[8]) ∧ is_element_of(ENTITY[7], GROUP[6])) ∧
      is_element_of(ENTITY[gld_T], GROUP[6]) ∧ is_-GROUP-_namely(GROUP[10], GROUP[6]) ∧ is_subset_of_or_equal_to(GROUP[10], GROUP[4])) ∧
   is_up-regulation_in(ENTITY[2], GROUP[4]) ∧ is_up-regulation_of(ENTITY[2], ENTITY[3]) ∧
    is_Role_in(ENTITY[1], ENTITY[2]) ∧ is_Role_of(ENTITY[1], ENTITY[Egr-2]) ∧
     xxx(EVENT[11]) ∧ LINK(EVENT[11]) = ENTITY[1])

# ::id 184_nonfiction_GENIA-1999;99115672,2;NE
# ::snt We previously identified a Fas ligand regulatory element -LRB- FLRE -RRB- in the Fas ligand -LRB- fasL -RRB- promoter that binds Egr family proteins and demonstrated that Egr-3 -LRB- PILOT -RRB- but not Egr-1 -LRB- NGFI-A , Krox-24 , Tis-8 , and Zif-268 -RRB- induces transcription of fasL .
∃ REF1[1] EVENT[9] EVENT[16] EVENT[11] ENTITY[2] ENTITY[3] ENTITY[15] ENTITY[14] GROUP[12] EVENT[8] GROUP[7] ENTITY[4] ENTITY[5] (
 Egr_family_proteins(GROUP[7]) ∧
  binds(EVENT[8], ENTITY[5], GROUP[7]) ∧ Fas_ligand_promoter(ENTITY[5]) ∧
   fasL(ENTITY[4]) ∧
    is_-ENTITY-_namely(ENTITY[5], ENTITY[4]) ∧
     REF1[1] = we ∧
      is_Fas_ligand_regulatory_element_in(ENTITY[3], ENTITY[5]) ∧
       FLRE(ENTITY[2]) ∧
        is_-ENTITY-_namely(ENTITY[3], ENTITY[2]) ∧
         CONJ_but(is_-ENTITY-_namely(ENTITY[Egr-3], ENTITY[PILOT]) ∧ is_element_of(ENTITY[Egr-3], GROUP[12]),
          ¬ ∃ GROUP[13] (
                is_element_of(ENTITY[NGFI-A], GROUP[13]) ∧ is_element_of(ENTITY[Krox-24], GROUP[13]) ∧
                 is_element_of(ENTITY[Tis-8], GROUP[13]) ∧ is_element_of(ENTITY[Zif-268], GROUP[13]) ∧
                 is_-ENTITY-_namely(ENTITY[Egr-1], GROUP[13]) ∧ is_element_of(ENTITY[Egr-1], GROUP[12]))) ∧
          fasL(ENTITY[15]) ∧
           is_transcription_of(ENTITY[14], ENTITY[15]) ∧
            TMP_previously(EVENT[9]) ∧
             past(EVENT[9]) ∧
              past(EVENT[11]) ∧
               CONJ_and(identified(EVENT[9], REF1[1], ENTITY[3]),
                demonstrated(EVENT[11], REF1[1], induces(EVENT[16], GROUP[12], ENTITY[14]))))

# ::id 185_nonfiction_GENIA-1999;99115672,3;NE
# ::snt The aberrant CD4 CD8 T cells from lpr/lpr and gld/gld mice , which have mutations in the genes encoding Fas and FasL , respectively , have an activated phenotype and constitutively express high levels of fasL mRNA , prompting us to ask what role if any the FLRE and Egr family proteins have in this aberrant expression of fasL .
∃ REF1[15] ATTRIB[32] ATTRIB[29] ATTRIB[25] EVENT[30] EVENT[34] EVENT[17] EVENT[16] ENTITY[28] ENTITY[33] GROUP[31] EVENT[12] EVENT[14] GROUP[3] GROUP[4] ENTITY[10] ENTITY[11] GROUP[9] GROUP[7] GROUP[6] GROUP[2] GROUP[22] GROUP[23] GROUP[21] ENTITY[26] ENTITY[24] ENTITY[20] GROUP[1] (
 lpr__slash__lpr_mice(GROUP[3]) ∧
  gld__slash__gld_mice(GROUP[4]) ∧
   is_subset_of_or_equal_to(GROUP[3], GROUP[2]) ∧ is_subset_of_or_equal_to(GROUP[4], GROUP[2]) ∧
    Fas(ENTITY[10]) ∧
     FasL(ENTITY[11]) ∧
      is_element_of(ENTITY[10], GROUP[9]) ∧ is_element_of(ENTITY[11], GROUP[9]) ∧
       encoding(EVENT[12], GROUP[7], GROUP[9]) ∧ genes(GROUP[7]) ∧
        is_mutations_in(GROUP[6], GROUP[7]) ∧
         have(EVENT[14], GROUP[1], GROUP[6]) ∧ is_aberrant_CD4_CD8_T_cells_from(GROUP[1], GROUP[2]) ∧
          FLRE_family_proteins(GROUP[22]) ∧
           Egr_family_proteins(GROUP[23]) ∧
            is_subset_of_or_equal_to(GROUP[22], GROUP[21]) ∧ is_subset_of_or_equal_to(GROUP[23], GROUP[21]) ∧
             is_equals(ENTITY[20], GROUP[21]) ∧
              aberrant(ATTRIB[25]) ∧
               fasL(ENTITY[26]) ∧
                is_expression_of(ENTITY[24], ENTITY[26]) ∧ is_expression_ATTRIBUTE(ENTITY[24], ATTRIB[25]) ∧
                 ADV_respectively(EVENT[12]) ∧
                  activated(ATTRIB[29]) ∧
                   is_phenotype_ATTRIBUTE(ENTITY[28], ATTRIB[29]) ∧
                    high(ATTRIB[32]) ∧
                     fasL_mRNA(ENTITY[33]) ∧
                      is_levels_ATTRIBUTE(GROUP[31], ATTRIB[32]) ∧ is_levels_of(GROUP[31], ENTITY[33]) ∧
                       REF1[15] = us ∧
                        ADV_constitutively(EVENT[34]) ∧
                         CONJ_and(CONJ_and(have(EVENT[30], GROUP[1], ENTITY[28]),
                               express(EVENT[34], GROUP[1], GROUP[31])),
                          prompting(EVENT[16], GROUP[1], REF1[15],
                           ask(EVENT[17], REF1[15],
                            QUEST(∃ EVENT[27] ? ENTITY[18] (
                                  ANY ENTITY[19] is_role_if(ENTITY[18], ENTITY[19]) ∧
                                   have(EVENT[27], ENTITY[20], ENTITY[18]) ∧
                                    in(EVENT[27]) = ENTITY[24]))))))

# ::id 186_nonfiction_GENIA-1999;99115672,4;NE
# ::snt Unstimulated MRL-lpr/lpr and C3H-gld/gld CD4 CD8 T cells constitutively contained high levels of two proteins that bound to the FLRE .
∃ SITUATION[10] ATTRIB[4] EVENT[8] EVENT[9] GROUP[1] GROUP[5] GROUP[3] GROUP[2] ENTITY[7] (
 FLRE(ENTITY[7]) ∧
  Unstimulated_CD4_CD8_T_cells(GROUP[2]) ∧
   is_element_of(ENTITY[MRL-lpr__slash__lpr], GROUP[1]) ∧ is_element_of(ENTITY[C3H-gld__slash__gld], GROUP[1]) ∧
    is_-GROUP-_namely(GROUP[2], GROUP[1]) ∧
     high(ATTRIB[4]) ∧
      (CD_two(GROUP[5]),
       bound(EVENT[8], GROUP[5]) ∧ to(EVENT[8]) = ENTITY[7] ∧ proteins(GROUP[5])) ∧
       is_levels_of(GROUP[3], GROUP[5]) ∧ is_levels_ATTRIBUTE(GROUP[3], ATTRIB[4]) ∧
        ADV_constitutively(SITUATION[10]) ∧
         past(EVENT[8]) ∧ past(EVENT[9]) ∧ is_FACT_THAT(SITUATION[10], contained(EVENT[9], GROUP[2], GROUP[3])))

# ::id 187_nonfiction_GENIA-1999;99115672,5;NE
# ::snt Supershift analysis revealed these proteins to be Egr-1 and Egr-2 -LRB- Krox-20 -RRB- ;
∃ EVENT[5] EVENT[3] GROUP[4] ENTITY[1] GROUP[2] (
 proteins(GROUP[2]) ∧
  Supershift_analysis(ENTITY[1]) ∧
   is_element_of(ENTITY[Egr-1], GROUP[4]) ∧ is_-ENTITY-_namely(ENTITY[Egr-2], ENTITY[Krox-20]) ∧ is_element_of(ENTITY[Egr-2], GROUP[4]) ∧
    past(EVENT[3]) ∧ revealed(EVENT[3], ENTITY[1], GROUP[2], copula(EVENT[5], GROUP[2], GROUP[4])))

# ::id 188_nonfiction_GENIA-1999;99115672,5;NE
# ::snt Egr-3 was not detected .
¬ ∃ EVENT[1] (past(EVENT[1]) ∧ detected(EVENT[1], _, ENTITY[Egr-3]))

# ::id 189_nonfiction_GENIA-1999;99115672,6;NE
# ::snt Activation of normal lymph node cells resulted in increased expression of Egr-1 , -2 , and -3 .
∃ ATTRIB[5] ATTRIB[3] EVENT[7] GROUP[2] GROUP[6] ENTITY[4] ENTITY[1] (
 normal(ATTRIB[3]) ∧
  is_lymph_node_cells_ATTRIBUTE(GROUP[2], ATTRIB[3]) ∧
   is_Activation_of(ENTITY[1], GROUP[2]) ∧
    increased(ATTRIB[5]) ∧
     is_element_of(ENTITY[Egr-1], GROUP[6]) ∧ is_element_of(ENTITY[-2], GROUP[6]) ∧ is_element_of(ENTITY[-3], GROUP[6]) ∧
      is_expression_of(ENTITY[4], GROUP[6]) ∧ is_expression_ATTRIBUTE(ENTITY[4], ATTRIB[5]) ∧
       past(EVENT[7]) ∧ resulted(EVENT[7], ENTITY[1]) ∧ in(EVENT[7]) = ENTITY[4])

# ::id 190_nonfiction_GENIA-1999;99115672,7;NE
# ::snt As with egr-3 , expression of egr-2 was blocked by cyclosporin A .
∃ EVENT[2] ENTITY[1] (
 is_expression_of(ENTITY[1], ENTITY[egr-2]) ∧
  past(EVENT[2]) ∧ blocked(EVENT[2], ENTITY[cyclosporin_A], ENTITY[1]) ∧ As_with(EVENT[2]) = ENTITY[egr-3])

# ::id 191_nonfiction_GENIA-1999;99115672,8;NE
# ::snt Although overexpressed Egr-1 was ineffective , overexpressed Egr-2 was as potent as Egr-3 in inducing fasL promoter-dependent reporter constructs in T cell hybridomas and HeLa cells ,
∃ SITUATION[5] ATTRIB[4] ATTRIB[2] SITUATION[1] EVENT[3] EVENT[10] EVENT[11] GROUP[7] GROUP[6] (
 ineffective(ATTRIB[2]) ∧
  is_FACT_THAT(SITUATION[1], copula(EVENT[3], ENTITY[overexpressed_Egr-1], ATTRIB[2])) ∧
   is_as_potent_as(ATTRIB[4], ENTITY[Egr-3]) ∧
    fasL_promoter-dependent_reporter_constructs(GROUP[6]) ∧
     ∃ GROUP[8] (T_cell_hybridomas(GROUP[8]) ∧ is_subset_of_or_equal_to(GROUP[8], GROUP[7])) ∧
      ∃ GROUP[9] (HeLa_cells(GROUP[9]) ∧ is_subset_of_or_equal_to(GROUP[9], GROUP[7])) ∧
      is_FACT_THAT(SITUATION[5], inducing(EVENT[10], ENTITY[overexpressed_Egr-2], GROUP[6]) ∧ in(EVENT[10]) = GROUP[7]) ∧
       past(EVENT[3]) ∧
        past(EVENT[11]) ∧
         copula(EVENT[11], ENTITY[overexpressed_Egr-2], ATTRIB[4]) ∧ in(EVENT[11]) = SITUATION[5] ∧
          Although(EVENT[11]) = SITUATION[1])

# ::id 192_nonfiction_GENIA-1999;99115672,8;NE
# ::snt and both up-regulated endogenous fasL mRNA in HeLa cells .
BOTH ENTITY[1] ∃ ATTRIB[3] EVENT[5] GROUP[4] ENTITY[2] (
 endogenous(ATTRIB[3]) ∧
  is_fasL_mRNA_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
   HeLa_cells(GROUP[4]) ∧
    past(EVENT[5]) ∧ up-regulated(EVENT[5], ENTITY[1], ENTITY[2]) ∧ in(EVENT[5]) = GROUP[4])

# ::id 193_nonfiction_GENIA-1999;99115672,9;NE
# ::snt FasL-dependent reporter constructs in MRL-lpr/lpr and C3H-gld/gld CD4 CD8 T cells were constitutively active ,
∃ ATTRIB[5] ATTRIB[2] EVENT[6] GROUP[3] GROUP[4] GROUP[1] (
 fasl-dependent(ATTRIB[2]) ∧
  CD4_CD8_T_cells(GROUP[4]) ∧
   is_element_of(ENTITY[MRL-lpr__slash__lpr], GROUP[3]) ∧ is_element_of(ENTITY[C3H-gld__slash__gld], GROUP[3]) ∧
    is_-GROUP-_namely(GROUP[4], GROUP[3]) ∧
     is_reporter_constructs_ATTRIBUTE(GROUP[1], ATTRIB[2]) ∧ is_reporter_constructs_in(GROUP[1], GROUP[4]) ∧
      constitutively_active(ATTRIB[5]) ∧ past(EVENT[6]) ∧ copula(EVENT[6], GROUP[1], ATTRIB[5]))

# ::id 194_nonfiction_GENIA-1999;99115672,9;NE
# ::snt and this activity was largely prevented by mutation of the critical Egr family binding element .
∃ ATTRIB[4] EVENT[5] ENTITY[2] ENTITY[3] ENTITY[1] (
 activity(ENTITY[1]) ∧
  critical(ATTRIB[4]) ∧
   is_Egr_family_binding_element_ATTRIBUTE(ENTITY[3], ATTRIB[4]) ∧
    is_mutation_of(ENTITY[2], ENTITY[3]) ∧
     ADV_largely(EVENT[5]) ∧ past(EVENT[5]) ∧ prevented(EVENT[5], ENTITY[2], ENTITY[1]))

# ::id 195_nonfiction_GENIA-1999;99115672,10;NE
# ::snt Thus , Egr-2 , in addition to Egr-3 , regulates FasL expression in activated normal T cells ,
∃ EVENT[4] GROUP[3] ENTITY[2] ENTITY[1] (
 is_addition_to(ENTITY[1], ENTITY[Egr-3]) ∧
  activated_normal_T_cells(GROUP[3]) ∧
   is_FasL_expression_in(ENTITY[2], GROUP[3]) ∧
    ADV_thus(EVENT[4]) ∧ regulates(EVENT[4], ENTITY[Egr-2], ENTITY[2]) ∧ in(EVENT[4]) = ENTITY[1])

# ::id 196_nonfiction_GENIA-1999;99115672,10;NE
# ::snt and Egr-2 is likely to play a direct role in aberrant fasL up-regulation in lpr/lpr and gld/gld CD4 CD8 T cells .
∃ ATTRIB[3] ATTRIB[1] EVENT[7] EVENT[8] GROUP[5] GROUP[6] ENTITY[4] ENTITY[2] (
 direct(ATTRIB[3]) ∧
  is_role_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
   CD4_CD8_T_cells(GROUP[6]) ∧
    is_element_of(ENTITY[lpr__slash__lpr], GROUP[5]) ∧ is_element_of(ENTITY[gld__slash__gld], GROUP[5]) ∧
     is_-GROUP-_namely(GROUP[6], GROUP[5]) ∧
      is_aberrant_fasL_up-regulation_in(ENTITY[4], GROUP[6]) ∧
       is_likely_to(ATTRIB[1], play(EVENT[7], _, ENTITY[2]) ∧ in(EVENT[7]) = ENTITY[4]) ∧
        copula(EVENT[8], ENTITY[Egr-2], ATTRIB[1]))

# ::id 197_nonfiction_GENIA-1999;99118181,1;NE
# ::snt Inhibition of NF-kappaB activation in vitro and in vivo : role of 26S proteasome .
∃ ATTRIB[6] ATTRIB[5] EVENT[7] ENTITY[4] ENTITY[2] ENTITY[1] ENTITY[3] (
 in_vitro(ATTRIB[5]) ∧
  in_vivo(ATTRIB[6]) ∧
   CONJ_and(is_NF-kappaB_activation_ATTRIBUTE(ENTITY[4], ATTRIB[5]), is_NF-kappaB_activation_ATTRIBUTE(ENTITY[4], ATTRIB[6])) ∧
    is_Inhibition_of(ENTITY[3], ENTITY[4]) ∧
     26S_proteasome(ENTITY[2]) ∧
      is_role_of(ENTITY[1], ENTITY[2]) ∧
       is_-ENTITY-_namely(ENTITY[3], ENTITY[1]) ∧ xxx(EVENT[7]) ∧ LINK(EVENT[7]) = ENTITY[3])

# ::id 198_nonfiction_GENIA-1999;99118181,2;NE
# ::snt It is becoming increasingly apparent that NF-kappaB plays a critical role in regulating the inflammatory response .
∃ ATTRIB[9] SITUATION[4] ATTRIB[3] SITUATION[1] ATTRIB[6] EVENT[7] EVENT[8] EVENT[10] ENTITY[2] ENTITY[5] (
 inflammatory(ATTRIB[6]) ∧
  is_response_ATTRIBUTE(ENTITY[5], ATTRIB[6]) ∧
   critical(ATTRIB[3]) ∧
    is_FACT_THAT(SITUATION[4], regulating(EVENT[7], _, ENTITY[5])) ∧
     is_role_in(ENTITY[2], SITUATION[4]) ∧ is_role_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
      is_FACT_THAT(SITUATION[1], plays(EVENT[8], ENTITY[NF-kappaB], ENTITY[2])) ∧
       increasingly_apparent(ATTRIB[9]) ∧ is_becoming(EVENT[10], SITUATION[1], ATTRIB[9]))

# ::id 199_nonfiction_GENIA-1999;99118181,3;NE
# ::snt Data obtained from studies in our laboratories demonstrate that the proteasome plays an important role in the inflammatory cascade by regulating the activation of NF-kappaB .
∃ SITUATION[13] ATTRIB[10] REF1[5] ATTRIB[12] EVENT[6] EVENT[15] EVENT[16] EVENT[7] GROUP[4] GROUP[3] ENTITY[9] GROUP[1] ENTITY[14] ENTITY[11] ENTITY[8] (
 proteasome(ENTITY[8]) ∧
  inflammatory(ATTRIB[12]) ∧
   is_cascade_ATTRIBUTE(ENTITY[11], ATTRIB[12]) ∧
    is_activation_of(ENTITY[14], ENTITY[NF-kappaB]) ∧
     REF1[5] = our ∧
      is_laboratories_POS(GROUP[4], REF1[5]) ∧
       is_studies_in(GROUP[3], GROUP[4]) ∧
        obtained(EVENT[6], _, GROUP[1]) ∧ from(EVENT[6]) = GROUP[3] ∧ Data(GROUP[1]) ∧
         important(ATTRIB[10]) ∧
          is_FACT_THAT(SITUATION[13], regulating(EVENT[15], _, ENTITY[14])) ∧
           is_role_by(ENTITY[9], SITUATION[13]) ∧ is_role_in(ENTITY[9], ENTITY[11]) ∧ is_role_ATTRIBUTE(ENTITY[9], ATTRIB[10]) ∧
            demonstrate(EVENT[7], GROUP[1], plays(EVENT[16], ENTITY[8], ENTITY[9])))

# ::id 200_nonfiction_GENIA-1999;99118181,4;NE
# ::snt Indeed , the availability of selective and orally active proteasome inhibitors should prove useful in delineating the roles of the proteasome and NF-kappaB in other pathophysiological conditions such as cancer and heart disease .
∃ ATTRIB[16] ATTRIB[15] ATTRIB[14] ATTRIB[7] ATTRIB[5] ENTITY[1] GROUP[4] GROUP[6] GROUP[3] ENTITY[12] ENTITY[18] ENTITY[19] GROUP[17] GROUP[13] GROUP[11] GROUP[10] ENTITY[2] (
 selective(ATTRIB[5]) ∧
  is_proteasome_inhibitors_ATTRIBUTE(GROUP[4], ATTRIB[5]) ∧
   orally_active(ATTRIB[7]) ∧
    is_proteasome_inhibitors_ATTRIBUTE(GROUP[6], ATTRIB[7]) ∧
     is_subset_of_or_equal_to(GROUP[4], GROUP[3]) ∧ is_subset_of_or_equal_to(GROUP[6], GROUP[3]) ∧
      is_availability_of(ENTITY[2], GROUP[3]) ∧
       proteasome(ENTITY[12]) ∧
        is_element_of(ENTITY[12], GROUP[11]) ∧ is_element_of(ENTITY[NF-kappaB], GROUP[11]) ∧
         other(ATTRIB[14]) ∧
          pathophysiological(ATTRIB[15]) ∧
           cancer(ENTITY[18]) ∧
            heart_disease(ENTITY[19]) ∧
             is_element_of(ENTITY[18], GROUP[17]) ∧ is_element_of(ENTITY[19], GROUP[17]) ∧
              is_such_as(ATTRIB[16], GROUP[17]) ∧
               is_conditions_ATTRIBUTE(GROUP[13], ATTRIB[16]) ∧ is_conditions_ATTRIBUTE(GROUP[13], ATTRIB[15]) ∧ is_conditions_ATTRIBUTE(GROUP[13], ATTRIB[14]) ∧
                is_roles_in(GROUP[10], GROUP[13]) ∧ is_roles_of(GROUP[10], GROUP[11]) ∧
                 deed(ENTITY[1]) ∧
                  MD_should(∃ SITUATION[9] ATTRIB[8] EVENT[20] EVENT[21] (
                        is_FACT_THAT(SITUATION[9], delineating(EVENT[20], _, GROUP[10])) ∧
                         is_useful_in(ATTRIB[8], SITUATION[9]) ∧
                          prove(EVENT[21], ENTITY[2], ATTRIB[8]) ∧ In(EVENT[21]) = ENTITY[1])))

# ::id 201_nonfiction_GENIA-1999;99119105,1;NE
# ::snt Requirement of GATA-1 and p45 NF-E2 expression in butyric acid -induced erythroid differentiation .
∃ ATTRIB[7] ATTRIB[5] EVENT[8] ENTITY[6] ENTITY[4] GROUP[2] ENTITY[3] ENTITY[1] (
 butyric_acid(ENTITY[6]) ∧
  is-induced_comp(ATTRIB[5], ENTITY[6]) ∧
   erythroid(ATTRIB[7]) ∧
    is_differentiation_ATTRIBUTE(ENTITY[4], ATTRIB[7]) ∧ is_differentiation_ATTRIBUTE(ENTITY[4], ATTRIB[5]) ∧
     is_NF-E2_expression_in(ENTITY[3], ENTITY[4]) ∧
      is_element_of(ENTITY[GATA-1], GROUP[2]) ∧ is_element_of(ENTITY[p45], GROUP[2]) ∧
       is_-ENTITY-_namely(ENTITY[3], GROUP[2]) ∧
        is_Requirement_of(ENTITY[1], ENTITY[3]) ∧ xxx(EVENT[8]) ∧ LINK(EVENT[8]) = ENTITY[1])

# ::id 202_nonfiction_GENIA-1999;99119105,2;NE
# ::snt Butyric acid -LRB- BA -RRB- is known to induce overexpression of fetal hemoglobin and then erythroid differentiation .
∃ EVENT[9] EVENT[2] GROUP[4] ENTITY[3] ENTITY[1] (
 Butyric_acid(ENTITY[1]) ∧
  is_-ENTITY-_namely(ENTITY[1], ENTITY[BA]) ∧
   CONJ_and_then(∃ ATTRIB[6] ENTITY[5] (fetal(ATTRIB[6]) ∧ is_hemoglobin_ATTRIBUTE(ENTITY[5], ATTRIB[6]) ∧ is_element_of(ENTITY[5], GROUP[4])),
    ∃ ATTRIB[8] ENTITY[7] (erythroid(ATTRIB[8]) ∧ is_differentiation_ATTRIBUTE(ENTITY[7], ATTRIB[8]) ∧ is_element_of(ENTITY[7], GROUP[4]))) ∧
    is_overexpression_of(ENTITY[3], GROUP[4]) ∧ is_known(EVENT[2], ENTITY[1], induce(EVENT[9], ENTITY[1], ENTITY[3])))

# ::id 203_nonfiction_GENIA-1999;99119105,3;NE
# ::snt Therefore , BA is currently under clinical investigation as a potential therapy for the treatment of sickle cell disease and cancer .
∃ ATTRIB[4] ATTRIB[2] ATTRIB[8] EVENT[10] ENTITY[3] ENTITY[1] ENTITY[7] ENTITY[9] GROUP[6] ENTITY[5] (
 sickle(ATTRIB[8]) ∧
  is_cell_disease_ATTRIBUTE(ENTITY[7], ATTRIB[8]) ∧
   cancer(ENTITY[9]) ∧
    is_element_of(ENTITY[7], GROUP[6]) ∧ is_element_of(ENTITY[9], GROUP[6]) ∧
     is_treatment_of(ENTITY[5], GROUP[6]) ∧
      clinical(ATTRIB[2]) ∧
       potential(ATTRIB[4]) ∧
        is_therapy_for(ENTITY[3], ENTITY[5]) ∧ is_therapy_ATTRIBUTE(ENTITY[3], ATTRIB[4]) ∧
         is_investigation_as(ENTITY[1], ENTITY[3]) ∧ is_investigation_ATTRIBUTE(ENTITY[1], ATTRIB[2]) ∧
          ADV_therefore(EVENT[10]) ∧
           TMP_currently(EVENT[10]) ∧ copula(EVENT[10], ENTITY[BA]) ∧ under(EVENT[10]) = ENTITY[1])

# ::id 204_nonfiction_GENIA-1999;99119105,4;NE
# ::snt Nevertheless , the molecular mechanisms involved in BA-induced differentiation remain largely unknown .
∃ ATTRIB[7] ATTRIB[5] ATTRIB[2] EVENT[8] EVENT[6] ENTITY[4] GROUP[1] (
 molecular(ATTRIB[2]) ∧
  ba-induced(ATTRIB[5]) ∧
   is_differentiation_ATTRIBUTE(ENTITY[4], ATTRIB[5]) ∧
    involved(EVENT[6], _, GROUP[1]) ∧ in(EVENT[6]) = ENTITY[4] ∧ is_mechanisms_ATTRIBUTE(GROUP[1], ATTRIB[2]) ∧
     largely_unknown(ATTRIB[7]) ∧ ADV_nevertheless(EVENT[8]) ∧ remain(EVENT[8], GROUP[1], ATTRIB[7]))

# ::id 205_nonfiction_GENIA-1999;99119105,5;NE
# ::snt Previous reports have shown that BA-induced overexpression of erythroid genes occurred at the transcriptional level , suggesting the involvement of erythroid transcription factors .
∃ ATTRIB[11] ATTRIB[9] ATTRIB[2] ATTRIB[5] ATTRIB[13] EVENT[14] EVENT[7] EVENT[6] GROUP[10] ENTITY[8] GROUP[1] ENTITY[12] GROUP[4] ENTITY[3] (
 transcriptional(ATTRIB[13]) ∧
  is_level_ATTRIBUTE(ENTITY[12], ATTRIB[13]) ∧
   erythroid(ATTRIB[5]) ∧
    is_transcription_factors_ATTRIBUTE(GROUP[4], ATTRIB[5]) ∧
     is_involvement_of(ENTITY[3], GROUP[4]) ∧
      previous(ATTRIB[2]) ∧
       is_reports_ATTRIBUTE(GROUP[1], ATTRIB[2]) ∧
        ba-induced(ATTRIB[9]) ∧
         erythroid(ATTRIB[11]) ∧
          is_genes_ATTRIBUTE(GROUP[10], ATTRIB[11]) ∧
           is_overexpression_of(ENTITY[8], GROUP[10]) ∧ is_overexpression_ATTRIBUTE(ENTITY[8], ATTRIB[9]) ∧
            is_before(EVENT[14], EVENT[7]) ∧
             CONJ_and(have_shown(EVENT[7], GROUP[1], occurred(EVENT[14], ENTITY[8]) ∧ at(EVENT[14]) = ENTITY[12]),
              suggesting(EVENT[6], GROUP[1], ENTITY[3])))

# ::id 206_nonfiction_GENIA-1999;99119105,6;NE
# ::snt Here , we intend to demonstrate the requirement of GATA-1 and NF-E2 transcription factors in the BA-induced erythroid differentiation of human leukemic K562 cells .
∃ SITUATION[13] REF1[1] ATTRIB[10] ATTRIB[9] EVENT[12] EVENT[2] ENTITY[5] ENTITY[6] GROUP[4] GROUP[11] ENTITY[8] GROUP[7] ENTITY[3] (
 transcription_factors(GROUP[7]) ∧
  GATA-1(ENTITY[5]) ∧
   NF-E2(ENTITY[6]) ∧
    is_element_of(ENTITY[5], GROUP[4]) ∧ is_element_of(ENTITY[6], GROUP[4]) ∧
     is_-GROUP-_namely(GROUP[7], GROUP[4]) ∧
      ba-induced(ATTRIB[9]) ∧
       erythroid(ATTRIB[10]) ∧
        human_leukemic_K562_cells(GROUP[11]) ∧
         is_differentiation_of(ENTITY[8], GROUP[11]) ∧ is_differentiation_ATTRIBUTE(ENTITY[8], ATTRIB[10]) ∧ is_differentiation_ATTRIBUTE(ENTITY[8], ATTRIB[9]) ∧
          is_requirement_in(ENTITY[3], ENTITY[8]) ∧ is_requirement_of(ENTITY[3], GROUP[7]) ∧
           REF1[1] = we ∧
            LOC_here(SITUATION[13]) ∧
             is_FACT_THAT(SITUATION[13], intend(EVENT[2], REF1[1], demonstrate(EVENT[12], REF1[1], ENTITY[3]))))

# ::id 207_nonfiction_GENIA-1999;99119105,7;NE
# ::snt Time-course experiments showed that nuclear levels of GATA-1 and p45 NF-E2 proteins increased during BA treatment .
∃ ATTRIB[5] ATTRIB[2] EVENT[9] EVENT[3] GROUP[6] GROUP[7] ENTITY[8] GROUP[4] GROUP[1] (
 time-course(ATTRIB[2]) ∧
  is_experiments_ATTRIBUTE(GROUP[1], ATTRIB[2]) ∧
   nuclear(ATTRIB[5]) ∧
    NF-E2_proteins(GROUP[7]) ∧
     is_element_of(ENTITY[GATA-1], GROUP[6]) ∧ is_element_of(ENTITY[p45], GROUP[6]) ∧
      is_-GROUP-_namely(GROUP[7], GROUP[6]) ∧
       is_levels_of(GROUP[4], GROUP[7]) ∧ is_levels_ATTRIBUTE(GROUP[4], ATTRIB[5]) ∧
        BA_treatment(ENTITY[8]) ∧
         is_before(EVENT[9], EVENT[3]) ∧
          past(EVENT[3]) ∧
           showed(EVENT[3], GROUP[1], increased(EVENT[9], GROUP[4]) ∧ during(EVENT[9]) = ENTITY[8]))

# ::id 208_nonfiction_GENIA-1999;99119105,8;NE
# ::snt Moreover , antisense oligodeoxynucleotides targeting either GATA-1 or p45 NF-E2 proteins inhibited both protein expression and BA-induced differentiation .
∃ ATTRIB[2] EVENT[6] GROUP[4] GROUP[5] GROUP[1] (
 antisense(ATTRIB[2]) ∧
  NF-E2_proteins(GROUP[5]) ∧
   CONJ_either_or(is_element_of(ENTITY[GATA-1], GROUP[4]), is_element_of(ENTITY[p45], GROUP[4])) ∧
    is_-GROUP-_namely(GROUP[5], GROUP[4]) ∧
     targeting(EVENT[6], GROUP[1], GROUP[5]) ∧ is_oligodeoxynucleotides_ATTRIBUTE(GROUP[1], ATTRIB[2]) ∧
      ADV_moreover(EVENT[6]) ∧
       BOTH GROUP[8] group[7] (
        (∃ ENTITY[9] (protein_expression(ENTITY[9]) ∧ is_element_of(ENTITY[9], GROUP[8])) ∧
           ∃ ATTRIB[11] ENTITY[10] (ba-induced(ATTRIB[11]) ∧ is_differentiation_ATTRIBUTE(ENTITY[10], ATTRIB[11]) ∧ is_element_of(ENTITY[10], GROUP[8])) ∧
         is_equals(group[7], GROUP[8])), ∃ EVENT[12] (past(EVENT[12]) ∧ inhibited(EVENT[12], GROUP[1], group[7]))))

# ::id 209_nonfiction_GENIA-1999;99119105,9;NE
# ::snt In contrast , BA-induced cell growth inhibition was not affected .
∃ ATTRIB[3] ENTITY[2] ENTITY[1] (
 contrast(ENTITY[1]) ∧
  ba-induced(ATTRIB[3]) ∧
   is_cell_growth_inhibition_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
    ¬ ∃ EVENT[4] (past(EVENT[4]) ∧ affected(EVENT[4], _, ENTITY[2]) ∧ In(EVENT[4]) = ENTITY[1]))

# ::id 210_nonfiction_GENIA-1999;99119105,10;NE
# ::snt These results provide the first direct evidence for the requirement of GATA-1 and NF-E2 in BA-induced differentiation process .
∃ ATTRIB[8] ATTRIB[4] ATTRIB[3] EVENT[9] ENTITY[7] GROUP[6] ENTITY[5] ENTITY[2] GROUP[1] (
 results(GROUP[1]) ∧
  first(ATTRIB[3]) ∧
   direct(ATTRIB[4]) ∧
    is_element_of(ENTITY[GATA-1], GROUP[6]) ∧ is_element_of(ENTITY[NF-E2], GROUP[6]) ∧
     ba-induced(ATTRIB[8]) ∧
      is_differentiation_process_ATTRIBUTE(ENTITY[7], ATTRIB[8]) ∧
       is_requirement_in(ENTITY[5], ENTITY[7]) ∧ is_requirement_of(ENTITY[5], GROUP[6]) ∧
        is_evidence_for(ENTITY[2], ENTITY[5]) ∧ is_evidence_ATTRIBUTE(ENTITY[2], ATTRIB[4]) ∧ is_evidence_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
         provide(EVENT[9], GROUP[1], ENTITY[2]))

# ::id 211_nonfiction_GENIA-1999;99120322,1;NE
# ::snt A novel growth-factor-dependent myeloid cell line derived from mouse bone marrow cells contains progenitors endowed with high proliferative potential .
∃ ATTRIB[12] ATTRIB[11] ATTRIB[9] ATTRIB[4] ATTRIB[3] ATTRIB[2] EVENT[7] EVENT[13] GROUP[6] ENTITY[10] GROUP[8] ENTITY[1] (
 novel(ATTRIB[2]) ∧
  growth-factor-dependent(ATTRIB[3]) ∧
   myeloid(ATTRIB[4]) ∧
    mouse_bone_marrow_cells(GROUP[6]) ∧
     derived(EVENT[7], _, ENTITY[1]) ∧ from(EVENT[7]) = GROUP[6] ∧
      is_cell_line_ATTRIBUTE(ENTITY[1], ATTRIB[4]) ∧ is_cell_line_ATTRIBUTE(ENTITY[1], ATTRIB[3]) ∧ is_cell_line_ATTRIBUTE(ENTITY[1], ATTRIB[2]) ∧
      high(ATTRIB[11]) ∧
       proliferative(ATTRIB[12]) ∧
        is_potential_ATTRIBUTE(ENTITY[10], ATTRIB[12]) ∧ is_potential_ATTRIBUTE(ENTITY[10], ATTRIB[11]) ∧
         is_endowed_with(ATTRIB[9], ENTITY[10]) ∧ is_progenitors_ATTRIBUTE(GROUP[8], ATTRIB[9]) ∧ contains(EVENT[13], ENTITY[1], GROUP[8]))

# ::id 212_nonfiction_GENIA-1999;99120322,2;NE
# ::snt Constitutive expression of human colony-stimulating factor-1 receptor -LRB- CSF-1R -RRB- confers long-lasting CSF-1-dependent proliferation to mouse myeloid cell lines .
∃ ATTRIB[7] ATTRIB[6] ATTRIB[2] EVENT[9] ENTITY[3] ENTITY[4] GROUP[8] ENTITY[5] ENTITY[1] (
 constitutive(ATTRIB[2]) ∧
  human_colony-stimulating_factor-1_receptor(ENTITY[4]) ∧
   CSF-1R(ENTITY[3]) ∧
    is_-ENTITY-_namely(ENTITY[4], ENTITY[3]) ∧
     is_expression_ATTRIBUTE(ENTITY[1], ATTRIB[2]) ∧ is_expression_of(ENTITY[1], ENTITY[4]) ∧
      long-lasting(ATTRIB[6]) ∧
       csf-1-dependent(ATTRIB[7]) ∧
        mouse_myeloid_cell_lines(GROUP[8]) ∧
         is_proliferation_to(ENTITY[5], GROUP[8]) ∧ is_proliferation_ATTRIBUTE(ENTITY[5], ATTRIB[7]) ∧ is_proliferation_ATTRIBUTE(ENTITY[5], ATTRIB[6]) ∧
          confers(EVENT[9], ENTITY[1], ENTITY[5]))

# ::id 213_nonfiction_GENIA-1999;99120322,3;NE
# ::snt We developed mice transgenic for human CSF-1R because mouse CSF-1 can not activate human CSF-1R .
∃ ATTRIB[5] ATTRIB[3] REF1[1] EVENT[10] ENTITY[4] ENTITY[6] GROUP[2] (
 REF1[1] = we ∧
  human(ATTRIB[5]) ∧
   is_CSF-1R_ATTRIBUTE(ENTITY[4], ATTRIB[5]) ∧
    is_transgenic_for(ATTRIB[3], ENTITY[4]) ∧
     is_mice_ATTRIBUTE(GROUP[2], ATTRIB[3]) ∧
      mouse_CSF-1(ENTITY[6]) ∧
       past(EVENT[10]) ∧
        CRD_because(MD_can(¬ ∃ ATTRIB[8] EVENT[9] ENTITY[7] (
                        human(ATTRIB[8]) ∧
                         is_CSF-1R_ATTRIBUTE(ENTITY[7], ATTRIB[8]) ∧ activate(EVENT[9], ENTITY[6], ENTITY[7]))),
         developed(EVENT[10], REF1[1], GROUP[2])))

# ::id 214_nonfiction_GENIA-1999;99120322,4;NE
# ::snt Then bone marrow cells from transgenic mice were plated onto MS-5 stromal cells expressing the membrane form of human CSF-1 -LRB- 2M-1 cells -RRB- in order to combine the hematopoietic supporting properties of stromal cells and the proliferative effects of CSF-1 .
∃ SITUATION[22] ATTRIB[3] ATTRIB[18] ATTRIB[16] ATTRIB[14] ATTRIB[9] EVENT[10] EVENT[20] EVENT[21] GROUP[2] GROUP[12] ENTITY[11] GROUP[4] GROUP[1] ENTITY[7] ENTITY[8] ENTITY[6] GROUP[15] GROUP[13] ENTITY[19] GROUP[17] (
 human(ATTRIB[9]) ∧
  is_CSF-1_ATTRIBUTE(ENTITY[8], ATTRIB[9]) ∧
   2M-1_cells(ENTITY[7]) ∧
    is_-ENTITY-_namely(ENTITY[8], ENTITY[7]) ∧
     is_membrane_form_of(ENTITY[6], ENTITY[8]) ∧
      hematopoietic(ATTRIB[14]) ∧
       stromal(ATTRIB[16]) ∧
        is_cells_ATTRIBUTE(GROUP[15], ATTRIB[16]) ∧
         is_supporting_properties_of(GROUP[13], GROUP[15]) ∧ is_supporting_properties_ATTRIBUTE(GROUP[13], ATTRIB[14]) ∧
          proliferative(ATTRIB[18]) ∧
           CSF-1(ENTITY[19]) ∧
            is_effects_ATTRIBUTE(GROUP[17], ATTRIB[18]) ∧ is_effects_of(GROUP[17], ENTITY[19]) ∧
             transgenic(ATTRIB[3]) ∧
              is_mice_ATTRIBUTE(GROUP[2], ATTRIB[3]) ∧
               is_bone_marrow_cells_from(GROUP[1], GROUP[2]) ∧
                expressing(EVENT[10], GROUP[4], ENTITY[6]) ∧ MS-5_stromal_cells(GROUP[4]) ∧
                 is_subset_of_or_equal_to(GROUP[13], GROUP[12]) ∧ is_subset_of_or_equal_to(GROUP[17], GROUP[12]) ∧
                  is_order_to(ENTITY[11], combine(EVENT[20], _, GROUP[12])) ∧
                   TMP_then(SITUATION[22]) ∧
                    past(EVENT[21]) ∧
                     is_FACT_THAT(SITUATION[22],
                      plated(EVENT[21], _, GROUP[1]) ∧ in(EVENT[21]) = ENTITY[11] ∧
                       onto(EVENT[21]) = GROUP[4]))

# ::id 215_nonfiction_GENIA-1999;99120322,5;NE
# ::snt Thus , we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions , whereas no cell line could be developed from nontransgenic mice .
∃ SITUATION[18] SITUATION[12] ATTRIB[4] ATTRIB[2] REF1[1] EVENT[6] EVENT[9] EVENT[11] EVENT[17] ENTITY[3] GROUP[8] (
 conditions(GROUP[8]) ∧
  REF1[1] = we ∧
   hematopoietic(ATTRIB[4]) ∧
    called(EVENT[6], ENTITY[3], ENTITY[47.10]) ∧
     grew(EVENT[9], ENTITY[3]) ∧ under(EVENT[9]) = GROUP[8] ∧ is_cell_line_ATTRIBUTE(ENTITY[3], ATTRIB[4]) ∧
     is_able_to(ATTRIB[2], derive(EVENT[11], _, ENTITY[3])) ∧
      is_FACT_THAT(SITUATION[12],
       ¬ ∃ ENTITY[13] (
             cell_line(ENTITY[13]) ∧
              MD_could(∃ ATTRIB[15] EVENT[16] GROUP[14] (
                    nontransgenic(ATTRIB[15]) ∧
                     is_mice_ATTRIBUTE(GROUP[14], ATTRIB[15]) ∧
                      developed(EVENT[16], _, ENTITY[13]) ∧
                       from(EVENT[16]) = GROUP[14])))) ∧
       ADV_thus(SITUATION[18]) ∧
        ADV_indefinitely(EVENT[9]) ∧
         past(EVENT[9]) ∧
          past(EVENT[17]) ∧
           is_FACT_THAT(SITUATION[18], copula(EVENT[17], REF1[1], ATTRIB[2]) ∧ whereas(EVENT[17]) = SITUATION[12]))

# ::id 216_nonfiction_GENIA-1999;99120322,6;NE
# ::snt Proliferation of 47.10 cells is severely affected by neutralizing anti-CSF-1R monoclonal antibodies .
∃ ATTRIB[6] ATTRIB[5] ATTRIB[4] EVENT[7] GROUP[2] GROUP[3] ENTITY[1] (
 47.10_cells(GROUP[2]) ∧
  is_Proliferation_of(ENTITY[1], GROUP[2]) ∧
   neutralizing(ATTRIB[4]) ∧
    anti-csf-1r(ATTRIB[5]) ∧
     monoclonal(ATTRIB[6]) ∧
      is_antibodies_ATTRIBUTE(GROUP[3], ATTRIB[6]) ∧ is_antibodies_ATTRIBUTE(GROUP[3], ATTRIB[5]) ∧ is_antibodies_ATTRIBUTE(GROUP[3], ATTRIB[4]) ∧
       ADV_severely(EVENT[7]) ∧ affected(EVENT[7], GROUP[3], ENTITY[1]))

# ::id 217_nonfiction_GENIA-1999;99120322,7;NE
# ::snt Morphologic and cytofluorometry analysis established that most 47.10 cells are immature myelomonocytic cells .
∃ ATTRIB[3] ATTRIB[2] EVENT[4] ENTITY[1] (
 morphologic(ATTRIB[2]) ∧
  cytofluorometry(ATTRIB[3]) ∧
   CONJ_and(is_analysis_ATTRIBUTE(ENTITY[1], ATTRIB[2]), is_analysis_ATTRIBUTE(ENTITY[1], ATTRIB[3])) ∧
    past(EVENT[4]) ∧
     established(EVENT[4], ENTITY[1],
      MOST GROUP[5] (47.10_cells(GROUP[5]),
       ∃ ATTRIB[8] ATTRIB[7] EVENT[9] GROUP[6] (
        immature(ATTRIB[7]) ∧
         myelomonocytic(ATTRIB[8]) ∧
          is_cells_ATTRIBUTE(GROUP[6], ATTRIB[8]) ∧ is_cells_ATTRIBUTE(GROUP[6], ATTRIB[7]) ∧
           copula(EVENT[9], GROUP[5], GROUP[6])))))

# ::id 218_nonfiction_GENIA-1999;99120322,8;NE
# ::snt Consistent with this phenotype , the myeloid transcription factor PU.1 , but not the erythroid transcription factor GATA-1 , is expressed in 47.10 cells .
∃ ATTRIB[6] ATTRIB[5] ATTRIB[3] EVENT[10] EVENT[8] GROUP[9] GROUP[1] ENTITY[2] ENTITY[4] ENTITY[7] (
 myeloid(ATTRIB[3]) ∧
  is_transcription_factor_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
   is_-ENTITY-_namely(ENTITY[2], ENTITY[PU.1]) ∧
    erythroid(ATTRIB[5]) ∧
     is_transcription_factor_ATTRIBUTE(ENTITY[4], ATTRIB[5]) ∧
      is_-ENTITY-_namely(ENTITY[4], ENTITY[GATA-1]) ∧
       phenotype(ENTITY[7]) ∧
        CONJ_but_not(is_element_of(ENTITY[2], GROUP[1]), is_element_of(ENTITY[4], GROUP[1])) ∧
         47.10_cells(GROUP[9]) ∧
          is_consistent_with(ATTRIB[6], ENTITY[7]) ∧
           CONJ_and(expressed(EVENT[10], _, GROUP[1]) ∧ in(EVENT[10]) = GROUP[9],
            xxx(EVENT[8], GROUP[1], ATTRIB[6])))

# ::id 219_nonfiction_GENIA-1999;99120322,9;NE
# ::snt A few 47.10 cells -LRB- 3-5 % -RRB- do not express lineage specific markers ;
FEW DEGREE[2] GROUP[1] (((CD_3-5(DEGREE[2]), %(DEGREE[2])) ∧ is_47.10_cells_MSR(GROUP[1], DEGREE[2])),
 ¬ ∃ ATTRIB[4] EVENT[5] GROUP[3] (lineage_specific(ATTRIB[4]) ∧ is_markers_ATTRIBUTE(GROUP[3], ATTRIB[4]) ∧ do_express(EVENT[5], GROUP[1], GROUP[3])))

# ::id 220_nonfiction_GENIA-1999;99120322,9;NE
# ::snt they differentiate spontaneously to lineage-positive cells after replating on 2M-1 cells .
∃ SITUATION[7] ATTRIB[3] REF1[1] EVENT[5] EVENT[6] GROUP[4] GROUP[2] (
 REF1[1] = they ∧
  lineage-positive(ATTRIB[3]) ∧
   is_cells_ATTRIBUTE(GROUP[2], ATTRIB[3]) ∧
    2M-1_cells(GROUP[4]) ∧
     ADV_spontaneously(SITUATION[7]) ∧
      is_FACT_THAT(SITUATION[7],
       CRD_after(replating(EVENT[5], REF1[1]) ∧ on(EVENT[5]) = GROUP[4],
        differentiate(EVENT[6], REF1[1]) ∧ to(EVENT[6]) = GROUP[2])))

# ::id 221_nonfiction_GENIA-1999;99120322,10;NE
# ::snt In agar cultures , 47.10 cells form 7- and 14 -day colonies in response to a cocktail of granulocyte/macrophage colony-stimulating factor -LRB- 2.5 ng/mL -RRB- , interleukin-3 -LRB- 1 ng/mL -RRB- , and mouse CSF-1 -LRB- 10 ng/mL -RRB- .
∃ EVENT[13] TIME[4] GROUP[7] ENTITY[6] ENTITY[5] GROUP[3] GROUP[2] GROUP[1] (
 agar_cultures(GROUP[1]) ∧
  47.10_cells(GROUP[2]) ∧
   (CD_7-and_14(TIME[4]), -day(TIME[4])) ∧
    is_colonies_TMP(GROUP[3], TIME[4]) ∧
     ∃ DEGREE[9] ENTITY[8] (
      (CD_2.5(DEGREE[9]), ng__slash__mL(DEGREE[9])) ∧
       is_granulocyte__slash__macrophage_colony-stimulating_factor_MSR(ENTITY[8], DEGREE[9]) ∧ is_element_of(ENTITY[8], GROUP[7])) ∧
      ∃ DEGREE[10] (
       (CD_1(DEGREE[10]), ng__slash__mL(DEGREE[10])) ∧
        is_MSR(ENTITY[interleukin-3], DEGREE[10]) ∧ is_element_of(ENTITY[interleukin-3], GROUP[7])) ∧
      ∃ DEGREE[12] ENTITY[11] (
       (CD_10(DEGREE[12]), ng__slash__mL(DEGREE[12])) ∧
        is_mouse_CSF-1_MSR(ENTITY[11], DEGREE[12]) ∧ is_element_of(ENTITY[11], GROUP[7])) ∧
      is_cocktail_of(ENTITY[6], GROUP[7]) ∧
       is_response_to(ENTITY[5], ENTITY[6]) ∧
        form(EVENT[13], GROUP[2], GROUP[3]) ∧ in(EVENT[13]) = ENTITY[5] ∧ In(EVENT[13]) = GROUP[1])

# ::id 222_nonfiction_GENIA-1999;99120322,11;NE
# ::snt Under these conditions , about 0.5 % of 47.10 cells formed large 14 -day colonies -LRB- > 1 mm -RRB- composed of mature monocytes and granulocytes , reflecting the presence of progenitors endowed with high proliferative potential -LRB- HPP-47.10 cells -RRB- .
∃ ATTRIB[9] ATTRIB[5] ATTRIB[19] ATTRIB[18] ATTRIB[15] EVENT[12] EVENT[21] EVENT[20] GROUP[3] GROUP[10] ENTITY[8] TIME[6] GROUP[4] ENTITY[2] ENTITY[16] ENTITY[17] GROUP[14] ENTITY[13] GROUP[1] (
 conditions(GROUP[1]) ∧
  high(ATTRIB[18]) ∧
   proliferative(ATTRIB[19]) ∧
    is_potential_ATTRIBUTE(ENTITY[17], ATTRIB[19]) ∧ is_potential_ATTRIBUTE(ENTITY[17], ATTRIB[18]) ∧
     HPP-47.10_cells(ENTITY[16]) ∧
      is_-ENTITY-_namely(ENTITY[17], ENTITY[16]) ∧
       is_endowed_with(ATTRIB[15], ENTITY[17]) ∧
        is_progenitors_ATTRIBUTE(GROUP[14], ATTRIB[15]) ∧
         is_presence_of(ENTITY[13], GROUP[14]) ∧
          47.10_cells(GROUP[3]) ∧
           (CD_about_0.5(ENTITY[2]), is%of(ENTITY[2], GROUP[3])) ∧
            large(ATTRIB[5]) ∧
             (CD_14(TIME[6]), -day(TIME[6])) ∧
              mature(ATTRIB[9]) ∧
               CONJ_and_granulocytes(∃ GROUP[11] (monocytes(GROUP[11]) ∧ is_subset_of_or_equal_to(GROUP[11], GROUP[10]))) ∧
                is_equals(ENTITY[8], GROUP[10]) ∧ is_ATTRIBUTE(ENTITY[8], ATTRIB[9]) ∧
                 composed(EVENT[12], _, GROUP[4]) ∧ of(EVENT[12]) = ENTITY[8] ∧
                  is_colonies_TMP(GROUP[4], TIME[6]) ∧ is_colonies_ATTRIBUTE(GROUP[4], ATTRIB[5]) ∧
                  past(EVENT[21]) ∧
                   CONJ_and(formed(EVENT[21], ENTITY[2], GROUP[4]) ∧ Under(EVENT[21]) = GROUP[1],
                    reflecting(EVENT[20], GROUP[4], ENTITY[13])))

# ::id 223_nonfiction_GENIA-1999;99120322,12;NE
# ::snt In conclusion , we have characterized a novel continuous myeloid cell line presenting a hierarchical structure similar to that of the bone marrow progenitor cell compartment .
∃ ATTRIB[8] ATTRIB[7] ATTRIB[4] REF1[2] EVENT[11] EVENT[12] ENTITY[6] ENTITY[3] ENTITY[1] ENTITY[10] ENTITY[9] (
 bone_marrow_progenitor_cell_compartment(ENTITY[10]) ∧
  is_of(ENTITY[9], ENTITY[10]) ∧
   conclusion(ENTITY[1]) ∧
    REF1[2] = we ∧
     novel_continuous_myeloid(ATTRIB[4]) ∧
      hierarchical(ATTRIB[7]) ∧
       is_similar_to(ATTRIB[8], ENTITY[9]) ∧
        is_structure_ATTRIBUTE(ENTITY[6], ATTRIB[8]) ∧ is_structure_ATTRIBUTE(ENTITY[6], ATTRIB[7]) ∧
         presenting(EVENT[11], ENTITY[3], ENTITY[6]) ∧ is_cell_line_ATTRIBUTE(ENTITY[3], ATTRIB[4]) ∧
          have_characterized(EVENT[12], REF1[2], ENTITY[3]) ∧ In(EVENT[12]) = ENTITY[1])

# ::id 224_nonfiction_GENIA-1999;99120900,1;NE
# ::snt Imbalanced expression of the glucocorticoid receptor isoforms in cultured lymphocytes from a patient with systemic glucocorticoid resistance and chronic lymphocytic leukemia .
∃ ATTRIB[2] ATTRIB[12] ATTRIB[11] ATTRIB[9] ATTRIB[5] EVENT[13] ENTITY[1] ENTITY[8] ENTITY[10] GROUP[7] ENTITY[6] GROUP[4] GROUP[3] (
 cultured(ATTRIB[5]) ∧
  systemic(ATTRIB[9]) ∧
   is_glucocorticoid_resistance_ATTRIBUTE(ENTITY[8], ATTRIB[9]) ∧
    chronic(ATTRIB[11]) ∧
     lymphocytic(ATTRIB[12]) ∧
      is_leukemia_ATTRIBUTE(ENTITY[10], ATTRIB[12]) ∧ is_leukemia_ATTRIBUTE(ENTITY[10], ATTRIB[11]) ∧
       is_element_of(ENTITY[8], GROUP[7]) ∧ is_element_of(ENTITY[10], GROUP[7]) ∧
        is_patient_with(ENTITY[6], GROUP[7]) ∧
         is_lymphocytes_from(GROUP[4], ENTITY[6]) ∧ is_lymphocytes_ATTRIBUTE(GROUP[4], ATTRIB[5]) ∧
          is_glucocorticoid_receptor_isoforms_in(GROUP[3], GROUP[4]) ∧
           imbalanced(ATTRIB[2]) ∧
            is_expression_of(ENTITY[1], GROUP[3]) ∧ is_expression_ATTRIBUTE(ENTITY[1], ATTRIB[2]) ∧
             xxx(EVENT[13]) ∧ LINK(EVENT[13]) = ENTITY[1])

# ::id 225_nonfiction_GENIA-1999;99120900,2;NE
# ::snt The human glucocorticoid receptor -LRB- GR -RRB- is expressed as two alternatively spliced isoforms , GRalpha and GRbeta .
∃ ATTRIB[6] ATTRIB[3] EVENT[7] GROUP[4] GROUP[5] ENTITY[1] ENTITY[2] (
 human(ATTRIB[3]) ∧
  is_glucocorticoid_receptor_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
   GR(ENTITY[1]) ∧
    is_-ENTITY-_namely(ENTITY[2], ENTITY[1]) ∧
     alternatively_spliced(ATTRIB[6]) ∧
      (CD_two(GROUP[5]), is_isoforms_ATTRIBUTE(GROUP[5], ATTRIB[6])) ∧
       is_element_of(ENTITY[GRalpha], GROUP[4]) ∧ is_element_of(ENTITY[GRbeta], GROUP[4]) ∧
        is_-GROUP-_namely(GROUP[5], GROUP[4]) ∧ expressed(EVENT[7], _, ENTITY[2]) ∧ as(EVENT[7]) = GROUP[5])

# ::id 226_nonfiction_GENIA-1999;99120900,3;NE
# ::snt Whereas GRalpha is a hormone-activated transcription factor , GRbeta does not bind glucocorticoids -LRB- GCs -RRB- , is transcriptionally inactive , and is a potential inhibitor of activated GRalpha .
∃ ATTRIB[11] ATTRIB[8] ATTRIB[3] SITUATION[1] EVENT[4] EVENT[9] EVENT[12] ENTITY[2] ENTITY[10] (
 hormone-activated(ATTRIB[3]) ∧
  is_transcription_factor_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
   is_FACT_THAT(SITUATION[1], copula(EVENT[4], ENTITY[GRalpha], ENTITY[2])) ∧
    transcriptionally_inactive(ATTRIB[8]) ∧
     potential(ATTRIB[11]) ∧
      is_inhibitor_ATTRIBUTE(ENTITY[10], ATTRIB[11]) ∧ is_inhibitor_of(ENTITY[10], ENTITY[activated_GRalpha]) ∧
       CONJ_and(¬ ∃ EVENT[7] ENTITY[5] GROUP[6] (
                  glucocorticoids(GROUP[6]) ∧
                   GCs(ENTITY[5]) ∧
                    is_-GROUP-_namely(GROUP[6], ENTITY[5]) ∧
                     does_bind(EVENT[7], ENTITY[GRbeta], GROUP[6]) ∧ Whereas(EVENT[7]) = SITUATION[1]),
        copula(EVENT[9], ENTITY[GRbeta], ATTRIB[8]) ∧ Whereas(EVENT[9]) = SITUATION[1],
        copula(EVENT[12], ENTITY[GRbeta], ENTITY[10]) ∧ Whereas(EVENT[12]) = SITUATION[1]))

# ::id 227_nonfiction_GENIA-1999;99120900,4;NE
# ::snt Differential expression of GR isoforms may play a role in generalized or tissue-specific GC resistance .
∃ ATTRIB[2] GROUP[3] ENTITY[1] (
 differential(ATTRIB[2]) ∧
  GR_isoforms(GROUP[3]) ∧
   is_expression_ATTRIBUTE(ENTITY[1], ATTRIB[2]) ∧ is_expression_of(ENTITY[1], GROUP[3]) ∧
    MD_may(∃ EVENT[10] GROUP[5] ENTITY[4] (
          CONJ_or(∃ ATTRIB[7] ENTITY[6] (generalized(ATTRIB[7]) ∧ is_GC_resistance_ATTRIBUTE(ENTITY[6], ATTRIB[7]) ∧ is_element_of(ENTITY[6], GROUP[5])),
           ∃ ATTRIB[9] ENTITY[8] (tissue-specific(ATTRIB[9]) ∧ is_GC_resistance_ATTRIBUTE(ENTITY[8], ATTRIB[9]) ∧ is_element_of(ENTITY[8], GROUP[5]))) ∧
           is_role_in(ENTITY[4], GROUP[5]) ∧ play(EVENT[10], ENTITY[1], ENTITY[4]))))

# ::id 228_nonfiction_GENIA-1999;99120900,5;NE
# ::snt GCs induce apoptosis in neoplastic lymphoid cells ;
∃ ATTRIB[5] ATTRIB[4] EVENT[6] GROUP[3] ENTITY[2] GROUP[1] (
 GCs(GROUP[1]) ∧
  neoplastic(ATTRIB[4]) ∧
   lymphoid(ATTRIB[5]) ∧
    is_cells_ATTRIBUTE(GROUP[3], ATTRIB[5]) ∧ is_cells_ATTRIBUTE(GROUP[3], ATTRIB[4]) ∧
     is_apoptosis_in(ENTITY[2], GROUP[3]) ∧ induce(EVENT[6], GROUP[1], ENTITY[2]))

# ::id 229_nonfiction_GENIA-1999;99120900,5;NE
# ::snt and , defective apoptosis is implicated in the genesis of chronic lymphocytic leukemia -LRB- CLL -RRB- .
∃ ATTRIB[2] ATTRIB[6] ATTRIB[5] EVENT[7] ENTITY[1] ENTITY[4] ENTITY[3] (
 chronic(ATTRIB[5]) ∧
  lymphocytic(ATTRIB[6]) ∧
   is_leukemia_ATTRIBUTE(ENTITY[4], ATTRIB[6]) ∧ is_leukemia_ATTRIBUTE(ENTITY[4], ATTRIB[5]) ∧
    is_-ENTITY-_namely(ENTITY[4], ENTITY[CLL]) ∧
     is_genesis_of(ENTITY[3], ENTITY[4]) ∧
      defective(ATTRIB[2]) ∧
       is_apoptosis_ATTRIBUTE(ENTITY[1], ATTRIB[2]) ∧ implicated(EVENT[7], _, ENTITY[1]) ∧ in(EVENT[7]) = ENTITY[3])

# ::id 230_nonfiction_GENIA-1999;99120900,6;NE
# ::snt We studied a patient with generalized GC resistance and CLL .
∃ REF1[1] EVENT[6] GROUP[3] ENTITY[2] (
 REF1[1] = we ∧
  ∃ ATTRIB[5] ENTITY[4] (generalized(ATTRIB[5]) ∧ is_GC_resistance_ATTRIBUTE(ENTITY[4], ATTRIB[5]) ∧ is_element_of(ENTITY[4], GROUP[3])) ∧
   is_element_of(ENTITY[CLL], GROUP[3]) ∧
   is_patient_with(ENTITY[2], GROUP[3]) ∧ past(EVENT[6]) ∧ studied(EVENT[6], REF1[1], ENTITY[2]))

# ::id 231_nonfiction_GENIA-1999;99120900,7;NE
# ::snt GR number in the patient 's transformed lymphocytes was approximately one half that of control cells with a approximately 10-fold reduction in binding affinity for dexamethasone .
∃ ATTRIB[9] ATTRIB[4] ATTRIB[7] EVENT[11] GROUP[2] ENTITY[10] ENTITY[8] ENTITY[1] ENTITY[3] GROUP[6] ENTITY[5] (
 patient(ENTITY[3]) ∧
  control(ATTRIB[7]) ∧
   is_cells_ATTRIBUTE(GROUP[6], ATTRIB[7]) ∧
    (CD_approximately_one_half(ENTITY[5]), is_element_of(ENTITY[5], GROUP[6])) ∧
     transformed(ATTRIB[4]) ∧
      is_lymphocytes_ATTRIBUTE(GROUP[2], ATTRIB[4]) ∧ is_lymphocytes_POS(GROUP[2], ENTITY[3]) ∧
       is_GR_number_in(ENTITY[1], GROUP[2]) ∧
        approximately_10-fold(ATTRIB[9]) ∧
         is_binding_affinity_for(ENTITY[10], ENTITY[dexamethasone]) ∧
          is_reduction_in(ENTITY[8], ENTITY[10]) ∧ is_reduction_ATTRIBUTE(ENTITY[8], ATTRIB[9]) ∧
           past(EVENT[11]) ∧ copula(EVENT[11], ENTITY[1], ENTITY[5]) ∧ with(EVENT[11]) = ENTITY[8])

# ::id 232_nonfiction_GENIA-1999;99120900,8;NE
# ::snt In vitro apoptosis induction in CLL cells was delayed in response to GCs , but not to other apoptosis inducers .
∃ ATTRIB[8] ATTRIB[2] EVENT[9] GROUP[3] GROUP[5] ENTITY[4] GROUP[7] ENTITY[1] (
 in_vitro(ATTRIB[2]) ∧
  CLL_cells(GROUP[3]) ∧
   is_apoptosis_induction_in(ENTITY[1], GROUP[3]) ∧ is_apoptosis_induction_ATTRIBUTE(ENTITY[1], ATTRIB[2]) ∧
    GCs(GROUP[5]) ∧
     is_response_to(ENTITY[4], GROUP[5]) ∧
      other(ATTRIB[8]) ∧
       is_apoptosis_inducers_ATTRIBUTE(GROUP[7], ATTRIB[8]) ∧
        past(EVENT[9]) ∧
         CONJ_but(delayed(EVENT[9], _, ENTITY[1]) ∧ in(EVENT[9]) = ENTITY[4],
          NOT ENTITY[6] (is_element_of(ENTITY[6], GROUP[7]),
           ∃ EVENT[9] (
            past(EVENT[9]) ∧
             delayed(EVENT[9], _, ENTITY[1]) ∧ to(EVENT[9]) = ENTITY[6]))))

# ::id 233_nonfiction_GENIA-1999;99120900,9;NE
# ::snt Sequencing of the GR cDNA and gene including the 2.3-kb coding region , the intron/exon junctions , the known 5'-regulatory region , and approximately 300 bp of the 3'-region revealed no alterations .
∃ ATTRIB[13] ATTRIB[12] ATTRIB[9] EVENT[16] GROUP[7] GROUP[3] ENTITY[2] ENTITY[1] ENTITY[4] ENTITY[8] GROUP[10] ENTITY[11] ENTITY[15] (
 GR_cDNA(ENTITY[4]) ∧
  2.3-kb(ATTRIB[9]) ∧
   is_coding_region_ATTRIBUTE(ENTITY[8], ATTRIB[9]) ∧
    intron__slash__exon_junctions(GROUP[10]) ∧
     known(ATTRIB[12]) ∧
      5'dash__regulatory(ATTRIB[13]) ∧
       is_region_ATTRIBUTE(ENTITY[11], ATTRIB[13]) ∧ is_region_ATTRIBUTE(ENTITY[11], ATTRIB[12]) ∧
        3'dash__region(ENTITY[15]) ∧
         is_element_of(ENTITY[4], GROUP[3]) ∧ ∃ ENTITY[5] (gene(ENTITY[5]) ∧ is_element_of(ENTITY[5], GROUP[3])) ∧
          is_element_of(ENTITY[8], GROUP[7]) ∧ is_subset_of_or_equal_to(GROUP[10], GROUP[7]) ∧ is_element_of(ENTITY[11], GROUP[7]) ∧
           ∃ ENTITY[14] ((CD_approximately_300(ENTITY[14]), is_bp_of(ENTITY[14], ENTITY[15])) ∧ is_element_of(ENTITY[14], GROUP[7])) ∧
           including(EVENT[16], ENTITY[2], GROUP[7]) ∧ is_equals(ENTITY[2], GROUP[3]) ∧
            is_Sequencing_of(ENTITY[1], ENTITY[2]) ∧
             ¬ ∃ EVENT[18] GROUP[17] (alterations(GROUP[17]) ∧ past(EVENT[18]) ∧ revealed(EVENT[18], ENTITY[1], GROUP[17])))

# ::id 234_nonfiction_GENIA-1999;99120900,10;NE
# ::snt Western blot with an N-terminal antibody showed normal levels of immunoreactive GR ,
∃ ATTRIB[7] ATTRIB[5] ATTRIB[3] EVENT[8] ENTITY[2] ENTITY[6] GROUP[4] ENTITY[1] (
 n-terminal(ATTRIB[3]) ∧
  is_antibody_ATTRIBUTE(ENTITY[2], ATTRIB[3]) ∧
   is_Western_blot_with(ENTITY[1], ENTITY[2]) ∧
    normal(ATTRIB[5]) ∧
     immunoreactive(ATTRIB[7]) ∧
      is_GR_ATTRIBUTE(ENTITY[6], ATTRIB[7]) ∧
       is_levels_of(GROUP[4], ENTITY[6]) ∧ is_levels_ATTRIBUTE(GROUP[4], ATTRIB[5]) ∧
        past(EVENT[8]) ∧ showed(EVENT[8], ENTITY[1], GROUP[4]))

# ::id 235_nonfiction_GENIA-1999;99120900,10;NE
# ::snt but quantitative analysis with isoform-specific C-terminal antibodies revealed a markedly reduced GRalpha expression , and high GRbeta expression .
∃ ATTRIB[5] ATTRIB[4] ATTRIB[2] EVENT[10] GROUP[3] GROUP[6] ENTITY[1] (
 quantitative(ATTRIB[2]) ∧
  isoform-specific(ATTRIB[4]) ∧
   c-terminal(ATTRIB[5]) ∧
    is_antibodies_ATTRIBUTE(GROUP[3], ATTRIB[5]) ∧ is_antibodies_ATTRIBUTE(GROUP[3], ATTRIB[4]) ∧
     is_analysis_with(ENTITY[1], GROUP[3]) ∧ is_analysis_ATTRIBUTE(ENTITY[1], ATTRIB[2]) ∧
      ∃ ATTRIB[8] ENTITY[7] (markedly_reduced(ATTRIB[8]) ∧ is_GRalpha_expression_ATTRIBUTE(ENTITY[7], ATTRIB[8]) ∧ is_element_of(ENTITY[7], GROUP[6])) ∧
       ∃ ENTITY[9] (high_GRbeta_expression(ENTITY[9]) ∧ is_element_of(ENTITY[9], GROUP[6])) ∧
       past(EVENT[10]) ∧ revealed(EVENT[10], ENTITY[1], GROUP[6]))

# ::id 236_nonfiction_GENIA-1999;99120900,11;NE
# ::snt These findings indicate that imbalanced expression of the GR isoforms may be a mechanism of GC resistance , and may have implications for tumorigenesis by enhancing cell survival .
∃ ATTRIB[4] EVENT[2] ENTITY[3] GROUP[5] GROUP[1] (
 findings(GROUP[1]) ∧
  GR_isoforms(GROUP[5]) ∧
   imbalanced(ATTRIB[4]) ∧
    is_expression_of(ENTITY[3], GROUP[5]) ∧ is_expression_ATTRIBUTE(ENTITY[3], ATTRIB[4]) ∧
     indicate(EVENT[2], GROUP[1],
      CONJ_and(MD_may(∃ EVENT[8] ENTITY[7] ENTITY[6] (
                 GC_resistance(ENTITY[7]) ∧
                  is_mechanism_of(ENTITY[6], ENTITY[7]) ∧ copula(EVENT[8], ENTITY[3], ENTITY[6]))),
       MD_may(∃ EVENT[12] EVENT[13] ENTITY[10] ENTITY[11] GROUP[9] (
             tumorigenesis(ENTITY[10]) ∧
              is_implications_for(GROUP[9], ENTITY[10]) ∧
               cell_survival(ENTITY[11]) ∧
                CRD_by(enhancing(EVENT[12], GROUP[9], ENTITY[11]), have(EVENT[13], ENTITY[3], GROUP[9])))))))

# ::id 237_nonfiction_GENIA-1999;99120900,12;NE
# ::snt Copyright 1999 Academic Press .
∃ EVENT[1] (xxx(EVENT[1]) ∧ LINK(EVENT[1]) = ENTITY[Copyright_1999] ∧ LINK(EVENT[1]) = ENTITY[Academic_Press])
